12-312022Q30001841925Falsehttp://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent00018419252022-01-012022-09-300001841925us-gaap:CommonStockMember2022-01-012022-09-300001841925indi:WarrantsMember2022-01-012022-09-300001841925us-gaap:CommonClassAMember2022-11-08xbrli:shares0001841925indi:CommonClassVMember2022-11-0800018419252022-09-30iso4217:USD00018419252021-12-31iso4217:USDxbrli:shares0001841925us-gaap:CommonClassAMember2021-12-310001841925us-gaap:CommonClassAMember2022-09-300001841925indi:CommonClassVMember2022-09-300001841925indi:CommonClassVMember2021-12-310001841925us-gaap:ProductMember2022-07-012022-09-300001841925us-gaap:ProductMember2021-07-012021-09-300001841925us-gaap:ProductMember2022-01-012022-09-300001841925us-gaap:ProductMember2021-01-012021-09-300001841925us-gaap:ServiceMember2022-07-012022-09-300001841925us-gaap:ServiceMember2021-07-012021-09-300001841925us-gaap:ServiceMember2022-01-012022-09-300001841925us-gaap:ServiceMember2021-01-012021-09-3000018419252022-07-012022-09-3000018419252021-07-012021-09-3000018419252021-01-012021-09-300001841925srt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-310001841925indi:CommonClassVMembersrt:ScenarioPreviouslyReportedMemberus-gaap:CommonStockMember2020-12-310001841925srt:ScenarioPreviouslyReportedMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001841925us-gaap:RetainedEarningsMembersrt:ScenarioPreviouslyReportedMember2020-12-310001841925srt:ScenarioPreviouslyReportedMemberus-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001841925us-gaap:ParentMembersrt:ScenarioPreviouslyReportedMember2020-12-310001841925srt:ScenarioPreviouslyReportedMemberus-gaap:NoncontrollingInterestMember2020-12-310001841925srt:ScenarioPreviouslyReportedMember2020-12-310001841925srt:RestatementAdjustmentMemberus-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-310001841925indi:CommonClassVMembersrt:RestatementAdjustmentMemberus-gaap:CommonStockMember2020-12-310001841925srt:RestatementAdjustmentMemberus-gaap:AdditionalPaidInCapitalMember2020-12-310001841925srt:RestatementAdjustmentMember2020-12-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2020-12-310001841925indi:CommonClassVMemberus-gaap:CommonStockMember2020-12-310001841925us-gaap:AdditionalPaidInCapitalMember2020-12-310001841925us-gaap:RetainedEarningsMember2020-12-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001841925us-gaap:ParentMember2020-12-310001841925us-gaap:NoncontrollingInterestMember2020-12-3100018419252020-12-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-01-012021-03-310001841925us-gaap:RetainedEarningsMember2021-01-012021-03-310001841925us-gaap:ParentMember2021-01-012021-03-310001841925us-gaap:NoncontrollingInterestMember2021-01-012021-03-3100018419252021-01-012021-03-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-03-310001841925indi:CommonClassVMemberus-gaap:CommonStockMember2021-03-310001841925us-gaap:AdditionalPaidInCapitalMember2021-03-310001841925us-gaap:RetainedEarningsMember2021-03-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001841925us-gaap:ParentMember2021-03-310001841925us-gaap:NoncontrollingInterestMember2021-03-3100018419252021-03-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-04-012021-06-300001841925us-gaap:AdditionalPaidInCapitalMember2021-04-012021-06-300001841925us-gaap:ParentMember2021-04-012021-06-3000018419252021-04-012021-06-300001841925us-gaap:RetainedEarningsMember2021-04-012021-06-100001841925us-gaap:ParentMember2021-04-012021-06-100001841925us-gaap:NoncontrollingInterestMember2021-04-012021-06-1000018419252021-04-012021-06-100001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-06-102021-06-100001841925indi:CommonClassVMemberus-gaap:CommonStockMember2021-06-102021-06-100001841925us-gaap:AdditionalPaidInCapitalMember2021-06-102021-06-100001841925us-gaap:ParentMember2021-06-102021-06-1000018419252021-06-102021-06-100001841925us-gaap:RetainedEarningsMember2021-06-102021-06-100001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-102021-06-100001841925us-gaap:NoncontrollingInterestMember2021-06-102021-06-100001841925us-gaap:RetainedEarningsMember2021-06-112021-06-300001841925us-gaap:ParentMember2021-06-112021-06-300001841925us-gaap:NoncontrollingInterestMember2021-06-112021-06-3000018419252021-06-112021-06-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-012021-06-300001841925us-gaap:NoncontrollingInterestMember2021-04-012021-06-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-06-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2021-06-300001841925us-gaap:AdditionalPaidInCapitalMember2021-06-300001841925us-gaap:RetainedEarningsMember2021-06-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-300001841925us-gaap:ParentMember2021-06-300001841925us-gaap:NoncontrollingInterestMember2021-06-3000018419252021-06-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-07-012021-09-300001841925us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001841925us-gaap:ParentMember2021-07-012021-09-300001841925us-gaap:RetainedEarningsMember2021-07-012021-09-300001841925us-gaap:NoncontrollingInterestMember2021-07-012021-09-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-09-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2021-09-300001841925us-gaap:AdditionalPaidInCapitalMember2021-09-300001841925us-gaap:RetainedEarningsMember2021-09-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001841925us-gaap:ParentMember2021-09-300001841925us-gaap:NoncontrollingInterestMember2021-09-3000018419252021-09-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001841925indi:CommonClassVMemberus-gaap:CommonStockMember2021-12-310001841925us-gaap:AdditionalPaidInCapitalMember2021-12-310001841925us-gaap:RetainedEarningsMember2021-12-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001841925us-gaap:ParentMember2021-12-310001841925us-gaap:NoncontrollingInterestMember2021-12-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-03-310001841925us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001841925us-gaap:ParentMember2022-01-012022-03-310001841925us-gaap:NoncontrollingInterestMember2022-01-012022-03-3100018419252022-01-012022-03-310001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-01-012022-03-310001841925us-gaap:RetainedEarningsMember2022-01-012022-03-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-03-310001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-03-310001841925us-gaap:AdditionalPaidInCapitalMember2022-03-310001841925us-gaap:RetainedEarningsMember2022-03-310001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001841925us-gaap:ParentMember2022-03-310001841925us-gaap:NoncontrollingInterestMember2022-03-3100018419252022-03-310001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-04-012022-06-300001841925us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-300001841925us-gaap:ParentMember2022-04-012022-06-300001841925us-gaap:NoncontrollingInterestMember2022-04-012022-06-3000018419252022-04-012022-06-300001841925us-gaap:CommonStockMember2022-04-012022-06-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-04-012022-06-300001841925us-gaap:RetainedEarningsMember2022-04-012022-06-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-04-012022-06-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-06-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-06-300001841925us-gaap:AdditionalPaidInCapitalMember2022-06-300001841925us-gaap:RetainedEarningsMember2022-06-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-300001841925us-gaap:ParentMember2022-06-300001841925us-gaap:NoncontrollingInterestMember2022-06-3000018419252022-06-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-07-012022-09-300001841925us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001841925us-gaap:ParentMember2022-07-012022-09-300001841925us-gaap:NoncontrollingInterestMember2022-07-012022-09-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-07-012022-09-300001841925us-gaap:RetainedEarningsMember2022-07-012022-09-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001841925us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-09-300001841925indi:CommonClassVMemberus-gaap:CommonStockMember2022-09-300001841925us-gaap:AdditionalPaidInCapitalMember2022-09-300001841925us-gaap:RetainedEarningsMember2022-09-300001841925us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001841925us-gaap:ParentMember2022-09-300001841925us-gaap:NoncontrollingInterestMember2022-09-3000018419252022-08-260001841925indi:AtTheMarketOfferingMember2022-08-262022-08-260001841925us-gaap:CommonClassAMember2022-01-012022-09-300001841925indi:AtTheMarketOfferingMember2022-01-012022-09-300001841925indi:AtTheMarketOfferingMember2022-07-012022-09-300001841925indi:SymeoGmbHMember2022-01-042022-01-040001841925indi:SymeoPromissoryNoteMemberindi:SymeoGmbHMemberus-gaap:LoansPayableMember2022-01-040001841925indi:CashConsiderationAccuralMemberindi:SymeoGmbHMember2022-01-012022-01-310001841925indi:SymeoGmbHMember2022-01-012022-01-310001841925us-gaap:CommonClassAMember2021-06-100001841925indi:AyDeeKayLLCMember2022-09-30xbrli:pure0001841925indi:IndieSemiconductorMemberindi:AyDeeKayLLCMember2022-09-300001841925indi:WuxiIndieMicroelectronicsLtdMemberindi:AyDeeKayLLCMember2022-09-3000018419252022-01-010001841925indi:InitialCashConsidationMemberindi:SymeoGmbHMember2022-01-012022-01-310001841925indi:InitialCashConsidationMemberindi:TeraXionIncMember2021-10-012021-10-310001841925indi:InitialCashConsidationMemberindi:ONDesignIsraelLtdMember2021-10-012021-10-310001841925indi:CashConsiderationAccuralMemberindi:TeraXionIncMember2021-10-012021-10-310001841925indi:CashConsiderationAccuralMemberindi:ONDesignIsraelLtdMember2021-10-012021-10-310001841925indi:SymeoGmbHMemberindi:CashConsiderationDebtRepaidMember2022-01-012022-01-310001841925indi:TeraXionIncMemberindi:CashConsiderationDebtRepaidMember2021-10-012021-10-310001841925indi:ONDesignIsraelLtdMemberindi:CashConsiderationDebtRepaidMember2021-10-012021-10-310001841925indi:TeraXionIncMember2021-10-012021-10-310001841925indi:ONDesignIsraelLtdMember2021-10-012021-10-310001841925indi:SymeoGmbHMemberindi:PurchasePriceEquityConsiderationMember2022-01-012022-01-310001841925indi:PurchasePriceEquityConsiderationMemberindi:TeraXionIncMember2021-10-012021-10-310001841925indi:ONDesignIsraelLtdMemberindi:PurchasePriceEquityConsiderationMember2021-10-012021-10-310001841925us-gaap:CommonStockMemberindi:SymeoGmbHMember2022-01-012022-01-310001841925us-gaap:CommonStockMemberindi:TeraXionIncMember2021-10-012021-10-310001841925us-gaap:CommonStockMemberindi:ONDesignIsraelLtdMember2021-10-012021-10-310001841925indi:SymeoGmbHMemberus-gaap:EmployeeStockOptionMember2022-01-012022-01-310001841925us-gaap:EmployeeStockOptionMemberindi:TeraXionIncMember2021-10-012021-10-310001841925indi:ONDesignIsraelLtdMemberus-gaap:EmployeeStockOptionMember2021-10-012021-10-310001841925indi:SymeoGmbHMember2022-09-300001841925indi:TeraXionIncMember2022-09-300001841925indi:ONDesignIsraelLtdMember2022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:SymeoGmbHMember2022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:ONDesignIsraelLtdMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMemberindi:SymeoGmbHMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMemberindi:ONDesignIsraelLtdMember2022-09-300001841925indi:SymeoGmbHMemberus-gaap:CustomerRelationshipsMember2022-09-300001841925us-gaap:CustomerRelationshipsMemberindi:TeraXionIncMember2022-09-300001841925indi:ONDesignIsraelLtdMemberus-gaap:CustomerRelationshipsMember2022-09-300001841925us-gaap:OrderOrProductionBacklogMemberindi:SymeoGmbHMember2022-09-300001841925us-gaap:OrderOrProductionBacklogMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:OrderOrProductionBacklogMemberindi:ONDesignIsraelLtdMember2022-09-300001841925us-gaap:TradeNamesMemberindi:SymeoGmbHMember2022-09-300001841925us-gaap:TradeNamesMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:TradeNamesMemberindi:ONDesignIsraelLtdMember2022-09-300001841925indi:TeraXionIncMember2021-08-272021-08-27iso4217:CAD0001841925indi:TeraXionIncMember2021-08-270001841925indi:TeraXionIncMemberus-gaap:CommonClassAMember2021-08-272021-08-270001841925indi:TeraXionIncMemberus-gaap:CommonClassAMember2021-08-270001841925indi:TeraXionIncMember2021-10-122021-10-120001841925indi:TeraXionIncMember2022-06-300001841925srt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:TeraXionIncMember2022-06-300001841925us-gaap:TechnologyBasedIntangibleAssetsMembersrt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMemberindi:TeraXionIncMember2022-06-300001841925srt:RestatementAdjustmentMemberus-gaap:InProcessResearchAndDevelopmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:CustomerRelationshipsMemberindi:TeraXionIncMember2022-06-300001841925srt:RestatementAdjustmentMemberus-gaap:CustomerRelationshipsMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:OrderOrProductionBacklogMemberindi:TeraXionIncMember2022-06-300001841925us-gaap:OrderOrProductionBacklogMembersrt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-09-300001841925us-gaap:TradeNamesMemberindi:TeraXionIncMember2022-06-300001841925us-gaap:TradeNamesMembersrt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-09-300001841925srt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-07-012022-09-300001841925srt:RestatementAdjustmentMemberindi:TeraXionIncMember2022-01-012022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:TeraXionIncMember2022-01-012022-09-300001841925us-gaap:CustomerRelationshipsMemberindi:TeraXionIncMember2022-01-012022-09-300001841925us-gaap:OrderOrProductionBacklogMemberindi:TeraXionIncMember2022-01-012022-09-300001841925us-gaap:TradeNamesMemberindi:TeraXionIncMember2022-01-012022-09-300001841925indi:TeraXionIncMember2022-01-012022-09-300001841925indi:TeraXionIncMember2021-01-012021-09-300001841925indi:TeraXionIncMember2021-07-012021-09-300001841925indi:ONDesignIsraelLtdMember2021-10-012021-10-010001841925srt:ScenarioForecastMemberindi:ONDesignIsraelLtdMember2022-01-012022-12-310001841925indi:ONDesignIsraelLtdMember2021-10-012022-09-300001841925indi:ONDesignIsraelLtdMemberus-gaap:SubsequentEventMember2022-10-310001841925indi:ONDesignIsraelLtdMember2021-10-010001841925indi:ONDesignIsraelLtdMemberus-gaap:InProcessResearchAndDevelopmentMember2022-06-300001841925srt:RestatementAdjustmentMemberindi:ONDesignIsraelLtdMemberus-gaap:InProcessResearchAndDevelopmentMember2022-09-300001841925indi:ONDesignIsraelLtdMemberus-gaap:InProcessResearchAndDevelopmentMember2022-09-300001841925us-gaap:TechnologyBasedIntangibleAssetsMemberindi:ONDesignIsraelLtdMember2022-06-300001841925us-gaap:TechnologyBasedIntangibleAssetsMembersrt:RestatementAdjustmentMemberindi:ONDesignIsraelLtdMember2022-09-300001841925indi:ONDesignIsraelLtdMember2022-06-300001841925srt:RestatementAdjustmentMemberindi:ONDesignIsraelLtdMember2022-09-300001841925srt:RestatementAdjustmentMemberindi:ONDesignIsraelLtdMember2022-07-012022-09-300001841925srt:RestatementAdjustmentMemberindi:ONDesignIsraelLtdMember2022-01-012022-09-300001841925indi:ONDesignIsraelLtdMember2022-01-012022-09-300001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-10-010001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-10-012021-10-010001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-10-010001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-10-012021-10-010001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2022-06-300001841925indi:SymeoGmbHMemberindi:ContingentConsiderationTrancheOneMember2022-01-040001841925indi:SymeoGmbHMemberindi:ContingentConsiderationTrancheTwoMember2022-01-040001841925indi:SymeoGmbHMember2022-01-012022-09-300001841925indi:SymeoGmbHMemberindi:ContingentConsiderationTrancheOneMember2022-09-300001841925indi:SymeoGmbHMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925indi:ProductionToolingMember2022-01-012022-09-300001841925indi:ProductionToolingMember2022-09-300001841925indi:ProductionToolingMember2021-12-310001841925indi:LaboratoryEquipmentMember2022-01-012022-09-300001841925indi:LaboratoryEquipmentMember2022-09-300001841925indi:LaboratoryEquipmentMember2021-12-310001841925srt:MinimumMemberus-gaap:OfficeEquipmentMember2022-01-012022-09-300001841925srt:MaximumMemberus-gaap:OfficeEquipmentMember2022-01-012022-09-300001841925us-gaap:OfficeEquipmentMember2022-09-300001841925us-gaap:OfficeEquipmentMember2021-12-310001841925us-gaap:LeaseholdImprovementsMember2022-09-300001841925us-gaap:LeaseholdImprovementsMember2021-12-310001841925us-gaap:ConstructionInProgressMember2022-09-300001841925us-gaap:ConstructionInProgressMember2021-12-310001841925us-gaap:DevelopedTechnologyRightsMember2022-01-012022-09-300001841925us-gaap:DevelopedTechnologyRightsMember2022-09-300001841925us-gaap:DevelopedTechnologyRightsMember2021-01-012021-12-310001841925us-gaap:DevelopedTechnologyRightsMember2021-12-310001841925us-gaap:ComputerSoftwareIntangibleAssetMember2022-01-012022-09-300001841925us-gaap:ComputerSoftwareIntangibleAssetMember2022-09-300001841925us-gaap:ComputerSoftwareIntangibleAssetMember2021-01-012021-12-310001841925us-gaap:ComputerSoftwareIntangibleAssetMember2021-12-310001841925us-gaap:CustomerRelationshipsMember2022-01-012022-09-300001841925us-gaap:CustomerRelationshipsMember2022-09-300001841925us-gaap:CustomerRelationshipsMember2021-01-012021-12-310001841925us-gaap:CustomerRelationshipsMember2021-12-310001841925indi:IntellectualPropertyLicensesMember2022-01-012022-09-300001841925indi:IntellectualPropertyLicensesMember2022-09-300001841925indi:IntellectualPropertyLicensesMember2021-01-012021-12-310001841925indi:IntellectualPropertyLicensesMember2021-12-310001841925us-gaap:TradeNamesMember2022-01-012022-09-300001841925us-gaap:TradeNamesMember2022-09-300001841925us-gaap:TradeNamesMember2021-01-012021-12-310001841925us-gaap:TradeNamesMember2021-12-310001841925us-gaap:OrderOrProductionBacklogMember2022-01-012022-09-300001841925us-gaap:OrderOrProductionBacklogMember2022-09-300001841925us-gaap:OrderOrProductionBacklogMember2021-01-012021-12-310001841925us-gaap:OrderOrProductionBacklogMember2021-12-310001841925us-gaap:InProcessResearchAndDevelopmentMember2022-09-300001841925us-gaap:InProcessResearchAndDevelopmentMember2021-12-310001841925indi:SymeoPromissoryNoteMemberus-gaap:LoansPayableMember2022-09-300001841925indi:TeraXionLineOfCreditMemberus-gaap:LineOfCreditMember2022-09-300001841925indi:TeraXionLineOfCreditMemberus-gaap:LineOfCreditMember2021-12-310001841925us-gaap:SecuredDebtMemberindi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:LineOfCreditMember2015-01-310001841925us-gaap:SecuredDebtMemberindi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:PrimeRateMemberus-gaap:LineOfCreditMember2015-01-312015-01-310001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:PrimeRateMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2015-01-312015-01-310001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2015-01-310001841925indi:AmendedPacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:LineOfCreditMember2021-11-050001841925indi:AmendedPacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-11-052021-11-050001841925indi:AmendedPacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-11-050001841925indi:PacWestRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-11-052021-11-050001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-09-300001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2021-12-310001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:LineOfCreditMember2022-09-300001841925indi:PacWestTermLoanAndRevolvingLineOfCreditMemberus-gaap:LineOfCreditMember2021-12-310001841925indi:TeraXionLineOfCreditMemberus-gaap:LineOfCreditMember2021-10-120001841925indi:TeraXionLineOfCreditMemberus-gaap:PrimeRateMemberus-gaap:LineOfCreditMember2021-10-122021-10-120001841925indi:TeraXionLineOfCreditMemberus-gaap:LineOfCreditMember2021-10-122021-10-120001841925indi:TeraXionLineOfCreditUsedAsSecuritizationMemberus-gaap:LineOfCreditMember2022-09-300001841925us-gaap:PrimeRateMemberindi:TeraXionLineOfCreditUsedAsSecuritizationMemberus-gaap:LineOfCreditMember2021-10-122021-10-120001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2019-11-13iso4217:CNY0001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2020-11-132020-11-130001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2022-01-190001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2022-06-212022-06-210001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2022-06-210001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:CITICGroupCorporationLtdMember2022-09-300001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2020-10-150001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2021-04-292021-04-290001841925indi:ShortTermLoanAgreementMemberus-gaap:LoansPayableMember2021-04-290001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2021-10-182021-10-180001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2021-10-180001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2022-04-270001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2022-06-242022-06-240001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2022-06-240001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2022-09-300001841925indi:NetherlandsChinaBusinessCouncilMemberus-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMember2021-12-310001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:BankOfNanjingMember2021-11-182021-11-180001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:BankOfNanjingMember2021-11-180001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:BankOfNanjingMember2022-09-300001841925us-gaap:LoansPayableMemberindi:ShortTermLoanAgreementMemberindi:BankOfNanjingMember2021-12-310001841925indi:SymeoPromissoryNoteMemberus-gaap:LoansPayableMember2022-01-040001841925indi:OtherDebtMember2022-07-012022-09-300001841925indi:OtherDebtMember2021-07-012021-09-300001841925indi:OtherDebtMember2022-01-012022-09-300001841925indi:OtherDebtMember2021-01-012021-09-300001841925indi:PublicWarrantsMember2022-09-300001841925us-gaap:CommonClassBMember2021-06-092021-06-090001841925us-gaap:CommonClassAMember2021-06-092021-06-090001841925indi:ThunderBridgeAcquisitionIILtdMemberindi:PrivatePlacementWarrantsMember2021-06-090001841925indi:PrivatePlacementWarrantsMember2021-06-090001841925indi:PrivatePlacementWarrantsMember2022-09-300001841925indi:WorkingCapitalWarrantsMember2022-01-012022-09-300001841925indi:PublicWarrantsMember2021-07-102021-07-100001841925indi:PublicWarrantsMember2022-01-012022-09-300001841925srt:MinimumMemberindi:PublicWarrantsMember2022-09-3000018419252021-06-100001841925indi:PublicWarrantsMember2021-06-100001841925indi:PrivateWarrantsMember2021-06-100001841925indi:EarnoutSharesMember2021-06-102021-06-100001841925indi:MilestoneOneEarnoutSharesMember2021-06-102021-06-100001841925indi:MilestoneTwoEarnoutSharesMember2021-06-102021-06-100001841925srt:MinimumMemberindi:MilestoneOneEarnoutSharesMember2021-06-100001841925srt:MaximumMemberindi:MilestoneOneEarnoutSharesMember2021-06-10indi:tradingDay0001841925indi:EscrowSharesMember2021-06-102021-06-100001841925indi:MilestoneOneEscrowSharesMember2022-09-300001841925indi:MilestoneTwoEscrowSharesMember2022-09-300001841925indi:CitySemiconductorIncMember2020-05-132020-05-130001841925indi:ContingentConsiderationTrancheOneMemberindi:CitySemiconductorIncMember2020-05-132020-05-130001841925indi:ContingentConsiderationTrancheOneMemberindi:CitySemiconductorIncMember2021-05-310001841925indi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2020-05-132020-05-130001841925indi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925indi:SymeoGmbHMember2022-01-040001841925us-gaap:ForeignExchangeForwardMember2022-09-300001841925us-gaap:ForeignExchangeForwardMember2022-07-012022-09-300001841925us-gaap:ForeignExchangeForwardMember2022-01-012022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:PrivateWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:PrivateWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:PrivateWarrantsMember2022-09-300001841925indi:PrivateWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:PublicWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:PublicWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:PublicWarrantsMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheOneMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheOneMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheOneMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:SymeoGmbHMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:SymeoPromissoryNoteMemberindi:SymeoGmbHMemberus-gaap:LoansPayableMember2022-09-300001841925us-gaap:FairValueInputsLevel2Memberindi:SymeoPromissoryNoteMemberindi:SymeoGmbHMemberus-gaap:LoansPayableMember2022-09-300001841925us-gaap:FairValueInputsLevel3Memberindi:SymeoPromissoryNoteMemberindi:SymeoGmbHMemberus-gaap:LoansPayableMember2022-09-300001841925indi:SymeoPromissoryNoteMemberindi:SymeoGmbHMemberus-gaap:LoansPayableMember2022-09-300001841925us-gaap:FairValueInputsLevel1Memberindi:PrivateWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel2Memberindi:PrivateWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel3Memberindi:PrivateWarrantsMember2021-12-310001841925indi:PrivateWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel1Memberindi:PublicWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel2Memberindi:PublicWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel3Memberindi:PublicWarrantsMember2021-12-310001841925indi:PublicWarrantsMember2021-12-310001841925us-gaap:FairValueInputsLevel1Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-12-310001841925us-gaap:FairValueInputsLevel2Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-12-310001841925us-gaap:FairValueInputsLevel3Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-12-310001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheOneMember2021-12-310001841925us-gaap:FairValueInputsLevel1Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:FairValueInputsLevel2Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:FairValueInputsLevel3Memberindi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925indi:ONDesignIsraelLtdMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:FairValueInputsLevel1Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:FairValueInputsLevel2Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:FairValueInputsLevel3Memberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925indi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ValuationTechniqueOptionPricingModelMember2022-09-300001841925us-gaap:MeasurementInputPriceVolatilityMemberus-gaap:ValuationTechniqueOptionPricingModelMember2021-12-310001841925us-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:MeasurementInputDiscountRateMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:CitySemiconductorIncMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:MeasurementInputDiscountRateMemberindi:ONDesignIsraelLtdMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:ContingentConsiderationTrancheOneMember2021-12-310001841925us-gaap:MeasurementInputDiscountRateMemberindi:ONDesignIsraelLtdMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:ContingentConsiderationTrancheTwoMember2021-12-310001841925us-gaap:MeasurementInputDiscountRateMemberindi:SymeoGmbHMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:ContingentConsiderationTrancheOneMember2022-09-300001841925us-gaap:MeasurementInputDiscountRateMemberindi:SymeoGmbHMemberus-gaap:ValuationTechniqueDiscountedCashFlowMemberindi:ContingentConsiderationTrancheTwoMember2022-09-300001841925us-gaap:MeasurementInputDiscountRateMemberindi:SymeoGmbHMemberus-gaap:ValuationTechniqueDiscountedCashFlowMember2022-09-300001841925indi:CommonClassVMemberindi:CommonUnitsExceptCommonUnitClassHMember2021-06-102021-06-10indi:vote0001841925indi:IndieSemiconductorMemberindi:AyDeeKayLLCMember2021-12-310001841925indi:WuxiIndieMicroelectronicsLtdMemberindi:AyDeeKayLLCMember2021-12-310001841925country:US2022-07-012022-09-300001841925country:US2021-07-012021-09-300001841925country:US2022-01-012022-09-300001841925country:US2021-01-012021-09-300001841925country:CN2022-07-012022-09-300001841925country:CN2021-07-012021-09-300001841925country:CN2022-01-012022-09-300001841925country:CN2021-01-012021-09-300001841925srt:EuropeMember2022-07-012022-09-300001841925srt:EuropeMember2021-07-012021-09-300001841925srt:EuropeMember2022-01-012022-09-300001841925srt:EuropeMember2021-01-012021-09-300001841925indi:NorthAmericaExcludingUnitedStatesMember2022-07-012022-09-300001841925indi:NorthAmericaExcludingUnitedStatesMember2021-07-012021-09-300001841925indi:NorthAmericaExcludingUnitedStatesMember2022-01-012022-09-300001841925indi:NorthAmericaExcludingUnitedStatesMember2021-01-012021-09-300001841925indi:AsiaPacificExcludingChinaMember2022-07-012022-09-300001841925indi:AsiaPacificExcludingChinaMember2021-07-012021-09-300001841925indi:AsiaPacificExcludingChinaMember2022-01-012022-09-300001841925indi:AsiaPacificExcludingChinaMember2021-01-012021-09-300001841925srt:SouthAmericaMember2022-07-012022-09-300001841925srt:SouthAmericaMember2021-07-012021-09-300001841925srt:SouthAmericaMember2022-01-012022-09-300001841925srt:SouthAmericaMember2021-01-012021-09-3000018419252022-10-012022-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerAMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerAMemberus-gaap:SalesRevenueNetMember2021-07-012021-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerAMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerAMemberus-gaap:SalesRevenueNetMember2021-01-012021-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerBMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerBMemberus-gaap:SalesRevenueNetMember2021-07-012021-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerBMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300001841925us-gaap:CustomerConcentrationRiskMemberindi:CustomerBMemberus-gaap:SalesRevenueNetMember2021-01-012021-09-300001841925indi:LargestCustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2022-01-012022-09-300001841925indi:LargestCustomerOneMemberus-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMember2021-01-012021-12-310001841925us-gaap:CostOfSalesMember2022-07-012022-09-300001841925us-gaap:CostOfSalesMember2021-07-012021-09-300001841925us-gaap:CostOfSalesMember2022-01-012022-09-300001841925us-gaap:CostOfSalesMember2021-01-012021-09-300001841925us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001841925us-gaap:ResearchAndDevelopmentExpenseMember2021-07-012021-09-300001841925us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001841925us-gaap:ResearchAndDevelopmentExpenseMember2021-01-012021-09-300001841925us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-300001841925us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-07-012021-09-300001841925us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-300001841925us-gaap:SellingGeneralAndAdministrativeExpensesMember2021-01-012021-09-300001841925indi:A2022OmnibusEquityIncentivePlanMember2022-07-012022-09-300001841925indi:A2022OmnibusEquityIncentivePlanMember2022-01-012022-09-300001841925indi:FinancialInstrumentsSubjectToMandatoryRedemptionMember2022-07-012022-09-300001841925indi:FinancialInstrumentsSubjectToMandatoryRedemptionMember2021-07-012021-09-300001841925indi:FinancialInstrumentsSubjectToMandatoryRedemptionMember2022-01-012022-09-300001841925indi:FinancialInstrumentsSubjectToMandatoryRedemptionMember2021-01-012021-09-300001841925indi:ClassBUnvestedUnitsMember2022-07-012022-09-300001841925indi:ClassBUnvestedUnitsMember2021-07-012021-09-300001841925indi:ClassBUnvestedUnitsMember2022-01-012022-09-300001841925indi:ClassBUnvestedUnitsMember2021-01-012021-09-300001841925us-gaap:PhantomShareUnitsPSUsMember2022-07-012022-09-300001841925us-gaap:PhantomShareUnitsPSUsMember2021-07-012021-09-300001841925us-gaap:PhantomShareUnitsPSUsMember2022-01-012022-09-300001841925us-gaap:PhantomShareUnitsPSUsMember2021-01-012021-09-300001841925us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300001841925us-gaap:RestrictedStockUnitsRSUMember2021-07-012021-09-300001841925us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300001841925us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300001841925indi:CommonClassVMember2022-07-012022-09-300001841925indi:CommonClassVMember2021-07-012021-09-300001841925indi:CommonClassVMember2022-01-012022-09-300001841925indi:CommonClassVMember2021-01-012021-09-300001841925indi:PublicWarrantsMember2022-07-012022-09-300001841925indi:PublicWarrantsMember2021-07-012021-09-300001841925indi:PublicWarrantsMember2022-01-012022-09-300001841925indi:PublicWarrantsMember2021-01-012021-09-300001841925indi:PrivateWarrantsMember2022-07-012022-09-300001841925indi:PrivateWarrantsMember2021-07-012021-09-300001841925indi:PrivateWarrantsMember2022-01-012022-09-300001841925indi:PrivateWarrantsMember2021-01-012021-09-300001841925us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001841925us-gaap:EmployeeStockOptionMember2021-07-012021-09-300001841925us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001841925us-gaap:EmployeeStockOptionMember2021-01-012021-09-300001841925indi:DerivativeLiabilityMember2022-07-012022-09-300001841925indi:DerivativeLiabilityMember2021-07-012021-09-300001841925indi:DerivativeLiabilityMember2022-01-012022-09-300001841925indi:DerivativeLiabilityMember2021-01-012021-09-300001841925indi:EscrowSharesMember2022-07-012022-09-300001841925indi:EscrowSharesMember2021-07-012021-09-300001841925indi:EscrowSharesMember2022-01-012022-09-300001841925indi:EscrowSharesMember2021-01-012021-09-300001841925indi:CorporateAndManufacturingFacilitiesMember2022-09-300001841925indi:AlisoViejoHeadquartersMember2015-07-310001841925indi:AlisoViejoHeadquartersMember2015-07-012015-07-31utr:sqft0001841925indi:AlisoViejoHeadquartersMember2015-08-012015-08-010001841925indi:ScotlandDesignCenterFacilityMember2015-10-310001841925indi:ScotlandDesignCenterFacilityMember2020-01-012020-01-310001841925indi:WuxiSalesAndDesignCenterMember2017-10-310001841925indi:WuxiSalesAndDesignCenterMember2017-10-012017-10-310001841925indi:DetroitOperatingLeaseMember2021-05-310001841925indi:DetroitOperatingLeaseMember2021-05-012021-05-310001841925indi:AustinTexasDesignCenterMember2021-10-310001841925indi:AustinTexasDesignCenterMember2021-10-012021-10-310001841925indi:TeraXionOfficeBuildingMember2021-10-012021-10-310001841925indi:TeraXionWarehouseMember2021-10-012021-10-310001841925indi:BostonMassachusettsDesignCenterMember2022-02-280001841925srt:MinimumMemberindi:FacilityLeasesMember2022-09-300001841925srt:MaximumMemberindi:FacilityLeasesMember2022-09-300001841925indi:FacilityLeasesMember2022-09-30
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 10-Q
___________________________________
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2022
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ________ to ________
Commission file number 001-40481
___________________________________________________________________
INDIE SEMICONDUCTOR, INC.
___________________________________________________________________
(Exact name of registrant as specified in its charter)
Delaware
87-0913788
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
32 Journey
Aliso Viejo, California

92656
(Address of Principal Executive Offices)
(Zip Code)
(949) 608-0854
Registrant’s telephone number, including area code
___________________________________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on
which registered
Class A common stock, par value $0.0001 per shareINDIThe Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one share of Class A common stock for $11.50 per shareINDIWThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes  x   No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
o
Accelerated filer
o
Non-accelerated filer
x
Smaller reporting company
x
Emerging growth company
x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).     Yes   o     No  x
The number of shares outstanding of the registrant’s Class A and Class V common stock as of November 8, 2022 was 125,131,743 (excluding 1,725,000 Class A shares held in escrow and 774,047 Class A shares subject to restricted stock awards) and 23,349,672, respectively.


Table of Contents
INDIE SEMICONDUCTOR, INC.
FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2022
Table of Contents
Page
Condensed Consolidated Financial Statements as of September 30, 2022 and December 31, 2021 and for the three and nine months ended September 30, 2022 and 2021 (Unaudited)
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive Loss
Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) and Noncontrolling Interest
Condensed Consolidated Statements of Cash Flows
Notes to Unaudited Condensed Consolidated Financial Statements
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds
Item 3.Defaults upon Senior Securities
Item 4.Mine Safety Disclosures
Item 5.Other Information


1

Table of Contents
FORWARD-LOOKING STATEMENTS

This report contains “forward-looking statements” (within the meaning of Section 21E of the United States Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended). Such statements include, but are not limited to, statements regarding the Company’s future business and financial performance and prospects, and other statements identified by words such as “will likely result,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “plan,” “project,” “outlook,” “should,” “could,” “may” or words of similar meaning. Such forward-looking statements are based upon the current beliefs and expectations of the Company’s management and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are difficult to predict and generally beyond our control. Actual results and the timing of events may differ materially from the anticipated results or other expectations expressed in such forward-looking statements as a result of various factors, including, among others, the following: downturns or volatility in general economic conditions; the impact of the COVID-19 pandemic or a similar public health crisis; the impact of Russia’s invasion of Ukraine; the Company’s reliance on contract manufacturing and outsourced supply chain and the availability of semiconductors and manufacturing capacity; competitive products and pricing pressures; the Company’s ability to win competitive bid selection processes and achieve additional design wins; the impact of any acquisitions the Company may make, including its ability to successfully integrate acquired businesses and risks that the anticipated benefits of any acquisitions may not be fully realized or take longer to realize than expected; management’s ability to develop, market and gain acceptance for new and enhanced products and expand into new technologies and markets; trade restrictions and trade tensions; and political or economic instability in the Company’s target markets; and additional factors disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the U.S. Securities and Exchange Commission (“SEC”) on April 11, 2022 (including those identified under “Risk Factors” therein), as such risk factors may be amended, supplemented or superseded from time to time in the Company’s other public reports filed with the SEC. indie cautions that the foregoing list of factors is not exclusive.

All information set forth herein speaks only as of the date hereof, and the Company disclaims any intention or obligation to update any forward-looking statements made in this report or in its other public filings, whether as a result of new information, future events or otherwise, except as required by law.

1

Table of Contents
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in thousands, except share and per share amounts)
(Unaudited)
September 30,
2022
December 31,
2021
Assets
Current assets:
Cash and cash equivalents$150,388 $219,081 
Restricted cash383 383 
Accounts receivable, net of allowance for doubtful accounts of $46 as of September 30, 2022 and $27 as of December 31, 2021
22,422 13,842 
Inventory, net11,579 9,080 
Prepaid expenses and other current assets9,507 5,648 
Total current assets194,279 248,034 
Property and equipment, net12,509 11,090 
Intangible assets, net60,864 96,285 
Goodwill142,038 115,206 
Operating lease right-of-use assets9,839 — 
Other assets and deposits1,874 270 
Total assets$421,403 $470,885 
Liabilities and stockholders' equity
Accounts payable$8,473 $5,441 
Accrued payroll liabilities8,566 4,021 
Accrued expenses and other current liabilities15,585 14,622 
Intangible asset contract liability7,973 5,516 
Deferred revenue1,627 1,840 
Current debt obligations13,082 2,275 
Total current liabilities55,306 33,715 
Long-term debt, net of current portion4,170 5,618 
Warrant liability51,872 100,467 
Intangible asset contract liability, net of current portion6,517 12,452 
Deferred tax liabilities, non-current11,885 21,164 
Operating lease liability, non-current7,879 — 
Other long-term liabilities7,425 5,612 
Total liabilities145,054 179,028 
Commitments and contingencies (Note 17)
Stockholders' equity
Preferred stock, $0.0001 par value, 10,000,000 shares authorized; no shares issued or outstanding
— — 
Class A common stock, $0.0001 par value, 250,000,000 shares authorized, 126,516,947 and 111,260,962 shares issued, 123,973,300 and 108,181,781 shares outstanding as of September 30, 2022 and December 31, 2021, respectively.
13 11 
Class V common stock, $0.0001 par value, 40,000,000 shares authorized, 23,749,676 and 30,448,081 issued and outstanding as of September 30, 2022 and December 31, 2021, respectively.
Additional paid-in capital544,997 514,891 
Accumulated deficit(231,425)(200,416)

2

Table of Contents
Accumulated other comprehensive loss(18,261)(1,443)
indie's stockholders' equity295,327 313,046 
Noncontrolling interest(18,978)(21,189)
Total stockholders' equity276,349 291,857 
Total liabilities and stockholders' equity$421,403 $470,885 
See accompanying notes to the condensed consolidated financial statements.

3

Table of Contents
INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(Amounts in thousands, except share and per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Revenue:
Product revenue$24,425 $11,099 $62,963 $27,470 
Contract revenue5,591 1,058 14,807 1,981 
Total revenue30,016 12,157 77,770 29,451 
Operating expenses:
Cost of goods sold14,970 6,930 44,340 17,097 
Research and development30,229 15,043 88,195 37,206 
Selling, general, and administrative10,676 11,442 35,403 23,015 
Total operating expenses55,875 33,415 167,938 77,318 
Loss from operations(25,859)(21,258)(90,168)(47,867)
Other income (expense), net:
Interest income612 16 820 36 
Interest expense(166)(25)(491)(1,175)
Gain from change in fair value of SAFEs— — — 21,600 
Gain (loss) from change in fair value of warrants(19,059)(40,401)48,595 (29,085)
Loss from change in fair value of earn-out liabilities— (45,496)— (27,557)
Gain (loss) from change in fair value of contingent considerations(121)(20)3,546 (120)
Gain from extinguishment of debt— — — 304 
Other income (expense)24 (1,013)(914)
Total other income (expense), net(18,710)(86,939)52,473 (36,911)
Net loss before income taxes(44,569)(108,197)(37,695)(84,778)
Income tax benefit (expense)(863)36 665 (34)
Net loss(45,432)(108,161)(37,030)(84,812)
Less: Net loss attributable to noncontrolling interest(7,825)(28,512)(6,022)(22,127)
Net loss attributable to indie Semiconductor, Inc.$(37,607)$(79,649)$(31,008)$(62,685)
Net loss attributable to common shares — basic$(37,607)$(79,649)$(31,008)$(62,685)
Net loss attributable to common shares — diluted$(37,607)$(79,649)$(31,008)$(62,685)
Net loss per share attributable to common shares — basic$(0.31)$(0.83)$(0.27)$(1.07)
Net loss per share attributable to common shares — diluted$(0.31)$(0.83)$(0.27)$(1.07)
Weighted average common shares outstanding — basic
120,507,152 96,368,379 116,272,459 58,791,245 
Weighted average common shares outstanding — diluted
120,507,152 96,368,379 116,272,459 58,791,245 


See accompanying notes to the condensed consolidated financial statements.

4

Table of Contents
INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(Amounts in thousands)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Net loss$(45,432)$(108,161)$(37,030)$(84,812)
Other comprehensive loss:
Foreign currency translation adjustments(9,809)172 (16,818)230 
Comprehensive loss(55,241)(107,989)(53,848)(84,582)
Less: Comprehensive loss attributable to noncontrolling interest(7,727)(28,514)(5,784)(22,127)
Comprehensive loss attributable to indie Semiconductor, Inc.$(47,514)$(79,475)$(48,064)$(62,455)
See accompanying notes to the condensed consolidated financial statements.

5

Table of Contents


INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) AND NONCONTROLLING INTEREST
(Amounts in thousands, except unit and share amounts)
(Unaudited)
Common Stock
Class A
Common Stock
Class V
Additional Paid-in CapitalAccumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Equity (Deficit) Attributable to indie Semiconductor, Inc.Noncontrolling InterestTotal Stockholders' Equity (Deficit)
Shares (1)AmountShares (1)Amount
Balance as of December 31, 2020— $— — $— $982 $(153,264)$(209)$(110,312)$8,820 $(101,492)
Retroactive application of recapitalization34,413,634 33,373,294 42,173 — — — — — 
Balance as of December 31, 202034,413,634 $33,373,294 $$43,155 $(153,264)$(209)$(110,312)$8,820 $(101,492)
Vesting of equity awards631,121 — — — — — — — — — 
Net income— — — — — 10,815 — 10,815 (454)10,361 
Foreign currency translation adjustment— — — — — — (88)(88)36 (52)
Balance as of March 31, 202135,044,755 $3 33,373,294 $3 $43,155 $(142,449)$(297)$(99,585)$8,402 $(91,183)
Vesting of equity awards1,133,889 — — — — — — — — — 
Share-based compensation— — — — 7,968 — — 7,968 — 7,968 
Net loss through June 10, 2021— — — — — (13,434)— (13,434)(132)(13,566)
Reverse recapitalization on June 10, 202160,441,289 454,077 — 250,129 — — 250,135 — 250,135 
Reverse recapitalization: ADK Minority Holders interest on June 10, 2021(378,605)— — — (36,831)40,892 40 4,101 (4,101)— 
Net income after June 10, 2021— — — — — 19,584 — 19,584 6,971 26,555 
Foreign currency translation adjustment— — — — — — 146 146 (34)112 
Balance as of June 30, 202196,241,328 $9 33,827,371 $3 $264,421 $(95,407)$(111)$168,915 $11,106 $180,021 
Vesting of equity awards187,205 —  — —  — — — — 
Share-based compensation —  — 6,217  — 6,217 — 6,217 
Reverse recapitalization adjustment —  — 1,100  — 1,100 — 1,100 
Net loss —  — — (79,649)— (79,649)(28,512)(108,161)
Foreign currency translation adjustment —  — —  172 172 (2)170 

6

Table of Contents


INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) AND NONCONTROLLING INTEREST
(Amounts in thousands, except unit and share amounts)
(Unaudited)
Balance as of September 30, 202196,428,533 $9 33,827,371 $3 $271,738 $(175,056)$61 $96,755 $(17,408)$79,347 
(1) Retroactively restated to give effect to the reverse recapitalization.

Common Stock
Class A
Common Stock
Class V
Additional Paid-in CapitalAccumulated DeficitAccumulated Other Comprehensive LossTotal Stockholders' Equity Attributable to indie Semiconductor, Inc.Noncontrolling InterestTotal Stockholders' Equity
Shares AmountSharesAmount
Balance as of December 31, 2021108,181,781 $11 30,448,081 $$514,891 $(200,416)$(1,443)$313,046 $(21,189)$291,857 
Vesting of equity awards250,378 — — — — — — — — — 
Issuance per net settlement of equity awards and cash exercise of stock options1,250,878 — — — (188)— — (188)259 71 
Issuance per Exchange of Class V to Class A2,224,148 — (2,224,148)— (2,345)— — (2,345)2,345 — 
Issuance on earn out awards3,070,494 — 1,895,879 — 872 — — 872 (872)— 
Share-based compensation— — — — 10,742 — — 10,742 — 10,742 
Net income— — — — — 10,833 — 10,833 2,873 13,706 
Foreign currency translation adjustment— — — — — — 863 863 21 884 
Balance as of March 31, 2022114,977,679 $11 30,119,812 $3 $523,972 $(189,583)$(580)$333,823 $(16,563)$317,260 
Vesting of equity awards136,306 — — — — — — — — — 
Issuance per net settlement of equity awards and cash exercise of stock options443,160 — — — (204)— — (204)205 
Share-based compensation— — — — 7,093 — — 7,093 — 7,093 
Issuance per Exchange of Class V to Class A3,737,109 (3,737,109)— (3,054)— — (3,053)3,054 
Issuance per Exchange of ADK LLC units to Class A29,358 — — — — — — — — — 
Net loss— — — — — (4,235)— (4,235)(1,070)(5,305)
Foreign currency translation adjustment— — — — — — (7,872)(7,872)119 (7,753)

7

Table of Contents


INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) AND NONCONTROLLING INTEREST
(Amounts in thousands, except unit and share amounts)
(Unaudited)
Balance as of June 30, 2022119,323,612 $12 26,382,703 $3 $527,807 $(193,818)$(8,452)$325,552 $(14,255)$311,297 
Vesting of equity awards196,630 —  — —  — — — — 
Issuance per net settlement of equity awards and cash exercise of stock options275,934 — — — (615) — (615)643 28 
Share-based compensation— — — — 7,893  — 7,893 — 7,893 
Issuance per Exchange of Class V to Class A2,633,027 (2,633,027)— (2,361) — (2,360)2,361 
Issuance per Exchange of ADK LLC units to Class A37,205 — — — — — — — — — 
Issuance in connection with At-The-Market equity offering1,506,892 —  — 12,273  — 12,273 — 12,273 
Net loss —  — — (37,607)— (37,607)(7,825)(45,432)
Foreign currency translation adjustment —  — —  (9,809)(9,809)98 (9,711)
Balance as of September 30, 2022123,973,300 $13 23,749,676 $3 $544,997 $(231,425)$(18,261)$295,327 $(18,978)$276,349 

See accompanying notes to the condensed consolidated financial statements.

8

Table of Contents
INDIE SEMICONDUCTOR, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in thousands)
(Unaudited)
Nine Months Ended
September 30,
20222021
Cash flows from operating activities:
Net loss$(37,030)$(84,812)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization11,170 2,397 
Inventory impairment charges1,192 78 
Share-based compensation 30,845 14,185 
Amortization of discount of debt226 198 
Bad debts24 125 
Gain from change in fair value remeasurement of SAFEs
— (21,600)
(Gain) loss from change in fair value of warrants
(48,595)29,085 
Loss from change in fair value of earn-out liabilities
— 27,557 
(Gain) loss from change in fair value of contingent considerations
(3,546)120 
(Gain) loss from change in fair value of currency forward contract
(211)1,200 
Gain from extinguishment of debt
— (304)
Deferred City Semi compensation203 375 
Deferred tax liabilities1,532 — 
Amortization of right-of-use assets1,463 — 
Changes in operating assets and liabilities:
Accounts receivable(8,854)(3,047)
Inventory(2,406)(2,730)
Accounts payable2,945 625 
Accrued expenses and other current liabilities1,587 2,578 
Accrued payroll liabilities(843)236 
Deferred revenue93 (1,113)
Prepaid and other current assets(6,129)(2,848)
Operating lease liabilities(1,159)— 
Other long-term liabilities(1,322)782 
Net cash used in operating activities(58,815)(36,913)
Cash flows from investing activities:
Purchases of property and equipment(4,508)(1,668)
Purchases of intangible assets— (784)
Business combinations, net of cash(8,705)— 
Net cash used in investing activities(13,213)(2,452)
Cash flows from financing activities:
Proceeds from issuance of SAFEs— 5,000 
Proceeds from issuance of common stock/At-the-market offering12,273 — 
Offering costs for the issuance of common stock/At-the-market offering(273)— 
Proceeds from issuance of debt obligations1,059 155 
Proceeds from reverse recapitalization— 377,663 
Issuance costs related to reverse recapitalization— (19,902)
Payments on debt obligations(1,404)(15,008)
Payments on financed software(3,224)(2,270)

9

Table of Contents
Redemption of Class H units— (900)
Payments on business combination(5,000)— 
Payments of City Semi deferred compensation(1,000)(399)
Proceeds from exercise of stock options100 — 
Net cash provided by financing activities2,531 344,339 
Effect of exchange rate changes on cash and cash equivalents804 193 
Net increase (decrease) in cash and cash equivalents(68,693)305,167 
Cash, cash equivalents and restricted cash at beginning of period219,464 18,698 
Cash, cash equivalents and restricted cash at end of period$150,771 $323,865 
Supplemental disclosure of cash flow information:
Cash paid for interest$218 $1,188 
Supplemental disclosure of non-cash investing and financing activities:
Purchases of property and equipment, accrued but not paid$275 $206 
Conversion of historical members' equity$— $41,278 
Class G warrants cashless exchange$— $407 
Conversion of SAFEs$— $86,100 
Conversion of Embry Notes$— $4,119 
Recognition of earn-out considerations$— $119,759 
Accrual for purchases of intangible assets$— $12,198 
Recognition of warrant liabilities$— $74,408 
Contingent consideration for business combination$8,204 $— 
Accrual for purchase consideration for business combination$9,674 $— 
See accompanying notes to the condensed consolidated financial statements.

10

Table of Contents
INDIE SEMICONDUCTOR, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(amounts in thousands, except unit and share amounts and per unit and per share amounts)
(Unaudited)
1.    Nature of the Business and Basis of Presentation

indie Semiconductor, Inc. (“indie”) and its predecessor for accounting purposes, Ay Dee Kay, LLC, a California limited liability company (“ADK LLC”) and its subsidiaries are collectively referred to herein as the “Company.” The Company offers highly innovative automotive semiconductors and software solutions for Advanced Driver Assistance Systems (“ADAS”), autonomous vehicle, connected car, user experience and electrification applications. The Company focuses on edge sensors across multiple modalities spanning LiDAR, radar, ultrasound and computer vision. These functions represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces are transforming the in-cabin experience to mirror and seamlessly connect to the mobile platforms people rely on every day. indie is an approved vendor to Tier 1 automotive suppliers and its platforms can be found in marquee automotive manufacturers around the world. Headquartered in Aliso Viejo, California, indie has design centers and sales offices in Austin, Texas; Boston, Massachusetts; Detroit, Michigan; San Francisco and San Jose, California; Cordoba, Argentina; Budapest, Hungary; Dresden and Munich, Germany; Cambridge, England; Edinburgh, Scotland; Rabat, Morocco; Haifa, Israel; Quebec City, Canada; Seoul, South Korea; Tokyo, Japan and several locations throughout China. The Company engages subcontractors to manufacture its products. The majority of these subcontractors are located in Asia.

Execution of At-The-Market Agreement

On August 26, 2022, the Company entered into an At Market Issuance Agreement (“ATM Agreement”) with B. Riley Securities, Inc., Craig-Hallum Capital Group LLC and Roth Capital Partners, LLC (collectively as “Sales Agents”) relating to shares of its Class A common stock, par value $0.0001 per share. In accordance with the terms of the Sales Agreement, the Company may offer and sell shares of its Class A common stock having an aggregate offering price of up to $150,000 from time to time through the Sales Agents, acting as the Company’s agent or principal. The Company implemented this program for the flexibility that it provides to the capital markets and to best time its equity capital needs. As of September 30, 2022, indie has raised gross proceeds of $12,273 and issued 1,506,892 shares of Class A common stock at an averaged per-share sales price of $8.14 through this program and had approximately $137,727 available for future issuances under the ATM Agreement. For the three months ended September 30, 2022, indie incurred total issuances costs of $273.

Recent Acquisitions

On October 21, 2021, indie entered into a definitive agreement with Analog Devices (“ADI”) to acquire Symeo GmbH (“Symeo”). The acquisition was approved by the German government on January 4, 2022 and closed on the same day. The total consideration paid for this acquisition consisted of (i) $8,705 in cash at closing, net of cash acquired; (ii) a $10,000 promissory note payable in January 2023 with a fair market value of $9,674 on January 4, 2022; and (iii) an equity-based earn-out of up to 858,369 shares of indie Class A common stock based on future revenue growth. The fair market value of this equity-based earn-out was $8,204 on January 4, 2022.

See Note 2 - Business Combinations for additional description of this acquisition.

Reverse Recapitalization with Thunder Bridge Acquisition II

On June 10, 2021, Thunder Bridge Acquisition II, Ltd. (“TB2”), consummated a series of transactions that resulted in the combination (the “Transaction”) of TB2 with ADK LLC pursuant to the Master Transactions Agreement dated December 14, 2020, as amended on May 3, 2021 (the “MTA”) by and among TB2, Thunder Bridge II Surviving Pubco, Inc., a Delaware corporation (“Surviving Pubco”), ADK LLC, and the other parties named therein. In connection with the Transaction, Surviving Pubco was formed to be the successor public company to TB2, TB2 was domesticated into a Delaware corporation and merged with and into and a merger subsidiary of Surviving Pubco, with Surviving Pubco continuing as the successor company, and a merger subsidiary of Surviving Pubco merged with and into ADK LLC, with ADK LLC continuing as the surviving limited liability company. On the same day, Surviving Pubco changed its name to indie Semiconductor, Inc., and listed shares of Class A common stock, par value $0.0001 per share on The Nasdaq Stock Market LLC under the symbol “INDI.”

11


Impact of COVID-19 and Macroeconomic Conditions

The impact of the COVID-19 pandemic as well as macroeconomic conditions, including rising interest rates, inflationary pressures, and volatility in the global financial markets, have affected business conditions in our industry. The duration, severity, and future impact of these conditions cannot be predicted; therefore the full extent to which these conditions will directly or indirectly impact the Company’s business operations, results of operations and financial condition is uncertain. Furthermore, like many companies in the semiconductor industry, we are experiencing various supply constraints, including global supply imbalances. While we are working with our global supply chain partners to mitigate this risk, the duration and extent of the supply chain disruptions remain uncertain. Refer to Part I, Item 1A of our 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 under the heading “Risk Factors” for more information.

Basis of Presentation

The condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) and the rules and regulations of the Securities and Exchange Commission (“SEC”). Any reference in these notes to applicable guidance is meant to refer to the authoritative U.S. GAAP as found in the Accounting Standards Codification (“ASC”) and the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”). The condensed consolidated financial statements include the condensed consolidated accounts of the Company’s majority-owned subsidiary, ADK LLC, of which 84% was owned by indie as of September 30, 2022. ADK LLC’s condensed consolidated financial statements include its wholly-owned subsidiaries Indie Services Corporation, indie LLC and Indie City LLC, all California entities, Ay Dee Kay Limited, a private limited company incorporated under the laws of Scotland, indie GmbH and Symeo GmbH, both of which are private limited liability companies incorporated under the laws of Germany, indie Kft, a limited liability company incorporated under the laws of Hungary, TeraXion Inc., a company incorporated under the laws of Canada, indie Semiconductor Israel Ltd., a private limited company incorporated under the laws of Israel, Ay Dee Kay S.A., a limited liability company incorporated under the laws of Argentina, indie Semiconductor Morocco, a limited liability company under the laws of Morocco, indie Semiconductor Japan KK, a limited liability company under the laws of Japan, Wuxi indie Microelectronics (“Wuxi”), a Chinese entity with 64% voting controlled and 44% owned by the Company as of September 30, 2022 and Wuxi’s wholly-owned subsidiaries, indie Semiconductor Japan, indie Semiconductor HK, Ltd and Shanghai Ziying Microelectronics Co., Ltd.

All significant intercompany accounts and transactions of the subsidiaries have been eliminated in consolidation. Certain prior period amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations. The noncontrolling interest attributable to the Company’s less-than-wholly-owned subsidiary is presented as a separate component from stockholders’ equity (deficit) in the condensed consolidated balance sheets, and a noncontrolling interest in the condensed consolidated statements of operations and condensed consolidated statements of stockholders’ equity (deficit) and noncontrolling interest.

Unaudited Interim Financial Information

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the SEC for interim financial reporting. Certain information and footnote disclosures, normally included in annual consolidated financial statements prepared in accordance with U.S. GAAP, have been condensed or omitted pursuant to those rules and regulations. However, in management’s opinion, the financial information reflects all adjustments, including those of a normal recurring nature, necessary to present fairly the results of operations, financial position, and cash flows of the Company for the periods presented. The results of operations, financial position, and cash flows for the Company during the interim periods are not necessarily indicative of those expected for the full year. This information should be read in conjunction with the Company’s consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on April 11, 2022.

Emerging Growth Company

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (“JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can choose not to take advantage of the extended transition period and comply with the requirements that apply to non-emerging growth companies, and any such election to not take advantage of the extended transition period is irrevocable. indie is an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), and have elected to take advantage of the benefits of the extended transition period for new or revised financial accounting standards. Following the

12

consummation of the Transaction, the Company will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of the Company’s common stock that is held by non-affiliates exceeds $700 million as of the end of that year’s second fiscal quarter, (ii) the last day of the fiscal year in which the Company achieves total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation), (iii) the date on which the Company issues more than $1 billion in non-convertible debt in the prior three-year period or (iv) December 31, 2024. The Company expects to continue to take advantage of the benefits of the extended transition period, although it may decide to early adopt such new or revised accounting standards to the extent permitted by such standards. This may make it difficult or impossible to compare the Company’s financial results with the financial results of another public company that is either not an emerging growth company or is an emerging growth company that has chosen not to take advantage of the extended transition period exemptions because of the potential differences in accounting standards used.

Significant Accounting Policies

The Company’s significant accounting policies are disclosed in its Annual Report on Form 10-K for the year ended December 31, 2021. Other than the accounting policies discussed in Note 16, Leases, related to the adoption of ASC 842, Leases, there has been no material change to the Company’s significant accounting policies during the nine months ended September 30, 2022.

Recent Accounting Pronouncements

Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which replaces the incurred loss impairment methodology with an expected credit loss model for which a company recognizes an allowance based on the estimate of expected credit loss. This ASU requires entities to measure the impairment of certain financial instruments, including accounts receivable, based on expected losses rather than incurred losses. This ASU is effective for fiscal years beginning after December 15, 2022, with early adoption permitted, and will be effective for the Company beginning in 2023. The Company is currently evaluating the impact of the new standard on the Company’s condensed consolidated financial statements and related disclosures.

Recently Adopted Accounting Pronouncements

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) (“ASU 2016-02”), whereby lessees will be required to recognize for all leases at the commencement date a lease liability, which is a lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis; and a right-of-use (“ROU”) asset, which is an asset that represents the lessee’s right to use, or control the use of, a specified asset for the lease term. Under the new guidance, lessor accounting is largely unchanged. A modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the condensed consolidated financial statements must be applied. The modified retrospective approach would not require any transition accounting for leases that expired before the earliest comparative period presented. The FASB issued ASU 2019-10-Financial Instruments-Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates in November 2019 and ASU 2020-05-Revenue from Contracts with Customers (Topic 606) and Leases (Topic 842): Effective Dates for Certain Entities in June 2020. The ASUs change some effective dates for ASU 2016-02 on leasing. After applying ASU 2019-10 and 2020-05, ASU 2016-02 is effective for annual periods beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2021.

The Company applied the transition requirements on the adoption date of January 1, 2022, rather than at the beginning of the earliest comparative period presented. This approach allows for a cumulative effect adjustment in the period of adoption, and prior periods will not be restated. In addition, the Company elected the package of practical expedients permitted under the transition guidance, which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. The Company also elected to use the hindsight practical expedient to consider any facts or circumstances that have changed through the January 1, 2022 adoption date that may affect the lease term due to renewal options and assess the impairment of the right-of-use asset. As an accounting policy election, the Company also excluded short-term leases (term of 12 months or less) from the balance sheet presentation and accounted for non-lease and lease components in a contract as a single lease component for certain asset classes. Effective January 1, 2022, the Company recorded the impact on its condensed consolidated balance sheet from the recognition of ROU asset and lease liability of $10,344. The impact to its condensed consolidated statements of operations, condensed consolidated statements of comprehensive income (loss) and condensed consolidated statements of cash flows is not material. See Note 16, Leases, for additional details.


13

In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes, which simplifies the accounting for income taxes by removing certain exceptions to the general principles of ASC 740Income Taxes. The amendments also improve consistent application of and simplify U.S. GAAP for other areas of ASC 740 by clarifying and amending existing guidance. ASU 2019-12 is effective for fiscal years beginning after December 15, 2020 (and December 15, 2021 for nonpublic companies) and early adoption is permitted. Depending on the amendment, adoption may be applied on a retrospective, modified retrospective, or prospective basis. The Company adopted ASU 2019-12 as of January 1, 2022 on a prospective basis. The standard had no material impact on the Company’s condensed consolidated financial statements and related disclosures.

In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the guidance on the issuer’s accounting for convertible debt instruments by removing the separation models for (1) convertible debt with a cash conversion feature and (2) convertible instruments with a beneficial conversion feature. As a result, entities will not separately present in equity an embedded conversion feature in such debt. Instead, they will account for a convertible debt instrument wholly as debt, unless certain other conditions are met. The elimination of these models will reduce reported interest expense and increase reported net income for entities that have issued a convertible instrument that was within the scope of those models before the adoption of ASU 2020-06. Also, ASU 2020-06 requires the application of the if-converted method for calculating diluted earnings per share and treasury stock method will be no longer available. The provisions of ASU 2020-06 are applicable for fiscal years beginning after December 15, 2021, with early adoption permitted no earlier than fiscal years beginning after December 15, 2020. The Company early adopted this update on January 1, 2022 using the modified retrospective method of transition and the impact to its condensed consolidated financial statements was not material.

14

2.    Business Combinations

The Company acquired TeraXion, Inc. (“TeraXion”) and ON Design Israel Ltd. (“ON Design Israel”) in October 2021 and Symeo GmbH (“Symeo”) in January 2022. These acquisitions were recorded by allocating the purchase consideration to the net assets acquired based on their estimated fair values at the acquisition date. The excess of the purchase consideration for the acquisition over the fair value of the net assets acquired is recorded as goodwill. The fair values were based on management’s analysis, including work performed by third-party valuation specialists. The following presents the final allocation of the purchase consideration to the assets acquired and liabilities assumed for TeraXion and ON Design Israel, and the preliminary allocation of the purchase consideration to the assets acquired and liabilities assumed for Symeo as of September 30, 2022:

Symeo GmbHTeraXionON Design Israel
Purchase price - cash consideration$10,000 $74,050 $6,107 
Purchase price - cash consideration (Accrual)9,674 — 7,500 
Add: debt paid at closing— 6,857 — 
Less: cash acquired(1,295)(5,625)(1,133)
Net cash paid18,379 75,282 12,474 
Purchase price - equity consideration
Common stock— 65,192 — 
Options— 17,249 — 
Total equity consideration— 82,441 — 
Earn out shares8,204 — — 
Contingent consideration— — 4,000 
Net consideration$26,583 $157,723 $16,474 
Fair value of net assets and liabilities assumed:
Current assets other than cash2,857 7,627 119 
Property and equipment1,039 4,992 1,424 
Developed technology6,631 17,305 — 
In-progress research & development2,170 — 10,100 
Customer relationships2,411 13,059 — 
Backlog603 16 — 
Trade name965 6,946 — 
Other non-current assets36 — 66 
Current liabilities(1,461)(5,840)(537)
Deferred revenue— (1,025)— 
Deferred tax liabilities, non-current(2,935)(10,030)(2,400)
Long-term debt— (7,580)— 
Total fair value of net assets acquired12,316 25,470 8,772 
Goodwill$14,267 $132,253 $7,702 

Any changes in the estimated fair values of the net assets recorded for the business combination of Symeo upon the finalization of more detailed analyses of the facts and circumstances that existed at the date of the transaction will change the allocation of the purchase price. Any subsequent changes to the purchase allocation during the measurement period that are material will be recorded in the reporting period in which the adjustment amounts are determined.

For all three acquisitions, trade receivables and payables, as well as other current and non-current assets and liabilities, were valued at the existing carrying value as they represented the fair value of those items at the acquisition date, based on

15

management’s judgments and estimates. The fair value of property, plant and equipment utilized a replacement cost method incorporating the age, quality and condition of the assets.

Because the acquisition related to Symeo occurred relatively recently, the magnitude of the transaction and the significant information to be obtained and analyzed, some of which resides in foreign jurisdictions, the Company’s fair value estimates for the purchase price allocation are preliminary and may change during the allowable measurement period, which is up to the point the Company obtains and analyzes the information that existed as of the date of the acquisition necessary to determine the fair values of the assets acquired and liabilities assumed, but in no case to exceed more than one year from the date of acquisition. As of November 10, 2022, the Company had not finalized the determination of fair values allocated to various assets and liabilities, including, but not limited to, property, plant and equipment, identifiable intangible assets, other assets, deferred taxes, goodwill, tax uncertainties, income taxes payable, and other liabilities. Specifically for the valuation of intangibles assets acquired, the Company used publicly available benchmarking information, as well as a variety of other assumptions, including market participant assumptions to determine the preliminary values. Any changes in the fair values of the assets acquired and liabilities assumed during the measurement period may result in material adjustments to goodwill.

Acquisition of TERAXION INC

On August 27, 2021, indie entered into a Share Purchase Agreement (the “Purchase Agreement”), pursuant to which indie’s wholly-owned Canadian subsidiary (“Purchaser”) agreed to purchase all of the outstanding capital stock of TeraXion from the existing stockholders. The transaction was completed on October 12, 2021 and TeraXion became a wholly-owned subsidiary of ADK, LLC as a result of this acquisition.

The aggregate purchase price of this acquisition was CAD $200,000 (the “Purchase Price”), which was payable 50% in cash and 50% in indie’s shares of Class A common stock, subject to various purchase price adjustments. Upon completion of the transaction, the total consideration paid for this acquisition consisted of (i) approximately $75,282 in cash (including debt paid at closing and net of cash acquired); (ii) the issuance by indie of 5,805,144 shares of indie Class A common stock with a fair value of $65,192 based on the market value of $11.23 per share; and (iii) the assumption by indie of TeraXion options, which became exercisable to purchase 1,542,332 shares of indie Class A common stock with a fair value of $17,249.

TeraXion is a market leader in the design and manufacture of innovative photonic components. The Company paid a premium (i.e. goodwill) over the fair value of the net tangible and identified intangible assets acquired as this acquisition accelerates indie’s vision of becoming a semiconductor and software level solutions provider for multiple sensor modalities spanning ADAS and autonomous vehicles. The goodwill is not expected to be deductible for tax purposes.

As of September 30, 2022, the Company finalized the opening net assets acquired and goodwill as follows:

Preliminary ValuationAdjustmentsFinal
Valuation
Property and equipment$6,009 $(1,017)$4,992 
Developed technology43,594 (26,289)17,305 
In-progress research & development10,304 (10,304)— 
Customer relationships12,682 377 13,059 
Backlog2,378 (2,362)16 
Trade name6,125 821 6,946 
Deferred tax liabilities, non-current(20,272)10,242 (10,030)
Goodwill103,721 28,532 132,253 

Changes in fair value of fixed assets and deferred tax liabilities, non-current were a result of gathering additional information during the measurement period. The Company also revised the initial values of intangible assets as a result of switching from utilizing publicly available benchmarking information to determine the fair value of the intangible assets to primarily utilizing an income method based on forecasts of expected future cash flows. As a result, the Company recorded an adjustment to the amortization of intangible assets of $2,491 in the condensed consolidated statement of operations during the three and nine

16

months ended September 30, 2022 that would have been recorded during the prior periods if the adjustment to the intangible assets had been recognized as of the date of the acquisition.

The fair value of property, plant and equipment utilized a replacement cost method incorporating the age, quality and condition of the assets.

Developed technology relates to various laser systems, optical sensing and optical communication products offered by TeraXion at the time of the acquisition. Developed technology was valued using relief from royalty of the income approach. The selected royalty rate was determined based on an analysis of licensing agreements related to similar technologies and was further adjusted to reflect the maintenance R&D expenses associated with sustaining the technology. The economic useful life was determined to be four years based on the technology cycle related to each developed technology, as well as the cash flows over the forecast period.

Customer relationships represents the fair value of future projected revenue that will be derived from sales of products to existing customers of TeraXion. The fair value was determined by applying the excess earnings method of the income approach. The economic useful life was determined to be ten years.

Backlog relates to various purchase orders in place with TeraXion’s customers at the time of the acquisition. The fair value was determined by applying the excess earnings method of the income approach. The economic useful life was determined to be two years was determined.

Trade name relates to the “TeraXion” trade name. The fair value was determined by applying the relief from royalty of the income approach. The selected royalty rate was determined based on an analysis of licensing agreements related to similar brand names. The economic useful life was determined to be seven years.

Under both the relief from royalty and multi-period excess earnings methods, the fair value models incorporated estimates of future cash flows, estimates of allocations of certain assets and cash flows, estimates of future growth rates and management’s judgment regarding the applicable discount rates to use to discount such estimates of cash flows. Because the estimates and assumptions made by management at the time of the acquisitions are unobservable and significant to the overall fair value measurement of these acquired identifiable intangible assets, the corresponding fair values are classified as Level 3 fair value hierarchy measurements.

As of September 30, 2022, indie incurred approximately $1,674 of acquisition-related costs, which were primarily legal expenses and recorded as part of the Selling, General and Administrative expenses.

There are no amounts of revenue and earnings of TeraXion included in the Company’s condensed consolidated statements of operations for the three and nine months ended September 30, 2021.

The unaudited pro forma financial information shown below summarizes the combined results of operations for the Company and TeraXion as if the closing of the acquisition had occurred on January 1, 2021:

Three months endedNine months ended
September 30, 2021September 30, 2021
Combined revenue$17,875 $47,374 
Combined net loss before income taxes(108,776)(86,638)

The unaudited pro forma financial information includes adjustments that are directly attributable to the business combination and are factually supportable. Pro forma information reflects adjustments that are expected to have a continuing impact on the Company’s results of operations and are directly attributable to the acquisition. The unaudited pro forma results include adjustments to reflect, among other things, direct transaction costs relating to the acquisition, the incremental intangible asset amortization to be incurred based on the preliminary values of each identifiable intangible asset, and to eliminate a portion of the interest expense related to legacy TeraXion’s former loans, which were repaid upon completion of the acquisition. The unaudited pro forma financial information is presented for illustrative purposes only and is not necessarily indicative of the operating results that would have been realized if the acquisition had taken place on January 1, 2021.

17

Acquisition of ON Design Israel Ltd.

On October 1, 2021, indie entered into a definitive agreement and completed its acquisition of ON Design Israel Ltd. for $4,974 in cash paid upon close (net of cash acquired), $7,500 is to be paid in 2022 of which $5,000 was paid as of September 30, 2022. The remaining balance of $2,500 is reflected in Accrued expenses and other current liabilities and was paid in October 2022. Lastly, up to $7,500 would become payable upon achievement of certain milestones. Upon completion of the acquisition, ON Design Israel was renamed to indie Semiconductor Design Israel Ltd and became a wholly-owned subsidiary of the Company.

The Company paid a premium (i.e. goodwill) over the fair value of the net tangible and identified intangible assets acquired as this acquisition brings the Company an engineering development team with broad experience in radar system implementation, which will accelerate indie’s entry into the radar market and enable the Company to capture strategic opportunities among Tier 1 customers. The goodwill is not expected to be deductible for tax purposes.

As of September 30, 2022, the Company finalized the opening net assets acquired and goodwill as follows:

Preliminary ValuationAdjustmentFinal
Valuation
Property and equipment$1,315 $109 $1,424 
Developed technology5,077 (5,077)— 
In-progress research & development1,562 8,538 10,100 
Current liabilities(754)217 (537)
Deferred tax liabilities, non-current(1,578)(822)(2,400)
Goodwill10,667 (2,965)7,702 

Changes in fair value of fixed assets and deferred tax liabilities, non-current were a result of gathering additional information during the measurement period. The Company also revised the initial values of intangible assets as a result of switching from utilizing publicly available benchmarking information to determine the fair value of the intangible assets to primarily utilizing an income method based on forecasts of expected future cash flows. As a result, the Company recorded an adjustment to the amortization of intangible assets of $169 in the condensed consolidated statement of operations during the three and nine months ended September 30, 2022 that would have been recorded during the prior periods if the adjustment to the intangible assets had been recognized as of the date of the acquisition.

The fair value of in-process research and development (“IPR&D”), was determined using the multi-period excess earnings method under the income approach. This method reflects the present value of the projected cash flows that are expected to be generated by the IPR&D, less charges representing the contribution of other assets to those cash flows. Under the multi-period excess earnings method, the fair value models incorporated estimates of future cash flows, estimates of allocations of certain assets and cash flows, estimates of future growth rates and management’s judgment regarding the applicable discount rates to use to discount such estimates of cash flows. Because the estimates and assumptions made by management at the time of the acquisitions are unobservable and significant to the overall fair value measurement of these acquired identifiable intangible assets, the corresponding fair values are classified as Level 3 fair value hierarchy measurements.

As of September 30, 2022, indie incurred approximately $392 of acquisition-related costs, which were primarily legal expenses and recorded as part of the Selling, General and Administrative expenses.
Total purchase consideration transferred at closing also included contingent consideration that had a fair value of $4,000 as of the acquisition date. The maximum contingent consideration payable in connection with the acquisition is $7,500. The acquisition date fair value of the contingent considerations was determined based on the Company’s assessment of the probability of achieving the performance targets that ultimately obligate the Company to transfer additional consideration to the seller. The contingent consideration is comprised of two tranches. The first tranche (“Tapeout”) is payable, up to a maximum of $2,500, upon the achievement of tapeout of certain product designs acquired from the seller within 30 months of the acquisition. The second tranche (“Design Win”) is payable, up to a maximum of $5,000, upon indie’s achievement of a design win related to certain acquired product designs within 36 months of the acquisition. The fair value of any outstanding contingent consideration liabilities will be remeasured as of the end of each reporting period with any resulting remeasurement gains or losses recognized in the condensed consolidated statement of operations. During the six months ended June 30, 2022, management determined that the product designs specified in the contingent consideration arrangement would be replaced with a new product design that is better aligned with customer requirements and which will not be eligible for either of the

18

contingent considerations. Accordingly, the fair value of Tapeout and Design Win contingent consideration liabilities were reduced to zero during the three months ended June 30, 2022.

Pro forma financial information for the three and nine months ended September 30, 2021 for ON Design Israel is not disclosed as the results are not material to the Company’s condensed consolidated financial statements.

Acquisition of Symeo GmbH

On October 21, 2021, indie entered into a definitive agreement with ADI to acquire Symeo. The acquisition was approved by the German government on January 4, 2022 and closed on the same day. The total consideration paid for this acquisition consisted of (i) $8,705 in cash at closing, net of cash acquired; (ii) a $10,000 promissory note payable in January 2023 with a fair market value of $9,674; and (iii) an equity-based earn-out of up to 858,369 shares of indie Class A common stock based on future revenue growth. The fair market value of this equity-based earn-out was $8,204 on January 4, 2022. The acquisition date fair value of the equity-based earn-out was determined based on the Company’s assessment of the probability of achieving the performance targets that ultimately obligate the Company to transfer additional consideration to the seller. This earn-out has two tranches. Both tranches are payable upon Symeo achieving a revenue threshold of $5,000 by March 31, 2023, another revenue threshold of $6,000 by March 31, 2024 and annual gross margin of Symeo for each period of greater than 65%. The fair value of any outstanding contingent consideration liabilities will be remeasured as of the end of each reporting period with any resulting remeasurement gains or losses recognized in the condensed consolidated statements of operations. The fair value of these contingent consideration liabilities was $4,330 and $4,007, respectively, as of September 30, 2022. The first tranche of this earn-out liability is reflected in Accrued expense and other current liabilities and the second tranche is reflected in Other long-term liabilities in the condensed consolidated balance sheet as of September 30, 2022.

indie incurred various acquisition-related costs, which were primarily legal expenses and recorded as part of the Selling, General and Administrative expenses. Total costs incurred is de minimis as of September 30, 2022.

Pro forma financial information for the three and nine months ended September 30, 2021 for Symeo is not disclosed as the results are not material to the Company’s condensed consolidated financial statements.
3.    Inventory, Net

Inventory, net consists of the following:
September 30, 2022December 31, 2021
Raw materials$4,241 $2,380 
Work-in-process5,264 6,301 
Finished goods4,069 2,151 
Inventory, gross13,574 10,832 
Less: Inventory reserves1,995 1,752 
Inventory, net$11,579 $9,080 
During the three months ended September 30, 2022 and 2021, the Company recognized write-downs in the value of inventory of $485 and $13, respectively. During the nine months ended September 30, 2022 and 2021, the Company recognized write-downs in the value of inventory of $1,192 and $78, respectively.

19

4.    Property and Equipment, Net

Property and equipment, net consists of the following:
Useful life (in years)September 30, 2022December 31, 2021
Production tooling4$10,055 $10,158 
Lab equipment45,484 4,489 
Office equipment
3 - 7
3,460 1,893 
Leasehold improvements*702 395 
Construction in progress1,111 256 
Property and equipment, gross20,812 17,191 
Less: Accumulated depreciation8,303 6,101 
Property and equipment, net$12,509 $11,090 
*Leasehold improvements are amortized over the shorter of the remaining lease term or estimated useful life of the leasehold improvement.
The Company recognized depreciation expense of $753 and $254 for the three months ended September 30, 2022 and 2021, respectively. The Company recognized depreciation expense of $2,311 and $685 for the nine months ended September 30, 2022 and 2021, respectively.

Fixed assets not yet in service consist primarily of capitalized internal-use software and certain tooling and other equipment that have not been placed into service.

5.    Intangible Assets, Net

Intangible assets, net consist of the following:

September 30, 2022December 31, 2021
Weighted
Average
Remaining
Useful Life
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Weighted
Average
Remaining
Useful Life
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Developed technology3.7$24,305 $(4,558)$19,747 6.7$49,040 $(1,374)$47,666 
Software licenses2.023,305 (10,009)13,296 2.523,297 (6,286)17,011 
Customer relationships8.115,470 (1,379)14,091 6.712,682 (365)12,317 
Intellectual property licenses1.31,777 (1,707)70 1.51,736 (1,687)49 
Trade names5.77,911 (967)6,944 6.76,125 (182)5,943 
Backlog1.3619 (203)416 1.82,378 (239)2,139 
Effect of exchange rate on gross carrying amount(4,705)(4,705)(631)— (631)
Intangible assets with finite lives68,682 (18,823)49,859 94,627 (10,133)84,494 
IPR&D12,270 — 12,270 11,866 — 11,866 
Effect of exchange rate on gross carrying amount(1,265)— (1,265)(75)— (75)
Total intangible assets with indefinite lives11,005 — 11,005 11,791 — 11,791 
Total intangible assets$79,687 $(18,823)$60,864 $106,418 $(10,133)$96,285 

The Company obtained software licenses, which it uses for its research and development efforts related to its products. In fiscal 2022 and 2021, the Company obtained additional software licenses. Further, the Company has acquired developed technology, customer relationships, trade names, backlog and IPR&D as a result of the business combinations. The change in gross amount

20

of intangible assets is related to the business combination valuation for TeraXion and ON Design that was finalized during the three months ended September 30, 2022. See Note 2 - Business Combinations for additional information.

Intangible assets with finite lives are amortized on a straight-line basis over the expected period to be benefited by future cash flows. The Company monitors and assesses these assets for impairment on a periodic basis. As of September 30, 2022, the Company determined that there was no impairment of intangible assets.

Amortization of intangible assets for the three months ended September 30, 2022 and 2021 was $51 and $1,459, respectively. Amortization for the nine months ended September 30, 2022 and 2021 was $8,859 and $2,222, respectively. Amortization of intangible assets is included within Cost of goods sold, Research and development expenses, and Selling, general and administrative expenses based their respective nature, in the condensed consolidated statements of operations.

Based on the amount of definite-lived intangible assets subject to amortization as of September 30, 2022, amortization expense for each of the next five fiscal years is expected to be as follows:

2022 (remaining three months)$3,455 
202314,933 
202411,806 
20256,462 
20263,389 
Thereafter9,814 
$49,859 
6.    Goodwill
The following table sets forth the carrying amount and activity of goodwill as of September 30, 2022:
Amount
Balance as of December 31, 2021$115,206 
Acquisitions (Note 2)14,268 
Measurement period adjustment for business combinations from prior year25,567 
Effect of exchange rate on goodwill(13,003)
Balance as of September 30, 2022$142,038 
The change in goodwill is primarily driven by $14,268 increase during the nine months ended September 30, 2022 due to acquisition of Symeo that was completed during the period, $25,567 increase related to the finalization of business combination valuations for TeraXion and ON Design and partially offset by $13,003 decrease in value due to effect of exchange rate on goodwill. See Note 2 for a detailed discussion of goodwill acquired as well as adjustments due to finalization of the business combination valuations.
The Company tests its goodwill for impairment annually as of the first day of its fourth fiscal quarter and in interim periods if certain events occur indicating the carrying value of goodwill may be impaired. There were no indicators of impairment noted during the nine months ended September 30, 2022.

21

7.    Debt
The following table sets forth the components of debt as of September 30, 2022 and December 31, 2021:
September 30, 2022December 31, 2021
Principal
Outstanding
Unamortized
Discount
and
Issuance Cost
Carrying
Amount
Principal
Outstanding
Unamortized
Discount
and
Issuance Cost
Carrying
Amount
Short term loans$1,830 $— $1,830 $810 $— $810 
Promissory note10,000 (100)9,900 — — — 
CIBC loan5,537 (15)5,522 7,102 (19)7,083 
Total debt$17,367 $(115)$17,252 $7,912 $(19)$7,893 
The outstanding debt as of September 30, 2022 and December 31, 2021 is classified in the condensed consolidated balance sheets as follows:
September 30, 2022December 31, 2021
Current liabilities - Current debt obligations$13,082 $2,275 
Noncurrent liabilities - Long-term debt, net of current maturities4,170 5,618 
Total debt$17,252 $7,893 
PacWest Revolving Line of Credit
The Company entered into a loan and security agreement with Pacific Western Bank (“PacWest”) in January 2015, that provided a term loan of up to $10,000 with a maturity date of September 2020. The term loan bore interest equal to the greater of one percent above the prime rate in effect, or 4.5% on outstanding borrowings. In addition, the loan and security agreement provided for a revolving line of credit. The revolving line of credit bore interest equal to the greater of seventy-five basis points above the prime rate in effect, or 4.25% on outstanding borrowings. The terms of the loan and security agreement have been amended from time to time and was most recently amended on November 5, 2021 as described below. The amendments have, among other things, extended the maturity date of the loan and adjusted the financial covenants’ borrowing limits. During 2020, the outstanding balance on the term loan was transferred to the revolving line of credit.

On November 5, 2021, the Company entered into an amendment to the PacWest loan agreement that (i) increased the maximum borrowing capacity under the revolving line of credit to $20,000, (ii) limited the security interests of the bank to the cash collateral set at 102.5% of the drawn amount of the loan, (iii) removed various reporting and restrictive covenants, (iv) extended the maturity date to November 4, 2022 and (iv) reduced the interest rate to 2.1% per annum. In addition, the amendment requires the Company to collateralize a cash balance equal to the total outstanding balance in a cash security account with PacWest. Upon execution of the amendment, the Company repaid the outstanding balance of $1,675 under the original line of credit to this new arrangement.
As of September 30, 2022 and December 31, 2021, there was no outstanding balance on the revolving line of credit. The Company’s borrowings under the revolving line of credit were subject to an aggregate borrowing limit of $20,000 as of September 30, 2022 and December 31, 2021. Total borrowings at any given time under the revolving line of credit are limited to a percentage of domestic accounts receivables less than 90 days past due and other factors.
The revolving line of credit is subject to debt covenants which, if violated, could result in the outstanding balance becoming immediately due. The Company has complied with or obtained waivers for all such covenants as of the date these financial statements were issued.

TeraXion Revolving Credit

In connection with the acquisition of TeraXion on October 12, 2021, the Company assumed a revolving credit with the Canadian Imperial Bank of Commerce (“CIBC”) with a credit limit of CAD9,440 bearing interest at prime rate plus 0.25%, repayable in monthly installments of CAD155 plus interest, maturing in October 2026. The repayment of monthly installments reduces the credit limit over time. As of September 30, 2022 and December 31, 2021 the outstanding principal balance and

22

credit limit of the loan was $5,537 and $7,102, or CAD7,583 and CAD8,976, respectively. This loan is secured with an authorized credit facility of CAD7,000 from the bank, bearing interest at prime rate plus 0.25%. This line of credit was unused as of September 30, 2022 and December 31, 2021.

Short Term Loans
Wuxi
On November 13, 2019, Wuxi entered into a short-term loan agreement with CITIC Group Corporation Ltd. with aggregate principal balance of CNY2,000, or approximately $285, and bearing interest of 4.785% per annum. The principal balance is denominated in Chinese Yuan and the outstanding balance is adjusted for changes in foreign currency exchange rates at each reporting period. On November 13, 2020, the terms of the agreement were extended for twelve months, and the principal and interest were due on November 15, 2021. On November 19, 2021, the total outstanding balance with CITIC Group Corporation was fully paid off. On January 19, 2022, Wuxi entered into a short-term loan agreement with CITIC Group Corporation Ltd. with aggregate principal balance of CNY2,000, or approximately $315, and bearing interest of 3.90% per annum. On June 21, 2022, Wuxi increased its short-term loan principal with CITIC by CNY3,000, or approximately $448, and bearing interest of 3.70% per annum. The principal balance is denominated in Chinese Yuan and the outstanding balance is adjusted for changes in foreign currency exchange rates at each reporting period. As of September 30, 2022, the total outstanding short-term loan with CITIC Group Corporation Ltd. was CNY5,000, or approximately $704.

On October 15, 2020, Wuxi entered into a short-term loan agreement with Bank of Ningbo (“NBCB”) with aggregate principal balance of CNY1,000 or approximately $151 and bearing interest of 4.785%. On April 29, 2021, Wuxi increased its short-term loan principal with NBCB by CNY1,000 or approximately $155 to a total principal balance of CNY4,000. On October 14, 2021, the borrowing from October 15, 2020 was fully paid off. On October 18, 2021, Wuxi re-entered into a short-term loan agreement with NBCB for CNY1,000, or approximately $150 and bearing interest of 4.785%. On April 26, 2022, the entire loan balance was paid off, and on April 27, 2022 Wuxi entered into a short-term loan agreement with NBCB with aggregate principal balance of CNY2,000, or approximately $304, and bearing interest of 4.26% per annum. On June 24, 2022, Wuxi increased its principal balance by CNY3,000, or $448, and bearing interest of 3.15% per annum. As of September 30, 2022, the total outstanding short-term loan with NBCB was CNY5,000, or $704. As of December 31, 2021, the total outstanding short-term loan with NBCB was CNY2,000, or $315.

On November 18, 2021, Wuxi also entered into a short-term loan agreement with Bank of Nanjing with aggregate principal balance of CNY3,000, or approximately $453, and bearing interest of 4.00%. As of September 30, 2022, the total outstanding short-term loan with Bank of Nanjing was CNY3,000, or $422. As of December 31, 2021, the total outstanding short-term loan with Bank of Nanjing was CNY3,000, or $472.

Symeo Promissory Note

In connection with the Symeo acquisition on January 4, 2022, the Company issued a short-term interest-free promissory note of $10,000, payable upon its maturity of January 31, 2023. As of September 30, 2022, the outstanding principal balance was $10,000 and the carrying value was $9,900.

The table below sets forth the components of interest expense for the three and nine months ended September 30, 2022 and September 30, 2021:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Interest expense on debt obligations:
Contractual interest$91 $24 $265 $977 
Amortization of discount and issuance cost75 226 198 
Total interest expense$166 $25 $491 $1,175 
8.    Warrant Liability

In connection with the June 10, 2021 Transaction, holders of TB2 Class A ordinary shares automatically received Class A common stock of indie, and holders of TB2 warrants automatically received 17,250,000 warrants of indie with substantively identical terms (“Public Warrants”). At the closing of the Transaction, 8,625,000 Class B ordinary shares of TB2 owned by

23

Thunder Bridge Acquisition II LLC, a Delaware limited liability company (the “Sponsor”), automatically converted into 8,625,000 shares of indie Class A common stock, and 8,650,000 private placement warrants held by the Sponsor, each exercisable for one Class A ordinary share of TB2 at $11.50 per share, automatically converted into warrants to purchase one share of indie Class A common stock at $11.50 per share with substantively identical terms (the “Private Placement Warrants”). Also at the Closing, TB2 issued 1,500,000 working capital warrants to an affiliate of the Sponsor in satisfaction of a working capital promissory note of $1,500 (the “Working Capital Warrants” and, together with the Private Placement Warrants, the “Private Warrants”). These Working Capital Warrants have substantially identical terms to the Private Placement Warrants.

The warrants may be exercised only during the period commencing on July 10, 2021 (30 days after the closing of the Transaction) through June 10, 2026. The Company may redeem the Public Warrants at a price of $0.01 per warrant upon 30 days’ notice, only in the event that the last sale price of the Class A common stock is at least $18.00 per share for any 20 trading days within a 30-trading day period ending on the third day prior to the date on which notice of redemption is given, provided there is an effective registration statement and current prospectus in effect with respect to the Class A common stock underlying such warrants during the 30 day redemption period. If the Company redeems the warrants as described above, management will have the option to require all holders to exercise warrants on a cashless basis.

In accordance with the warrant agreement relating to the Public Warrants, the Company is required to use its best efforts to maintain the effectiveness of the registration statement covering the warrants. If a registration statement is not effective within 90 days following the consummation of a business combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company shall have failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to an available exemption from registration under the Securities Act. In the event that a registration statement is not effective at the time of exercise or no exemption is available for a cashless exercise, the holder of such warrant shall not be entitled to exercise such warrant for cash and in no event (whether in the case of a registration statement being effective or otherwise) will the Company be required to net cash settle the warrant exercise.

The terms of the Private Warrants are identical to the Public Warrants as described above, except that the Private Warrants are not redeemable so long as they are held by the Sponsor or its permitted transferees.

The Company has reviewed the terms of warrants to purchase its Class A common stock to determine whether warrants should be classified as liabilities or stockholders’ equity in its condensed consolidated balance sheet. In order for a warrant to be classified in stockholders’ equity, the warrant must be (a) indexed to the Company’s equity and (b) meet the conditions for equity classification in ASC 815-40, Derivatives and Hedging – Contracts in an Entity’s Own Equity. If a warrant does not meet the conditions for equity classification, it is carried on the condensed consolidated balance sheet as a warrant liability measured at fair value, with subsequent changes in the fair value of the warrant recorded in the statement of operations as change in fair value of warrants in Other income (expense), net. The Company determined that all warrants are required to be carried as a liability in the condensed consolidated balance sheet at fair value, with changes in fair value recorded in the condensed consolidated statement of operations (see Note 10). At the closing of the Transaction on June 10, 2021, the warrants had an initial fair value of $74,408, which was recorded as liability and a reduction to additional paid in capital in the condensed consolidated balance sheet.

The following table is a summary of the number of shares of the Company’s Class A common stock issuable upon exercise of warrants outstanding at June 10, 2021:

Number of SharesExercise
Price
Redemption PriceExpiration DateClassificationInitial Fair Value
Public Warrants17,250,000 $11.50 $18.00 June 10, 2026Liability$42,435 
Private Warrants10,150,000 $11.50 N/AJune 10, 2026Liability$31,973 

As of September 30, 2022, there have been no exercises of the warrants and the fair value was $51,872.

9.     Contingent and Earn-Out Liabilities
Earn-Out Milestones

Certain of indie’s stockholders are entitled to receive up to 10,000,000 earn-out shares of the Company’s Class A common stock if the earn-out milestones are met. The earn-out milestones represent two independent criteria, each of which entitles the eligible stockholders to 5,000,000 earn-out shares per milestone met. Each earn-out milestone is considered met if at any time following the Transaction and prior to December 31, 2027, the volume weighted average price of indie’s Class A common

24

stock is greater than or equal to $12.50 or $15.00 for any twenty trading days within any thirty-trading day period, respectively. Further, the earn-out milestones are also considered to be met if indie undergoes a Sale. A Sale is defined as the occurrence of any of the following for indie: (i) engage in a “going private” transaction pursuant to Rule 13e-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise cease to be subject to reporting obligations under Sections 13 or 15(d) of the Exchange Act; (ii) Class A common stock ceases to be listed on a national securities exchange, other than for the failure to satisfy minimum listing requirements under applicable stock exchange rules; or (iii) change of ownership (including a merger or consolidation) or approval of a plan for complete liquidation or dissolution.
Escrow Shares
3,450,000 Class A common shares of indie were placed in escrow for the potential future release to the Sponsor in the event the earn-out milestones are met. The earn-out milestones for the Escrow Shares are identical to those of the earn-out shares. Achievement of each milestone entitles the shareholders to 50% of the total Escrow Shares. The Escrow Shares have been accounted for as a liability and remeasured to fair value each reporting period.
As of November 9, 2021, the first earn-out milestone was achieved while the second Earn-Out Milestone remains unachieved. The achievement of the first earn-out milestone eliminated the variability in the arrangement that previously prevented this instrument to be equity-classified. As a result, the earn-out liabilities associated with the first Earn-Out Milestone were recorded to Additional paid-in capital in the condensed consolidated balance sheet at its fair value. At the same time, the unearned liabilities associated with the second Earn-Out Milestones were also remeasured to its fair value and reclassified per ASC 815-40 to Additional paid-in capital in the condensed consolidated balance sheet.
As of December 31, 2021, there was no liability remaining on the balance sheet.
Contingent Considerations

On May 13, 2020, in connection with the acquisition of City Semiconductor, Inc. (“City Semi”), the Company recorded contingent consideration as a long-term liability at a fair value of $1,180. The contingent consideration is comprised of two tranches. The first tranche is payable, up to a maximum of $500, upon the achievement of cash collection targets within twelve months of the acquisition, and $456 was achieved in May 2021. The second tranche is payable, up to a maximum of $1,500, upon the shipment of a product incorporating the acquired developed technology. In September 2021, the Company paid off the first tranche of the contingent consideration. The fair value of the second tranche contingent consideration liabilities was $1,340 as of September 30, 2022.

On October 1, 2021, in connection with the acquisition of ON Design Israel, the Company recorded contingent consideration as a long-term liability at a fair value of $4,000. The contingent consideration is comprised of two tranches. The first tranche is payable, up to a maximum of $2,500, upon the achievement of Tapeout of certain product designs acquired from the seller within 30 months of the acquisition. The second tranche is payable, up to a maximum of $5,000, upon indie’s achievement of a Design Win related to certain acquired product designs within 36 months of the acquisition. During the three months ended June 30, 2022, management determined that the product design specified in the contingent consideration provision would be replaced with a new product design that is better aligned with customer requirements and which will not be eligible for either of the contingent considerations. Accordingly, the fair value for both the Tapeout and Design Win were reduced to zero as of June 30, 2022. The change in fair value since the acquisition date is recorded in Other income (expense), net in the condensed consolidated statement of operations for the nine months ended September 30, 2022.

On January 4, 2022, in connection with the acquisition of Symeo, the Company recorded contingent considerations as a current and a long-term liability at a fair value of $4,212 and $3,992, respectively. The contingent consideration is comprised of two tranches. The first tranche is payable upon the achievement of a revenue threshold of $5,000 by December 31, 2022. The second tranche is payable upon Symeo’s achievement of a revenue threshold of $6,000 by December 31, 2023. The fair value of the first and second tranche contingent consideration liabilities as of September 30, 2022 was $4,330 and $4,007, respectively. The change in fair value since the acquisition date is recorded in Other income (expense), net in the condensed consolidated statement of operations for the three and nine months ended September 30, 2022.
10.    Fair Value Measurements
The Company’s debt instruments are recorded at their carrying values in its condensed consolidated balance sheets, which may differ from their respective fair values. The fair values of the Company’s term loans generally approximated their carrying values given their relative shorter-term in nature. The fair value of the promissory note in relation with the Symeo acquisition was determined using valuation inputs categorized as Level 3.

25


As of September 30, 2022, the Company held currency forward contracts of $3,550 to sell United States dollars and to buy Canadian dollars at a forward rate. Any changes in the fair value of these contracts are reflected in the condensed consolidated statement of operations. The fair value of the currency forward contracts was determined using valuation inputs categorized as Level 2. The change in fair value the three and nine months ended September 30, 2022 was a gain of $211.

The following table presents the Company’s fair value hierarchy for financial liabilities:

Fair Value Measurements as of September 30, 2022
Level 1Level 2Level 3Total
Liabilities:
Private Placement Warrants$— $— $20,994 $20,994 
Public Warrants$30,878 $— $— $30,878 
City Semi Contingent Consideration - Second Tranche$— $— $1,340 $1,340 
Symeo Contingent Consideration - First Tranche$— $— $4,330 $4,330 
Symeo Contingent Consideration - Second Tranche$— $— $4,007 $4,007 
Symeo Promissory Note$— $— $9,674 $9,674 
Fair Value Measurements as of December 31, 2021
Level 1Level 2Level 3Total
Liabilities:
Private Placement Warrants$— $— $40,092 $40,092 
Public Warrants$60,375 $— $— $60,375 
ON Design Israel Contingent Consideration - Tapeout$— $— $1,817 $1,817 
ON Design Israel Contingent Consideration - Design Win$— $— $2,222 $2,222 
City Semi Contingent Consideration - Second Tranche$— $— $980 $980 

As of September 30, 2022 and December 31, 2021, the Company’s cash and cash equivalents were all held in cash or Level 1 instruments where the fair values approximate the carrying values.

Level 3 Disclosures

Warrants

Warrants were valued using the Black-Scholes-Merton formula and a Monte Carlo Simulations analysis. Calculating the fair value of warrants requires the input of subjective assumptions. Other reasonable assumptions could provide differing results. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value.

Earn-out Liabilities

Earn-out liabilities that are specifically indexed to the Company’s stock price were valued using a Monte Carlo analysis in order to simulate the future path of the Company’s stock price over the earn-out period. The carrying amount of the liability may fluctuate significantly and actual amounts paid may be materially different from the liability’s estimated value.

Contingent Considerations

Contingent considerations were valued based on the consideration expected to be transferred. The Company estimated the fair value based on the probability of achievement of various milestones identified within each contingent consideration arrangement, using certain assumptions that require significant judgement and discount rates. The discount rates were based on the estimated cost of debt plus a premium, which included consideration of expected term of the earn-out payment, yield on treasury instruments and an estimated credit rating for the Company.
The following table presents the significant unobservable inputs assumed for each of the fair value measurements:

26


September 30, 2022December 31, 2021
InputInput
Liabilities:
Warrants
Expected volatility50.50 %36.00 %
City Semi Contingent Consideration - Second Tranche
Discount rate10.80 %10.80 %
ON Design Israel Contingent Consideration - Tapeout
Discount rateN/A4.37 %
ON Design Israel Contingent Consideration - Design Win
Discount rateN/A4.37 %
Symeo Contingent Consideration - First Tranche
Discount Rate8.03 %N/A
Symeo Contingent Consideration - Second Tranche
Discount Rate8.03 %N/A
Symeo Promissory Note
Discount rate3.13 %N/A

11.    Noncontrolling Interest

In connection with the closing of the Transaction on June 10, 2021, certain members of ADK LLC (the “ADK Minority Holders”) retained an approximate 26% membership interest in ADK LLC. The ADK Minority Holders may from time to time, after December 10, 2021, exchange with indie, such holders’ units in ADK LLC for an equal number of shares of indie’s Class A common stock. As a result, indie’s ownership interest in ADK LLC will increase. The ADK Minority Holders’ ownership interests are accounted for as noncontrolling interests in the Company’s condensed consolidated financial statements. The Company’s ownership of ADK LLC, was approximately 84% as of September 30, 2022.

In connection with the Transaction, the Company issued to ADK Minority Holders an aggregate of 33,827,371 shares of Class V common stock of indie (the “Class V Holders”). The shares of Class V common stock provides no economic rights in indie to the holder thereof; however, each Class V Holder is entitled to vote with the holders of Class A common stock of indie, with each share of Class V common stock entitling the holder to one (1) vote per share of Class V common stock at the time of such vote (subject to customary conversion rate adjustments for stock splits, stock dividends and reclassifications). As of September 30, 2022, the Company had an aggregate of 23,749,676 shares of Class V common stock issued and outstanding.

ADK LLC held 64% and 50% voting control and 44% and 50% ownership interest in Wuxi as of September 30, 2022 and December 31, 2021, respectively. From time to time, Wuxi has sold equity ownership and the transactions have reduced ADK LLC’s controlling interest in Wuxi on the condensed consolidated balance sheets. As of September 30, 2022, ADK LLC maintained its controlling ownership in Wuxi. Accordingly, Wuxi’s financial statements are consolidated with those of ADK LLC and its other wholly-owned subsidiaries as of and for the three and nine months ended September 30, 2022 and 2021. Minority interests held in Wuxi are accounted for as non-controlling interests in the Company’s condensed consolidated financial statements.
12.    Revenue
Disaggregation of Revenue
The Company disaggregates revenue from contracts with customers by geographic region, as the Company’s management believes it best depicts how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.

27

The following tables present revenue disaggregated by geography of the customer’s shipping location for the three and nine months ended September 30, 2022 and 2021:

Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
United States$11,426 $2,033 $26,676 $5,910 
Greater China10,911 7,591 31,163 17,800 
Europe5,368 711 13,022 1,523 
Rest of North America1,109 1,286 3,440 2,513 
Rest of Asia Pacific881 127 2,442 701 
South America321 409 1,027 1,004 
Total revenue$30,016 $12,157 $77,770 $29,451 

Contract Balances
Certain assets or liabilities are recorded depending on the timing of revenue recognition, billings and cash collections on a contract-by-contract basis. Contract liabilities primarily relate to deferred revenue, including advance consideration received from customers for contracts prior to the transfer of control to the customer, and therefore revenue is recognized upon delivery of products and services or as the services are performed. The Company recorded unbilled revenue of $1,851 and $402 as of September 30, 2022 and December 31, 2021, respectively, as part of its Prepaid expenses and other current assets in the accompanying condensed consolidated balance sheets.
The following table presents the liabilities associated with the engineering services contracts as of September 30, 2022 and December 31, 2021:
September 30,
2022
December 31,
2021
Deferred revenue$1,627 $1,840 
As of September 30, 2022 and December 31, 2021, contract liabilities were included as Deferred revenue and classified as current liabilities in the condensed consolidated balance sheets.
During the three months ended September 30, 2022 and 2021, the Company recognized $139 and $206, respectively, of revenue related to amounts that were previously included in deferred revenue at the beginning of the period. During the nine months ended September 30, 2022 and 2021, the Company recognized $1,103 and $819, respectively, of revenue related to amounts that were previously included in deferred revenue at the beginning of the period. Deferred revenue fluctuates over time due to changes in the timing of payments received from customers and revenue recognized for services provided.
Revenue related to remaining performance obligations represents the amount of contracted development arrangements that has not been recognized, which includes deferred revenue on the condensed consolidated balance sheet and unbilled amounts that will be recognized as revenue in future periods. As of September 30, 2022, the amount of performance obligations that have not been recognized as revenue was $39,885, of which approximately 63% is expected to be recognized as revenue over the next twelve months and the remainder thereafter. This amount excludes the value of remaining performance obligations for contracts with an original expected length of one year or less. Variable consideration that has been constrained is excluded from the amount of performance obligations that have not been recognized.
Concentrations
As identified below, some of our customers accounted for more than 10% of the Company’s total revenue for the three and nine months ended September 30, 2022 and 2021:


28

Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Customer A36.7 %25.7 %37.3 %39.3 %
Customer B— %12.9 %— %5.4 %

The loss of these customers would have a material impact on the Company’s condensed consolidated financial results.
The largest customer represented 27% of accounts receivable as of September 30, 2022 and the one largest customer represented 31% of accounts receivable as of December 31, 2021. No other individual customer represented more than 10% of accounts receivable at either September 30, 2022 or December 31, 2021.
13.    Share-Based Compensation

Stock compensation expense is recorded in cost of goods sold, research and development, and general and administrative expenses based on the classification of the work performed by the grantees.

The following table sets forth the share-based compensation for the periods presented:

Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Cost of goods sold$68 $— $81 $— 
Research and development7,048 2,588 21,112 5,185 
Selling, general, and administrative2,547 3,629 9,652 9,000 
Total$9,663 $6,217 $30,845 $14,185 

Stock compensation expense for the three and nine months ended September 30, 2022 included $1,770 and $5,117, respectively, which represents liability classified awards for the Company’s 2022 annual incentive plan accrual.
14.    Net Loss per Common Share
Basic and diluted net loss per common share was calculated as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
Numerator:
Net loss$(45,432)$(108,161)$(37,030)$(84,812)
Less: Net loss attributable to noncontrolling interest(7,825)(28,512)(6,022)(22,127)
Net loss attributable to indie Semiconductor, Inc.$(37,607)$(79,649)$(31,008)$(62,685)
Net loss attributable to common shareholders - dilutive$(37,607)$(79,649)$(31,008)$(62,685)
Denominator:
Weighted average shares outstanding - basic120,507,152 96,368,379 116,272,459 58,791,245 
Weighted average common shares outstanding—diluted120,507,152 96,368,379 116,272,459 58,791,245 
Net loss per share attributable to common shares— basic$(0.31)$(0.83)$(0.27)$(1.07)
Net loss per share attributable to common shares— diluted$(0.31)$(0.83)$(0.27)$(1.07)

29

The Company’s potentially dilutive securities, which include SAFEs, unvested Class B units, unvested phantom units, unvested restricted stock units, convertible Class V common shares, warrants for Class A units (public and private), unexercised options, earn-out shares and escrow shares, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. The Company excluded the following potential shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to shareholders for the periods indicated as their inclusion would have had an antidilutive effect:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2022202120222021
SAFEs— — — 7,651,982 
Unvested Class B units— — — 1,817,375 
Unvested Phantom units1,060,119 1,727,730 1,060,119 1,727,730 
Unvested Restricted stock units8,248,983 3,437,188 8,248,983 3,437,188 
Convertible Class V common shares23,749,676 33,827,371 23,749,676 33,827,371 
Public warrants for the purchase of Class A common shares17,250,000 17,250,000 17,250,000 17,250,000 
Private warrants for the purchase of Class A common shares10,150,000 10,150,000 10,150,000 10,150,000 
Unexercised options368,875 — 368,875 — 
Earn-out Shares5,262,657 10,000,000 5,262,657 10,000,000 
Escrow Shares1,725,000 3,450,000 1,725,000 3,450,000 
67,815,310 79,842,289 67,815,310 89,311,646 
15.    Income Taxes

We are subject to U.S. federal and state taxes with respect to our allocable share of any taxable income or loss of ADK, LLC, as well as any stand-alone income or loss we generate. ADK, LLC is treated as a partnership for U.S. income tax purposes and for most applicable state and local income tax purposes and generally does not pay income taxes in most jurisdictions. Instead, ADK, LLC’s taxable income or loss is passed through to its members, including us. Despite its status as a partnership in the United States, ADK, LLC’s foreign subsidiaries are taxable entities operating in foreign jurisdictions. As such, these foreign subsidiaries record a tax expense or benefit in jurisdictions where a valuation allowance has not been recorded.

Our effective tax rate in 2022 will differ from the U.S. federal statutory rate primarily due to changes in valuation allowance, tax expense or benefit in foreign jurisdictions taxed at different tax rates and foreign research and development tax credits and incentives, and changes in non-controlling interest.

Based primarily on our limited operating history and ADK LLC’s historical domestic losses, we believe there is a significant uncertainty as to when we will be able to use our domestic, federal and state, deferred tax assets (“DTAs”). Therefore, we have recorded a valuation allowance against these DTAs for which we have concluded that it is not more likely than not that these will be realized.

As part of reverse capitalization, the Company entered into Tax Receivable Agreements (“TRAs”) with certain shareholders that will represent approximately 85% of the calculated tax savings based on the portion of basis adjustments on future exchanges of ADK, LLC units and other carryforward attributes assumed that we anticipate to be able to utilize in future years. Through September 30, 2022, there have been exchanges of units that would generate a DTA; however, as there is a full valuation allowance on the related DTA, we have not recorded a liability under the TRAs.

The Company recorded a benefit (provision) for income taxes of $(863) and $36 for the three months ended September 30, 2022 and 2021, respectively. The Company recorded a benefit (provision) for income taxes of $665 and $(34) for the nine months ended September 30, 2022 and 2021, respectively. Income tax expense and benefits are primarily related to the Company’s operations in Canada and Europe.

Recent Change in U.S. Tax Law

Prior to 2022, IRC Section 174 allowed taxpayers to deduct “research or experimental” (“R&E”) expenditures in the year in which they were incurred.


30

The 2017 tax reform act amended Section 174, effective for amounts paid or incurred in tax years beginning after December 31, 2021, to require taxpayers to charge their R&E expenditures to a capital account. Capitalized costs are required to be amortized over five years (15 years for expenditures attributable to foreign research).

Due to the Company’s significant R&E expenses the impact of this law change will mean that a significant portion of the Company’s total operating expenses will be taken as a deduction over a 5-year period rather than be currently deductible. The Company does not expect to pay cash taxes as a result of this change as its remaining forecasted operating expenses after excluding R&E expenses are sufficiently significant for the Company to remain in a taxable loss for 2022.
16. Leases
The Company’s lease arrangements consist primarily of corporate and manufacturing facility agreements. The leases expire at various dates through 2028, some of which include options to extend the lease term. The options with the longest potential total lease term consist of options for extension of up to five years following expiration of the original lease term. All of the leases are operating leases. The Company is headquartered in Aliso Viejo, California and has various research and design centers, sales support offices, and manufacturing facilities throughout the world. The key lease terms for the principal locations are summarized below:
In July 2015, the Company entered into a five-year operating lease for its 14,881 square foot headquarters in Aliso Viejo, California, which is payable monthly with periodic rent adjustments over the lease term. The lease requires a security deposit of $30, which is recorded in other assets on the Company’s condensed consolidated balance sheets as well as a tiered, time-based letter of credit that has now reached its lowest tier of $200. Subsequently, the rentable area was expanded to 18,000 square feet and the lease was extended through the end of June 2023. Rent expense is approximately $38 per month.
In October 2015, the Company entered into a five-year operating lease for its Scotland Design Center in Edinburgh, Scotland, which is payable monthly with periodic rent adjustments over the lease term. The lease expired in October 2020. During 2019, the Company entered into a sub-lease agreement with a third party for the Scotland Design Center facility. Separately, effective January 2020, the Company entered into a lease for a property in Scotland. The lease agreement has a term through June 2024 and monthly rent of approximately $16 per month.
In October 2017, the Company entered into a 26-month operating lease for its Wuxi sales and design center. Rent for the associated office is payable monthly with periodic rent adjustments over the lease term. The lease was subsequently extended through December 2022. Rent expense is approximately $8 per month.

In May 2021, the Company entered into a seven-year operating lease for a location in Detroit, Michigan, which is payable monthly with periodic rent adjustments over the lease term. The lease will expire in 2028 with an initial monthly rent of approximately $22 per month.

In October 2021, the Company entered into a five-year operating lease for its design center in Austin, Texas. Rent for the associated office is payable monthly with periodic rent adjustments over the lease term, which expires in October 2026. Rent expense is approximately $13 per month.

In October 2021, the Company acquired TeraXion and assumed its existing operating lease for an office building and a warehouse in Quebec City, Canada. Rent for the associated office is payable at approximately $38 per month. The lease will expire on May 31, 2028. Rent for the associate warehouse is at approximately $3 per month. This lease will expire on November 30, 2023.

In February 2022, the Company entered into a two-year operating lease for its design center in Boston, Massachusetts, which is payable monthly with periodic rent adjustments over the lease term. The lease will expire March 31, 2024.

The total monthly rent for the remaining locations of the Company around the world is not material.

ASC 842 Adoption

The Company adopted ASC 842 using the modified retrospective method on January 1, 2022. The Company determines if an arrangement is a lease at its inception. ROU assets and liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. The Company uses its estimated incremental borrowing rate in determining the present value of lease payments considering the term of the lease, which is derived from information available at the lease commencement date. The lease term includes renewal options when it is reasonably certain that the option will be exercised,

31

and excludes termination options. To the extent that the Company’s agreements have variable lease payments, the Company includes variable lease payments that depend on an index or a rate and excludes those that depend on facts or circumstances occurring after the commencement date, other than the passage of time. Lease expense for these leases is recognized on a straight-line basis over the lease term. The Company has elected the package of practical expedients permitted under the transition guidance, which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company also excluded short-term leases (term of 12 months or less) from the balance sheet presentation and accounted for non-lease and lease components in a contract as a single lease component for certain asset classes. Effective January 1, 2022, the Company recorded the impact on its condensed consolidated balance sheet from the recognition of ROU asset and lease liability of $10,344.

The Company’s facility leases have remaining lease terms ranging from less than one year to six years, some of which include options to extend the lease term for up to six years.

The table below represents lease-related assets and liabilities recorded on the condensed consolidated balance sheet:

Balance Sheet ClassificationSeptember 30, 2022
Assets
Operating lease right-of-use assetsOperating lease right-of-use assets$9,839 
Liabilities
Operating lease liabilities (current)Accrued expenses and other current liabilities$1,632 
Operating lease liabilities (noncurrent)Operating lease liabilities7,879 
Total lease liabilities$9,511 

Lease Costs

The following lease costs were included in the condensed consolidated statements of operations for the three and nine months ended September 30, 2022:

Three Months Ended
September 30, 2022
Nine Months Ended
September 30, 2022
Operating lease cost$607 $1,824 
Short-term lease cost11 114 
Variable lease cost43 140 
Total lease cost$661 $2,078 

Supplemental Information

The table below presents supplemental information related to operating leases as of September 30, 2022:

Cash paid for amounts included in the measurement of operating lease liabilities$533 
Right-of-use assets obtained in exchange for new operating lease liabilities$909 
Weighted average remaining lease term7.37 years
Weighted average discount rate4.78 %

Undiscounted Cash Flows

The table below reconciles the undiscounted cash flows for each of the first five years and total of the remaining years to the operating lease liabilities recorded on the condensed consolidated balance sheet as September 30, 2022:


32

2022 (remaining three months)$530 
20231,947 
20241,431 
20251,310 
20261,308 
Thereafter4,819 
Total minimum lease payments11,345 
Less imputed interest(1,834)
Present value of future minimum lease payments9,511 
Less current obligations under leases(1,632)
Long-term lease obligations$7,879 

Disclosures related to Periods Prior to Adoption of New Lease Standard

Minimum lease payments under operating leases with non-cancelable terms in excess of one year as of December 31, 2021, were as follows:

2022$1,869 
20231,674 
20241,303 
20251,177 
20261,201 
Thereafter1,686 
Total minimum lease payments$8,910 
17.    Commitments and Contingencies
Litigation
The Company may be a party to routine claims or litigation incidental to its business. The Company does not believe that it is a party to any pending legal proceeding that is likely to have a material adverse effect on its business, financial condition, results of operations or cash flows.
Royalty Agreement
The Company has entered into license agreements to use certain technology in its design and manufacture of its products. The agreements require royalty fees for each semiconductor sold using the licensed technology. Total royalty expense incurred in connection with these contracts during the three months ended September 30, 2022 and 2021 was $368 and $221, respectively. Total royalty expense incurred in connection with these contracts during the nine months ended September 30, 2022 and 2021 was $872 and $561, respectively. These expenses are included in cost of goods sold in the condensed consolidated statements of operations. Accrued royalties of $933 and $264 are included in accrued expenses in the Company’s condensed consolidated balance sheets as of September 30, 2022 and consolidated balance sheets as of December 31, 2021, respectively.
Tax Distributions
To the extent the Company has funds legally available, the board of directors will approve distributions to each member of ADK LLC, prior to March 15 of each year, in an amount per unit that, when added to all other distributions made to such member with respect to the previous calendar year, equals the estimated federal and state income tax liabilities applicable to such member as the result of its, his or her ownership of the units and the associated net taxable income allocated with respect to such units for the previous calendar year. There were no distributions approved by the board of directors or paid by the Company during the nine months ended September 30, 2022 and 2021.

33

18. Supplemental Financial Information

Accrued expenses and other current liabilities consist of the following:

September 30, 2022December 31, 2021
Accrued purchase consideration from business combinations$2,500 $7,500 
City Semi deferred compensation— 833 
Contingent consideration4,830 — 
Operating lease liabilities, current1,632 — 
Accrued royalties933 264 
Other (1)5,690 6,025 
Accrued expenses and other current liabilities$15,585 $14,622 
(1) Amount represents accruals for various operating expenses such as professional fees, open purchase orders, current lease liabilities and other estimates that are expected to be paid within the next 12 months.

34

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF INDIE
Unless the context otherwise requires, all references in this section to the “Company,” “we,” “us, or “our” refer to the business of indie and its subsidiaries prior to the consummation of the Transaction. Throughout this section, unless otherwise noted, “indie” refers to indie Semiconductor and its consolidated subsidiaries.
The following discussion and analysis provides information that management believes is relevant to an assessment and understanding of our consolidated results of operations and financial condition. You should read this discussion and analysis in conjunction with the accompanying unaudited condensed consolidated financial statements and notes thereto included elsewhere in this Form 10-Q. Certain amounts may not foot due to rounding. This discussion and analysis contains forward-looking statements. See “Forward Looking Statements.” We urge you to consider the risks and uncertainties discussed in this Quarterly Report on Form 10-Q and the Company’s Annual Report on Form 10-K for the Fiscal Year ended December 31, 2021, under the heading “Risk Factors” and in the other documents we have filed with the SEC in evaluating our forward-looking statements. We assume no obligation to update any of these forward-looking statements except as required by law. Actual results may differ materially from those contained in any forward-looking statements.
OUR COMPANY
indie Semiconductor offers highly innovative automotive semiconductors and software solutions for Advanced Driver Assistance Systems (“ADAS”), autonomous vehicle, connected car, user experience and electrification applications. We focus on edge sensors across multiple modalities spanning LiDAR, radar, ultrasound and computer vision. These functions represent the core underpinnings of both electric and autonomous vehicles, while the advanced user interfaces are transforming the in-cabin experience to mirror and seamlessly connect to the mobile platforms we rely on every day. We are an approved vendor to Tier 1 automotive suppliers and our platforms can be found in marquee automotive manufacturers around the world. Headquartered in Aliso Viejo, California, indie has design centers and sales offices in Austin, Texas; Boston, Massachusetts; Detroit, Michigan; San Francisco and San Jose, California; Cordoba, Argentina; Budapest, Hungary; Dresden and Munich, Germany; Cambridge, England; Edinburgh, Scotland; Rabat, Morocco; Haifa, Israel; Quebec City, Canada; Seoul, South Korea; Tokyo, Japan and several locations throughout China.

We maintain design centers for our semiconductor engineers and designers in the United States, Argentina, Hungary, Germany, Scotland, Morocco, Israel, and China. We engage subcontractors to manufacture our products. These subcontractors, as well as the majority of our customers’ locations, are primarily in Asia. For the nine months ended September 30, 2022 and 2021, approximately 53% and 67%, respectively, of our product revenues were recognized for shipments to customer locations in Asia.

Execution of At-The-Market Agreement

On August 26, 2022, we entered into an At Market Issuance Agreement (“ATM Agreement”) with B. Riley Securities, Inc., Craig-Hallum Capital Group LLC and Roth Capital Partners, LLC (collectively as “Sales Agents”) relating to shares of our Class A common stock, par value $0.0001 per share. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our Class A common stock having an aggregate offering price of up to $150.0 million from time to time through the Sales Agents, acting as our agent or principal. We implemented this program for the flexibility that it provides to the capital markets and to best time its equity capital needs. As of September 30, 2022, we have raised gross proceeds of $12.3 million and issued 1,506,892 shares of Class A common stock at an averaged per-share sales price of $8.14 through this program. For the three months ended September 30, 2022, we incurred total issuances costs of $0.3 million.

Recent Acquisitions

Symeo GmbH
On October 21, 2021, we entered into a definitive agreement with Analog Devices (“ADI”) to acquire Symeo GmbH (“Symeo”). The acquisition was approved by the German government on January 4, 2022 and closed on the same day. The total consideration paid for this acquisition consisted of (i) $8.7 million in cash at closing, net of cash acquired; (ii) a $10.0 million promissory note payable in January 2023 with a fair market value of $9.7 million; and (iii) an equity-based earn-out of up to 858,369 shares of indie Class A common stock based on future revenue growth. The fair market value of this equity-based earn-out was $8.2 million on January 4, 2022.

See Note 2 - Business Combinations for additional description of this acquisition.
35

Table of Contents

Impact of COVID-19 and Macroeconomic Conditions

The impact of the COVID-19 pandemic as well as macroeconomic conditions, including rising interest rates, inflationary pressures, and volatility in the global financial markets have affected business conditions in our industry. The duration, severity, and future impact of these conditions cannot be predicted; therefore the full extent to which these conditions will directly or indirectly impact the Company’s business operations, results of operations and financial condition is uncertain. Furthermore, like many companies in the semiconductor industry, we are experiencing various supply constraints, including global supply imbalances. While we are working with our global supply chain partners to mitigate this risk, the duration and extent of the supply chain disruptions remain uncertain. Refer to Part I, Item 1A of our 2021 Annual Report on Form 10-K for the fiscal year ended December 31, 2021 under the heading “Risk Factors” for more information.
OPERATING RESULTS

Comparison of the Three Months Ended September 30, 2022 and 2021
Revenue
Three Months Ended September 30,
20222021
(in thousands)$% of Revenue$% of Revenue$ Change% Change
Revenue:
Product revenue$24,425 81 %$11,099 91 %$13,326 120 %
Contract revenue5,591 19 %1,058 %4,533 428 %
Total revenue$30,016 100 %$12,157 100 %$17,859 147 %
Revenue for the three months ended September 30, 2022 was $30.0 million, compared to $12.2 million for the three months ended September 30, 2021, an increase of $17.9 million or 147%, which was primarily driven by a $13.3 million increase in product revenue as well as an increase in contract revenue. The increase in product revenue was due primarily to higher product volume (units sold) given the continued growth in demand from our customers globally. Change in product mix and increases in average selling price (“ASP”) also contributed to the increase in product revenue year-over-year. The increase in contract revenue of $4.5 million or 428% was primarily due to commencement of a large multi-year non-recurring engineering project with a top customer in the current year.
Operating Expenses

Three Months Ended September 30,
20222021
(in thousands)$% of Revenue$% of Revenue$ Change% Change
Operating expenses:
Cost of goods sold$14,970 50 %$6,930 57 %$8,040 116 %
Research and development30,229 101 %15,043 124 %15,186 101 %
Selling, general, and administrative10,676 36 %11,442 94 %(766)(7)%
Total operating expenses$55,875 186 %$33,415 275 %$22,460 67 %

Cost of goods sold for the three months ended September 30, 2022 was $15.0 million, compared to $6.9 million for the three months ended September 30, 2021. The increase of $8.0 million or 116% was primarily due to a $4.1 million increase in product shipments in connection with the increase in products sold, as described above, a $1.7 million increase due to change in product mix and a $2.6 million increase in product cost. Total cost of goods sold for the three months ended September 30, 2022 also included $1.5 million in amortization related to acquired intangible assets as a result of the recent business combinations.
Research and development expense for the three months ended September 30, 2022 was $30.2 million, compared to $15.0 million for the three months ended September 30, 2021. The increase of $15.2 million or 101% was primarily due to a $6.6

36

million increase in personnel costs as we increased the number of employees working on product development, a $6.3 million increase in product development costs, $4.5 million increase in share-based compensation expense. The increase in share-based compensation expense was primarily driven by the additional awards issued since the prior year. We expect research and development expense to continue to increase as we continue to grow our headcount organically to support expanded product development activities.
Selling, general and administrative expense for the three months ended September 30, 2022 was $10.7 million, compared to $11.4 million for the three months ended September 30, 2021. The decrease of $0.8 million or 7% was primarily due to a $0.7 million adjustment recorded to amortization for intangible assets as a result of finalizing the purchase accounting for the business combinations of TeraXion and OnDesign. We expect selling, general, and administrative expense to continue to increase as we grow our headcount to support our global expansion and to fulfill our obligations as a publicly traded company.

Other income (expense), net
Three Months Ended
September 30,
20222021
(in thousands)$$$ Change% Change
Other income (expense), net:
Interest income$612 $16 $596 3725 %
Interest expense(166)(25)(141)564 %
Loss from change in fair value of warrants(19,059)(40,401)21,342 (53)%
Loss from change in fair value of earn-out liabilities— (45,496)45,496 (100)%
Loss from change in fair value of contingent considerations(121)(20)(101)505 %
Other income (expense)24 (1,013)1,037 (102)%
Total other income (expense), net$(18,710)$(86,939)$68,229 (78)%
Interest income for the three months ended September 30, 2022 was $0.6 million, compared to $16 thousand for the three months ended September 30, 2021. Interest income increased in the current period primarily as a result of increases in interest rates associated with the money market funds and marketable securities.

For the three months ended September 30, 2022 and 2021, we recognized gains (losses) from change in fair value for warrants, earn-out liabilities, and contingent considerations. The gains (losses) recorded for both the three months ended September 30, 2022 and 2021 represent the following:

i) Warrants: During the three months ended September 30, 2022, we recognized an unrealized loss from change in fair value of our warrants of $19.1 million, which reflected the increase in fair value of our warrant liability. The increase in fair value of our warrant liability of $19.1 million was primarily a result of the increase of the closing price of our Class A common stock listed on the Nasdaq to $7.32 per share on September 30, 2022 from $5.70 per share on June 30, 2022. In the same period in the prior year, the increase in fair value was a result of the closing price our Class A common stock listed on the Nasdaq to $12.31 per share on September 30, 2021 from $9.88 per share on June 30, 2021.

ii) Earn-out liabilities: The increase in fair value of our earn-out liabilities of $45.5 million was primarily a result of the increase of the closing price of our Class A common stock listed on the Nasdaq to $12.31 per share on September 30, 2021 from $9.88 per share on June 30, 2021. On November 9, 2021, the first earn-out milestone was achieved, which eliminated the variability in the arrangement that previously prevented this instrument to be equity-classified. As a result, the earn-out liabilities were recorded to Additional Paid-in Capital at its fair value in November 2021 and no changes in fair value were recorded going forward.

For the three months ended September 30, 2021, other expense was primarily related to a mark-to-market loss we recorded in relation to a currency forward contract. On September 3, 2021, we entered into a CAD $85 million currency forward contract to hedge against the potential fluctuations in exchange rate between the Canadian dollar and U.S. dollar in preparation for the closing of the TeraXion acquisition in October 2021. This contract’s fair value was remeasured as of period-end, which resulted in an unrealized loss of $1.2 million and represented the change in the exchange rate between the contract issuance date and period-end. This unrealized loss was offset to a de minimis amount in the fourth quarter of 2021 as this currency forward contract was settled upon the completion of the acquisition of TeraXion in October 2021.


37

Income Tax Expense
We evaluate our estimated annual effective tax rate (“AETR”) on a quarterly basis based on current and forecasted operating results. The relationship between our income tax provision or benefit and our pretax book income or loss can vary significantly from period to period. This is due to factors such as the overall level of pretax book income or loss, changes in the blend of jurisdictional income or loss that is taxed at different rates, changes in domestic and foreign valuation allowances and changes in non-controlling interest. Consequently, our AETR may fluctuate significantly period to period and may make quarterly comparisons less than meaningful.

Income tax expense for the three months ended September 30, 2022 were due to results of foreign operations. Tax expense recorded for the same period last year was also the result of foreign operations.

Comparison of the Nine Months Ended September 30, 2022 and 2021
Revenue

Nine Months Ended September 30,
20222021
(in thousands)$% of Revenue$% of Revenue$ Change% Change
Revenue:
Product revenue$62,963 81 %$27,470 93 %$35,493 129 %
Contract revenue14,807 19 %1,981 %12,826 647 %
Total revenue$77,770 100 %$29,451 100 %$48,319 164 %
Revenue for the nine months ended September 30, 2022 was $77.8 million, compared to $29.5 million for the nine months ended September 30, 2021, an increase of $48.3 million or 164%, which was primarily driven by a $35.5 million increase in product revenue as well as an increase in contract revenue. The increase in product revenue was due primarily to higher product volume (units sold) given the continued growth in demand from our customers globally. Change in product mix and increases in ASP also contributed to the increase in product revenue year-over-year. The increase in contract revenue of $12.8 million or 647% was primarily due to commencement of a large multi-year non-recurring engineering project with a top customer in the current year.
Operating expenses

Nine Months Ended September 30,
20222021
(in thousands)$% of Revenue$% of Revenue$ Change% Change
Operating expenses:
Cost of goods sold$44,340 57 %$17,097 58 %$27,243 159 %
Research and development88,195 113 %37,206 126 %50,989 137 %
Selling, general, and administrative35,403 46 %23,015 78 %12,388 54 %
Total operating expenses$167,938 216 %$77,318 263 %$90,620 117 %
Cost of goods sold for the nine months ended September 30, 2022 was $44.3 million, compared to $17.1 million for the nine months ended September 30, 2021. The increase of $27.2 million or 159% was primarily due to a $11.3 million increase in product shipments in connection with the increase in products sold as described above, a $5.3 million increase due to change in product mix and a $5.0 million increase in product cost. Total cost of goods sold for the nine months ended September 30, 2022 also included $5.0 million in amortization related to acquired intangible assets as a result of the recent business combinations.
Research and development (“R&D”) expense for the nine months ended September 30, 2022 was $88.2 million, compared to $37.2 million for the nine months ended September 30, 2021. This increase of $51.0 million or 137% was primarily due to a $18.6 million increase in personnel costs as we increased the number of employees working on product development, a $15.9

38

million increase in share-based compensation expense, $12.7 million increase in product development costs and a $2.7 million increase in amortization expense related to R&D project licenses and acquired intangible assets from business combinations. We started recognizing share-based compensation expense in the second quarter of the prior year as it required the consummation of the Transaction in June 2021 and implementation of the 2021 Omnibus Equity Plan in August 2021 to be recognized. We expect research and development expense to continue to increase as we continue to grow our headcount organically to support expanded product development activities.
Selling, general and administrative expense for the nine months ended September 30, 2022 was $35.4 million, compared to $23.0 million for the nine months ended September 30, 2021. The increase of $12.4 million or 54% was primarily due to a a $4.8 million increase in personnel costs due to increase in headcounts, a $2.0 million increase in intangible asset amortization from business combinations, $2.4 million increase in outside professional fees and a $0.7 million increase in share-based compensation expense. We started recognizing share-based compensation expense in the second quarter of the prior year as it required the consummation of the Transaction in June 2021 and implementation of the 2021 Omnibus Equity Plan in August 2021 to be recognized. We expect selling, general, and administrative expense to continue to increase as we grow our headcount to support our global expansion and to fulfill our obligations as a publicly traded company.

Nine Months Ended
September 30,
20222021
(in thousands)$$$ Change% Change
Other income (expense), net:  
Interest income$820 $36 $784 2178 %
Interest expense(491)(1,175)684 (58)%
Gain from change in fair value of SAFEs— 21,600 (21,600)(100)%
Gain (loss) from change in fair value of warrants48,595 (29,085)77,680 (267)%
Loss from change in fair value of earn-out liabilities— (27,557)27,557 (100)%
Gain (loss) from change in fair value of contingent considerations3,546 (120)3,666 (3055)%
Gain from extinguishment of debt— 304 (304)(100)%
Other income (expense)(914)917 (100)%
Total other income (expense), net$52,473 $(36,911)$89,384 (242)%
Interest income for the nine months ended September 30, 2022 was $0.8 million, increased by $0.8 million or 2178% from the nine months ended September 30, 2021. The increase was a result of higher cash balances held in interest bearing accounts.
Interest expense for the nine months ended September 30, 2022 was $0.5 million, compared to $1.2 million for the nine months ended September 30, 2021. Interest expense relates to the routine cash and non-cash interest expenses on outstanding debt obligations. The decrease was primarily driven by all historical long-term debts held by indie before the Transaction being paid off as of June 30, 2021 post our consummation of the Transaction.
For the nine months ended September 30, 2022 and 2021, we recognized gains (losses) from change in fair value for simple agreements for future equity (“SAFE’s”), warrants, earn-out liabilities, and contingent considerations. The gains (losses) recorded for the both the nine months ended September 30, 2022 and 2021 represent the following:

i) SAFEs: Upon the closing of the Transaction on June 10, 2021, the SAFE holders converted their SAFEs to Class A common stock of indie. The gain of $21.6 million for the nine months ended September 30, 2021 represents the decrease in fair value in SAFEs from December 31, 2020 to June 10, 2021. No change in fair value of SAFEs is recorded going forward.

ii) Warrants: During the nine months ended September 30, 2022, we recognized an unrealized gain from change in fair value of our warrants of $48.6 million, which reflected the decrease in fair value of our warrant liability. The decrease in fair value of our warrant liability of $48.6 million was primarily a result of the decrease of the closing price of our Class A common stock listed on the Nasdaq to $7.32 per share on September 30, 2022 from $11.99 per share on December 31, 2021. In the same period in the prior year, the increase in fair value was a result of the closing price our Class A common stock listed on the Nasdaq to $12.31 per share on September 30, 2021 from $10.87 per share on June 10, 2021.


39

iii) Earn-out liabilities: The increase in fair value of our earn-out liabilities of $27.6 million was primarily a result of the increase of the closing price of our Class A common stock listed on the Nasdaq to $12.31 per share on September 30, 2021 from $10.87 per share on June 10, 2021. On November 9, 2021, the first earn-out milestone was achieved, which eliminated the variability in the arrangement that previously prevented this instrument to be equity-classified. As a result, the earn-out liabilities were recorded to Additional Paid-in Capital at its fair value in November 2021 and no changes in fair value were recorded going forward.

iv) Contingent considerations: During the nine months ended September 30, 2022, we recognized an unrealized net gain from change in fair value of our contingent considerations of $3.5 million. During the nine months ended September 30, 2022, management determined that the product design specified in the contingent consideration arrangement would be replaced with a new product design that is better aligned with customer requirements and which will not be eligible for either of the contingent considerations. Accordingly, the fair value for both the Tapeout and Design Win were reduced to zero, resulting in a gain of $3.9 million.

For the nine months ended September 30, 2021, other expense was primarily related to a currency forward contract executed in preparation for the closing of the TeraXion acquisition in October 2021. At the time, we entered into a CAD $85 million currency forward contract on September 3, 2021 to hedge against the potential fluctuations in exchange rate between the Canadian dollar and U.S. dollar. This contract’s fair value was remeasured as of period-end, which resulted in an unrealized loss of $1.2 million and represented the change in the exchange rate between the contract issuance date and period-end and is recorded as part of Other income (expense) for the nine months ended September 30, 2021. This unrealized loss was offset to a de minimis amount in the fourth quarter of 2021 as this currency forward contract was settled upon the completion of the acquisition of TeraXion in October 2021.

Income Tax Benefits
We evaluate our estimated AETR on a quarterly basis based on current and forecasted operating results. The relationship between our income tax provision or benefit and our pretax book income or loss can vary significantly from period to period. This is due to factors such as the overall level of pretax book income or loss, changes in the blend of jurisdictional income or loss that is taxed at different rates, changes in domestic and foreign valuation allowances and changes in non-controlling interest. Consequently, our AETR may fluctuate significantly period to period and may make quarterly comparisons less than meaningful.

Income tax benefits for the nine months ended September 30, 2022 were due to results of foreign operations. Tax expense recorded for the same period last year was also the result of foreign operations.

JOBS Act

The JOBS Act permits an emerging growth company (“EGC”) such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We have elected to use the extended transition period under the JOBS Act until the earlier of the date we (1) are no longer an emerging growth company or (2) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our condensed consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

We will remain an emerging growth company until the earliest to occur of: (1) the last day of the fiscal year in which we have more than $1.235 billion in annual revenue; (2) the date on which we are deemed to be a “large accelerated filer,” which would occur if the market value of our equity securities held by nonaffiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter; (3) the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period; and (4) the last day of the fiscal year ending after the fifth anniversary of our initial public offering, or December 31, 2024.

We may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for public companies.
Liquidity and Capital Resources
Historically, we derive liquidity primarily from debt and equity financing activities as we have historically had negative cash flows from operations. On June 10, 2021, we completed the Transaction, which resulted in approximately $341.3 million of net cash proceeds. On November 5, 2021, we also entered into an amendment to the PacWest loan agreement that (i) increased the

40

maximum borrowing capacity under the revolving line of credit to $20 million, (ii) limited the security interests of the bank to the cash collateral set at 102.5% of the drawn amount of the loan, (iii) removed various reporting and restrictive covenants, (iv) extended the maturity date to November 4, 2022 and (iv) reduced the interest rate to 2.1% per annum. We currently do not have any outstanding balance under this revolving line of credit.

Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, working capital requirements related to inventory, accounts payable and accounts receivable, and general and administrative expenditures. In addition, from time to time, we use cash to fund our mergers and acquisitions as well as for purchases of various capital and software assets. Our immediate sources of liquidity are cash, cash equivalents and our revolving credit facility. We believe that our existing cash and cash equivalents, funds anticipated to be generated from our operations, and available borrowing on our revolving credit facility will be sufficient to meet our working capital needs for at least the next 12 months. Our future capital requirements may vary from those currently planned and will depend on many factors, including our rate of sales growth, the timing and extent of spending on various business initiatives, including potential merger and acquisition activities, our international expansion, the timing of new product introductions, market acceptance of our solutions, and overall economic conditions including the potential impact of global supply imbalances, rising interest rates, inflationary pressures, COVID-19 and volatility in the global financial markets. To the extent that current and anticipated future sources of liquidity are insufficient to fund our future business activities and requirements, we may be required to seek additional equity or debt financing.

On August 26, 2022, we entered into the ATM Agreement with the Sales Agents relating to shares of our Class A common stock. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our Class A common stock having an aggregate offering price of up to $150.0 million from time to time through the Sales Agents, acting as our agent or principal. We implemented this program for the flexibility that it provides to the capital markets and to best time its equity capital needs. As of September 30, 2022, we have raised gross proceeds of $12.3 million and issued 1,506,892 shares of Class A common stock at an averaged per-share sales price of $8.14 through this program and had approximately $137.7 million available for future issuances under the ATM Agreement. For the three months ended September 30, 2022, indie incurred total issuances costs of $0.3 million.

As of September 30, 2022, our balance of cash and cash equivalents was $150.4 million.

Acquisitions

Since the closing of the Transaction, we have completed multiple acquisitions. We continually assess and plan to selectively pursue inorganic growth opportunities that are complementary to our existing technologies and portfolio of products and/or accelerate our growth initiatives. See Note 2 - Business Combinations for additional information about our recent acquisitions.

In connection with our acquisitions, we may from time to time be required to make future payments or issue additional shares of our common stock to satisfy our obligations under the acquisition agreements, including to satisfy certain earn-out requirements. For example, in January, 2022 we completed the acquisition of Symeo GmbH, for which we made an initial cash payment of approximately $10.0 million. An additional $10.0 million will be due in 2023, as well as an equity based earn out of shares of indie Class A common stock based on future revenue growth. In addition, in October 2021, we acquired ON Design Israel Ltd. for $5.0 million in cash paid upon close (net of cash acquired), $5.0 million paid as of September 30, 2022, and a final payment of $2.5 million was made in October 2022.
We expect to continue to incur net operating losses and negative cash flows from operations. We also expect our research and development expenses, general and administrative expenses and capital expenditures will increase over time as we continue to expand our operations, product offerings and customer base.


41

The following table summarizes our condensed consolidated cash flows for the nine months ended September 30, 2022 and 2021:

Nine Months Ended
September 30,
ChangeChange
20222021$%
Net cash used in operating activities$(58,815)$(36,913)$(21,902)59 %
Net cash used in investing activities(13,213)(2,452)(10,761)439 %
Net cash provided by financing activities2,531 344,339 (341,808)(99)%
Operating Activities
Our primary use of cash is to fund operating expenses, which consist primarily of research and development expenditures, working capital requirements related to inventory, accounts payable and general and administrative expenditures.

For the nine months ended September 30, 2022, net cash used in operating activities was $58.8 million, which included net loss of $37.0 million and reflected adjustments for certain non-cash items and changes in operating assets and liabilities. Non-cash decreases primarily consisted of $52.4 million of net gains resulting from a change in fair value for warrants and contingent considerations. These non-cash decreases were partially offset by $30.8 million in share-based compensation expense and $11.2 million in depreciation and amortization. Changes in operating assets and liabilities from operations used $16.1 million of cash, primarily driven by an increase in accounts receivable, inventory and prepaid and other current assets.
Cash used in operating activities during the nine months ended September 30, 2021 was $36.9 million, which included net loss of $84.8 million and was adjusted for certain non-cash items and changes in operating assets and liabilities. Non-cash charges primarily consisted of $36.4 million of gains resulting from a change in fair values for SAFEs, warrants, earn-out liabilities, contingent considerations and currency forward contract, and a $0.3 million net gain from extinguishment of long-term debts and forgiveness from the PPP loan. These non-cash decreases were partially offset by $14.2 million in share-based compensation expense and $2.4 million in depreciation and amortization. Changes in operating assets and liabilities from operations used $5.5 million of cash, primarily driven by an increase in accounts receivable, inventory and prepaid and other current assets.
Investing Activities
Net cash used in investing activities for the nine months ended September 30, 2022 and 2021 was $13.2 million and $2.5 million, respectively. During the period ended September 30, 2022, the decrease in cash was primarily due to the acquisition of Symeo for $8.7 million, net of cash acquired, as well as an increase in cash used of $4.5 million for the purchase of capital expenditures. During the period ended September 30, 2021, our primary investing activities consisted of capital expenditures. We expect that we will make additional capital expenditures in the future, including licenses to various intangible assets, in order to support the future growth of our business.
Financing Activities
Net cash provided by financing activities for the nine months ended September 30, 2022 was $2.5 million, which was primarily attributed to $12.0 million of net proceeds from the issuance of common stocks through the ATM, partially offset by $5.0 million paid to OnSemi as part of the deferred payments in relation to the acquisition of ON Design Israel Ltd, $3.2 million of payments on financed software and a $1.0 million payment of City Semi deferred compensation.
Net cash provided by financing activities for the nine months ended September 30, 2021 of $344.3 million was primarily attributed to $377.7 million of net cash acquired from TB2 as we closed the Transaction on June 10, 2021 and $5.0 million of proceeds from issuance of SAFEs in April 2021. These increases in cash were partially offset by $19.9 million of transaction costs incurred in connection with the Transaction and $15.0 million for the repayment of long-term debt and related termination fees. Total transaction costs incurred in relation to the Transaction was approximately $44.5 million.

Future Material Cash Obligations

Following is a summary of our material cash requirements from known contractual and other obligations, including commitments for capital expenditures, as of September 30, 2022:


42

Future Estimated Cash Payments Due by Period
Contractual ObligationsLess than 1 year1 - 3 years3-5 years>5 yearsTotal
Debt obligations$13,186 $2,712 $1,469 $— $17,367 
Operating leases2,053 2,844 2,593 3,855 11,345 
Deferred business acquisition payments2,500 — — — 2,500 
Total contractual obligations$17,739 $5,556 $4,062 $3,855 $31,212 
Critical Accounting Estimates

The discussion and analysis of our financial condition and results of operations are based upon our condensed consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles (“GAAP”). The preparation of these financial statements requires us to make estimates and judgments in applying our most critical accounting policies that can have a significant impact on the results we report in our financial statements. The SEC has defined critical accounting estimates as those that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on a registrant’s financial condition or results of operations. Based on this definition, our most critical accounting estimates include revenue recognition, which impacts the recording of net revenue; inventory valuation, which impacts the cost of goods sold and gross margin; business combinations, which impacts the fair value of acquired assets and assumed liabilities; goodwill and long-lived assets, which impacts the fair value of goodwill and intangible assets; warrants and earn-out liabilities valuations, which impacts the fair value of these financial instruments; and income taxes, which impacts the income tax provision. We have other significant accounting policies that do not generally require subjective estimates or judgments or would not have a material impact on our results of operations. The Company’s critical accounting policies and estimates are disclosed under Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations in its Annual Report on Form 10-K for the fiscal year ended December 31, 2021.

There have been no material changes to our critical accounting policies and estimates as disclosed in our Annual Report on Form 10-K filed for the year ended December 31, 2021.

Recently Issued and Adopted Accounting Pronouncements

We describe the recently issued and adopted accounting pronouncements that apply to us in Note 1 - Nature of Business and Basis to our condensed consolidated financial statements presented herein.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Risk

We have international operations, giving rise to exposure to market risks from changes in currency exchange rates. Our primary foreign currency exposures are the Canadian dollar, Chinese yuan/renminbi and Israeli New Shekel. We have intercompany loans with certain of our foreign subsidiaries that are long-term in nature. Repayments of such principal amounts are neither planned nor anticipated in the foreseeable future and are therefore treated analogous to equity for accounting purposes. As a result, the foreign exchange gains and losses on these borrowings are excluded from the determination of Net income (loss) and recorded as a component of Accumulated other comprehensive income (loss) in the condensed consolidated balance sheets. A cumulative foreign currency translation loss of $18.3 million as of September 30, 2022 and $61 thousand as of December 31, 2021. The year-over-year change was driven by the cumulative foreign currency translation loss recorded in relation to permanently invested intercompany loans as of September 30, 2022 as the US dollar strengthened against foreign currencies.

As our international operations grow, our risks associated with fluctuation in foreign currency rates will become greater, and we will continue to reassess our approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar could increase the costs of our international expansion and operation. To mitigate the risk, we plan to enter into additional foreign currency forward contracts in the foreseeable future.


43

Table of Contents
Investment and Interest Rate Risk

Our exposure to interest rate and general market risks relates principally to our cash and cash equivalents (money market funds and marketable securities purchased with less than ninety days until maturity) that totals approximately $150.4 million as of September 30, 2022.

The main objectives of our investment activities are liquidity and preservation of capital. Our cash equivalent investments have short-term maturity periods that dampen the impact of market or interest rate risk. Credit risk associated with our investments is not material because our investments are diversified across securities with high credit ratings.

Given the objectives of our investment activities, and the relatively low interest income generated from our cash, cash equivalents, and other investments, we do not believe that investment or interest rate risks currently pose material exposures to our business or results of operations even in the current environment of rising interest rates.
ITEM 4. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures
Our management, including our Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of September 30, 2022 and based on this evaluation, have concluded that, as a result of the material weaknesses in internal control over financial reporting as described below, our disclosure controls and procedures were not effective as of September 30, 2022.

Per Rule 13a-15(e), the term disclosure controls and procedures means controls and other procedures of an issuer that are designed to ensure that information required to be disclosed by the issuer in the reports that it files or submits under the Exchange Act (15 U.S.C. 78a et seq.) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its Chief Executive Officer and Chief Financial Officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Material Weaknesses in Internal Control over Financial Reporting and Remediation Plan

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we conducted an assessment of our internal control over financial reporting as of December 31, 2021, based on the framework in Internal Control - Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission (the “2013 COSO Framework”). As a result of this evaluation, management identified the following material weaknesses in internal control over financial reporting as of December 31, 2021, which remain unremediated as of September 30, 2022:

a.Control Environment: The Company did not have a sufficient number of personnel with assigned responsibility and accountability for the design, operation and documentation of internal control over financial reporting in accordance with the 2013 COSO Framework.

b.Risk Assessment: The Company did not have an effective risk assessment process that defined clear financial reporting objectives and evaluated risks, including identifying and analyzing risks related to non-routine transactions such as mergers and acquisitions, at a sufficient level of detail to identify all relevant risks of material misstatement across the Company or within each acquired entity.

c.Information and Communication: The Company did not have effective information control processes, including those related to the use of manual spreadsheets, to ensure the reliability of information used in certain computations related to financial reporting.

d.Monitoring Activities: The Company did not have effective monitoring activities to assess the operation of internal control over financial reporting, including the continued appropriateness of control design and level of documentation maintained to support control effectiveness.

e.Control Activities: As a consequence of the aforementioned deficiencies, the Company did not have effective control activities related to the design and operation of process-level controls across certain key financial reporting processes.

The Company’s remediation efforts related to the foregoing material weaknesses are ongoing, and the Company will continue its initiatives to implement and document policies and procedures and strengthen the Company’s internal control environment.

44

Table of Contents
Remediation of the identified material weaknesses and strengthening the Company’s internal control environment will require a substantial effort throughout 2022 and, possibly, the first quarter of 2023. The material weaknesses cannot be considered completely remediated until the applicable controls have operated for a sufficient period of time and management has concluded, through testing, that these controls are operating effectively. In addition, it is possible that certain controls the Company plans to implement in 2022 will not have operated for a sufficient period of time in 2022 to test their operating effectiveness as part of the Company’s evaluation of internal control over financial reporting as of December 31, 2022 and may extend to the following year.

To remediate the material weaknesses described above, the Company is pursuing the following remediation steps:

i.We will continue to seek, train and retain individuals that have appropriate skills and experience related to designing operating and documenting internal controls over financial reporting, coupled with the addition of finance staff to improve the current segregation of roles and responsibilities; and

ii.We have launched a company-wide initiative to implement a new enterprise resource planning (“ERP”) system capable of automating some of our manual financial reporting processes, enhancing our information technology control environment, and mitigating some of the internal control gaps and limitations that cannot be addressed by the current system; and

iii.We have engaged third party specialists to conduct a comprehensive review, update and enhancement of the design and documentation of key business processes to ensure the components of internal control over financial reporting are present and functioning in accordance with the 2013 COSO Framework; and

iv.We are in the process of establishing an internal audit function which will perform routine risk assessments and gap analysis of our control environment and report regularly to the audit committee on the progress and results of our remediation plan, including the identification, status, and resolution of internal control deficiencies.

We believe that our remediation plan will be sufficient to address the identified material weaknesses and strengthen our internal control over financial reporting. As we continue to evaluate, and work to improve our internal control over financial reporting, we may determine that additional measures to address control deficiencies or modifications to the remediation plan are necessary. It cannot be assured, however, when we will remediate such material weaknesses, nor can we be certain whether additional actions will be required. Moreover, it cannot be assured that additional material weaknesses will not arise in the future.

Changes in Internal Control Over Financial Reporting

As described above under “Management's Remediation Plan”, we are taking actions to remediate the material weaknesses in our internal control over financial reporting. Except as described above, there were no changes in internal control over financial reporting during the three months ended September 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

45

Table of Contents
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
We are not party to any material legal proceedings. From time to time, we may be involved in legal proceedings or subject to claims incident to the ordinary course of business. The outcome of litigation is inherently uncertain, and there can be no assurances that favorable outcomes will be obtained. In addition, regardless of the outcome, such proceedings or claims can have an adverse impact on us, which may be material because of defense and settlement costs, diversion of resources and other factors.
ITEM 1A. RISK FACTORS
The business, financial condition, and operating results of the Company can be affected by many factors, whether currently known or unknown, including but not limited to those described in Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the Fiscal Year ended December 31, 2021 under the heading “Risk Factors,” any one or more of which could, directly or indirectly, cause the Company’s actual financial condition and operating results to vary materially from past or the anticipated future financial condition and operating results. Any of these factors, in whole or in part, could materially and adversely affect the Company’s business, financial condition, operating results, and stock price. There have been no material changes to the Company’s risk factors disclosed under the heading “Risk Factors” in Part 1, Item 1A in the Company’s Annual Report on Form 10-K for the Fiscal Year ended December 31, 2021 filed on April 11, 2022.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

On various dates between July 28, 2022 and September 16, 2022 the Company issued an aggregate of 2,670,232 shares of its Class A common stock to three ADK Minority Holders in exchange for an equal number of their ADK LLC units. The shares of Class A common stock were issued to the three ADK Minority Holders in reliance on the exemption under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”). In connection with such exchange, 2,633,027 shares of Class V common stock held by the ADK Minority Holders were cancelled and 37,205 shares of ADK LLC units were exchanged to Class A common stock.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES
None.
ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.
ITEM 5. OTHER INFORMATION
None.
ITEM 6. EXHIBITS.
(d) Exhibits
Exhibit
Number
Description of Exhibit

46

Table of Contents
101 .INS
Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
101 .SCHInline XBRL Taxonomy Extension Schema Document
101 .CALInline XBRL Taxonomy Extension Calculation Linkbase Document
101 .DEFInline XBRL Taxonomy Definition Linkbase Document
101 .LABInline XBRLTaxonomy Extension Label Linkbase Document
101 .PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
104
Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)

47

Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
INDIE SEMICONDUCTOR, INC.
November 10, 2022By:/s/ Thomas Schiller
Name:Thomas Schiller
Title:Chief Financial Officer & EVP of Strategy
(Principal Financial Officer)

48
Exhibit 10.2
















INDIE SEMICONDUCTOR, INC.

2021 OMNIBUS EQUITY INCENTIVE PLAN














Effective June 10, 2021

As approved by Shareholders of Thunder Bridge Acquisition II, Ltd. (the predecessor by mergers to indie Semiconductor, Inc.) on June 9, 2021 and subsequently modified by the Stockholders and Board of Directors of indie Semiconductor, Inc. on June 22, 2022.



INDIE SEMICONDUCTOR, INC.
2021 OMNIBUS EQUITY INCENTIVE PLAN

image_0a.jpg
PURPOSE

The purpose of this indie Semiconductor, Inc. 2021 Omnibus Equity Incentive Plan (the “Plan”) is to benefit indie Semiconductor, Inc., a Delaware corporation (the “Company”) and its stockholders, by assisting the Company and its subsidiaries to attract, retain and provide incentives to key management employees, directors, and consultants of the Company and its Affiliates, and to align the interests of such service providers with those of the Company’s stockholders. Accordingly, the Plan provides for the granting of Non-qualified Stock Options, Incentive Stock Options, Restricted Stock Awards, Restricted Stock Unit Awards, Stock Appreciation Rights, Performance Stock Awards, Performance Unit Awards, Unrestricted Stock Awards, Distribution Equivalent Rights or any combination of the foregoing.
image_1a.jpg
DEFINITIONS

The following definitions shall be applicable throughout the Plan unless the context otherwise requires:

2.1Affiliate” shall mean any corporation which, with respect to the Company, is a “subsidiary corporation” within the meaning of Section 424(f) of the Code or other entity in which the Company has a controlling interest in such entity or another entity which is part of a chain of entities in which the Company or each entity has a controlling interest in another entity in the unbroken chain of entities ending with the applicable entity.

2.2Award” shall mean, individually or collectively, any Option, Restricted Stock Award, Restricted Stock Unit Award, Performance Stock Award, Performance Unit Award, Stock Appreciation Right, Distribution Equivalent Right or Unrestricted Stock Award.

2.3Award Agreement” shall mean a written agreement between the Company and the Holder with respect to an Award, setting forth the terms and conditions of the Award, as amended.

2.4Board” shall mean the Board of Directors of the Company.

2.5Base Value” shall have the meaning given to such term in Section 14.2.

2.6Cause” shall mean (i) if the Holder is a party to an employment or service agreement with the Company or an Affiliate which agreement defines “Cause” (or a similar term), “Cause” shall have the same meaning as provided for in such agreement, or
(ii) for a Holder who is not a party to such an agreement, “Cause” shall mean termination




by the Company or an Affiliate of the employment (or other service relationship) of the Holder by reason of the Holder’s (A) intentional failure to perform reasonably assigned duties, (B) dishonesty or willful misconduct in the performance of the Holder’s duties,
(C) involvement in a transaction which is materially adverse to the Company or an Affiliate, (D) breach of fiduciary duty involving personal profit, (E) willful violation of any law, rule, regulation or court order (other than misdemeanor traffic violations and misdemeanors not involving misuse or misappropriation of money or property), (F) commission of an act of fraud or intentional misappropriation or conversion of any asset or opportunity of the Company or an Affiliate, or (G) material breach of any provision of the Plan or the Holder’s Award Agreement or any other written agreement between the Holder and the Company or an Affiliate, in each case as determined in good faith by the Board, the determination of which shall be final, conclusive and binding on all parties.

2.1Change of Control” shall mean, except as otherwise provided in an Award Agreement, (i) for a Holder who is a party to an employment or consulting agreement with the Company or an Affiliate which agreement defines “Change of Control” (or a similar term), “Change of Control” shall have the same meaning as provided for in such agreement, or (ii) for a Holder who is not a party to such an agreement, “Change of Control” shall mean the satisfaction of any one or more of the following conditions (and the “Change of Control” shall be deemed to have occurred as of the first day that any one or more of the following conditions shall have been satisfied):

(a)Any person (as such term is used in paragraphs 13(d) and 14(d)(2) of the Exchange Act, hereinafter in this definition, “Person”), other than the Company or an Affiliate or an employee benefit plan of the Company or an Affiliate, becomes the beneficial owner (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company’s then outstanding securities;

(b)The closing of a merger, consolidation or other business combination (a “Business Combination”) other than a Business Combination in which holders of the Shares immediately prior to the Business Combination have substantially the same proportionate ownership of the common stock or ordinary shares, as applicable, of the surviving corporation immediately after the Business Combination as immediately before;

(c)The closing of an agreement for the sale or disposition of all or substantially all of the Company’s assets to any entity that is not an Affiliate;

(d)The approval by the holders of shares of Shares of a plan of complete liquidation of the Company, other than a merger of the Company into any subsidiary or a liquidation as a result of which persons who were stockholders of the Company immediately prior to such liquidation have substantially the same proportionate ownership of shares of common stock or ordinary shares, as applicable, of the surviving corporation immediately after such liquidation as immediately before; or

2



(a)Within any twenty-four (24) month period, the Incumbent Directors shall cease to constitute at least a majority of the Board or the board of directors of any successor to the Company; provided, however, that any director elected to the Board, or nominated for election, by a majority of the Incumbent Directors then still in office, shall be deemed to be an Incumbent Director for purposes of this paragraph (e), but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of an individual, entity or “group” other than the Board (including, but not limited to, any such assumption that results from paragraphs (a), (b), (c), or (d) of this definition).

Unless otherwise provided in an applicable Award Agreement, solely for the purpose of determining the timing of any payments pursuant to any Award constituting a “deferral of compensation” subject to Code Section 409A, a Change of Control shall be limited to a “change in the ownership of the Company,” a “change in the effective control of the Company,” or a “change in the ownership of a substantial portion of the assets of the Company” as such terms are defined in Section 1.409A-3(i)(5) of the U.S. Treasury Regulations.

2.1Code” shall mean the United States of America Internal Revenue Code of 1986, as amended. Reference in the Plan to any section of the Code shall be deemed to include any amendments or successor provisions to any section and any regulation under such section.

2.2Committee” shall mean a committee of directors selected by the Board as provided in Section 4.1.

2.3Company” shall have the meaning given to such term in the introductory paragraph, including any successor thereto.

2.4Consultant” shall mean any natural person that provides bona fide services as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1) of Form S-8 of the Securities Act of 1933, as amended.

2.5Director” shall mean a member of the Board or a member of the board of directors of an Affiliate, in either case, who is not an Employee.

2.6Distribution Equivalent Right” shall mean an Award granted under Article XIII of the Plan which entitles the Holder to receive bookkeeping credits, cash payments and/or Share distributions equal in amount to the distributions that would have been made to the Holder had the Holder held a specified number of Shares during the period the Holder held the Distribution Equivalent Right.

2.7Distribution Equivalent Right Award Agreement” shall mean a written agreement between the Company and a Holder with respect to a Distribution Equivalent Right Award.

3



2.8Effective Date” shall mean June 10, 2021.

2.9Employee” shall mean any employee, including any officer, of the Company or an Affiliate.

2.10Exchange Act” shall mean the United States of America Securities Exchange Act of 1934, as amended.

2.11Fair Market Value” shall mean, as of any specified date, the closing sales price of the Shares for such date (or, in the event that the Shares are not traded on such date, on the immediately preceding trading date) on the NASDAQ Stock Market (“NASDAQ”), as reported by NASDAQ, or such other domestic or foreign national securities exchange on which the Shares may be listed. If the Shares are not listed on NASDAQ or on a national securities exchange, but are quoted on the OTC Bulletin Board or by the National Quotation Bureau, the Fair Market Value of the Shares shall be the mean of the highest bid and lowest asked prices per Share for such date. If the Shares are not quoted or listed as set forth above, Fair Market Value shall be determined by the Board in good faith by any fair and reasonable means (which means may be set forth with greater specificity in the applicable Award Agreement). The Fair Market Value of property other than Shares shall be determined by the Board in good faith by any fair and reasonable means consistent with the requirements of applicable law.

2.12Family Member” of an individual shall mean any child, stepchild, grandchild, parent, stepparent, spouse, former spouse, sibling, niece, nephew, mother-in- law, father-in-law, son-in-law, daughter-in-law, brother-in-law or sister-in-law, including adoptive relationships, any person sharing the Holder’s household (other than a tenant or employee of the Holder), a trust in which such persons have more than fifty percent (50%) of the beneficial interest, a foundation in which such persons (or the Holder) control the management of assets, and any other entity in which such persons (or the Holder) own more than fifty percent (50%) of the voting interests.

2.13Holder” shall mean an Employee, Director or Consultant who has been granted an Award or any such individual’s beneficiary, estate or representative, who has acquired such Award in accordance with the terms of the Plan, as applicable.

2.14Incentive Stock Option” shall mean an Option which is intended by the Committee to constitute an “incentive stock option” and conforms to the applicable provisions of Section 422 of the Code.

2.15Incumbent Director” shall mean, with respect to any period of time specified under the Plan for purposes of determining whether or not a Change of Control has occurred, the individuals who were members of the Board at the beginning of such period.

2.16Non-qualified Stock Option” shall mean an Option which is not an Incentive Stock Option or which is designated as an Incentive Stock Option but does not meet the applicable requirements of Section 422 of the Code.

4



2.17Option” shall mean an Award granted under Article VII of the Plan of an option to purchase Shares and shall include both Incentive Stock Options and Non- qualified Stock Options.

2.18Option Agreement” shall mean a written agreement between the Company and a Holder with respect to an Option.

2.19Performance Criteria” shall mean the criteria selected by the Committee for purposes of establishing the Performance Goal(s) for a Holder for a Performance Period.

2.20Performance Goals” shall mean, for a Performance Period, the written goal or goals established by the Committee for the Performance Period based upon the Performance Criteria, which may be related to the performance of the Holder, the Company or an Affiliate.

2.21Performance Period” shall mean one or more periods of time, which may be of varying and overlapping durations, selected by the Committee, over which the attainment of the Performance Goals shall be measured for purposes of determining a Holder’s right to, and the payment of, a Performance Stock Award or a Performance Unit Award.

2.22Performance Stock Award” or “Performance Stock” shall mean an Award granted under Article XII of the Plan under which, upon the satisfaction of predetermined Performance Goals, Shares are paid to the Holder.

2.23Performance Stock Agreement” shall mean a written agreement between the Company and a Holder with respect to a Performance Stock Award.

2.24Performance Unit Award” or “Performance Unit” shall mean an Award granted under Article XI of the Plan under which, upon the satisfaction of predetermined Performance Goals, a cash payment shall be made to the Holder, based on the number of Units awarded to the Holder.

2.25Performance Unit Agreement” shall mean a written agreement between the Company and a Holder with respect to a Performance Unit Award.

2.26Plan” shall mean this indie Semiconductor, Inc. 2021 Omnibus Equity Incentive Plan, as amended from time to time, together with each of the Award Agreements utilized hereunder.

2.27Restricted Stock Award” and “Restricted Stock” shall mean an Award granted under Article VIII of the Plan of Shares, the transferability of which by the Holder is subject to Restrictions.

2.28Restricted Stock Agreement” shall mean a written agreement between the Company and a Holder with respect to a Restricted Stock Award.

5



2.29Restricted Stock Unit Award” and “RSUs” shall refer to an Award granted under Article X of the Plan under which, upon the satisfaction of predetermined individual service-related vesting requirements, a payment in cash or Shares shall be made to the Holder, based on the number of Units awarded to the Holder.

2.30Restricted Stock Unit Agreement” shall mean a written agreement between the Company and a Holder with respect to a Restricted Stock Award.

2.31Restriction Period” shall mean the period of time for which Shares subject to a Restricted Stock Award shall be subject to Restrictions, as set forth in the applicable Restricted Stock Agreement.

2.32Restrictions” shall mean the forfeiture, transfer and/or other restrictions applicable to Shares awarded to an Employee, Director or Consultant under the Plan pursuant to a Restricted Stock Award and set forth in a Restricted Stock Agreement.

2.33Rule 16b-3” shall mean Rule 16b-3 promulgated by the Securities and Exchange Commission under the Exchange Act, as such may be amended from time to time, and any successor rule, regulation or statute fulfilling the same or a substantially similar function.

2.34Shares” or “Stock” shall mean the Class A common stock of the Company, par value $0.0001 per share.

2.35Stock Appreciation Right” or “SAR” shall mean an Award granted under Article XIV of the Plan of a right, granted alone or in connection with a related Option, to receive a payment equal to the increase in value of a specified number of Shares between the date of Award and the date of exercise.

2.36Stock Appreciation Right Agreement” shall mean a written agreement between the Company and a Holder with respect to a Stock Appreciation Right.

2.37Tandem Stock Appreciation Right” shall mean a Stock Appreciation Right granted in connection with a related Option, the exercise of some or all of which results in termination of the entitlement to purchase some or all of the Shares under the related Option, all as set forth in Article XIV.

2.38Ten Percent Stockholder” shall mean an Employee who, at the time an Option is granted to him or her, owns shares possessing more than ten percent (10%) of the total combined voting power of all classes of shares of the Company or of any parent corporation or subsidiary corporation thereof (both as defined in Section 424 of the Code), within the meaning of Section 422(b)(6) of the Code.

2.39Termination of Service” shall mean a termination of a Holder’s employment with, or status as a Director or Consultant of, the Company or an Affiliate, as applicable, for any reason, including, without limitation, Total and Permanent Disability or death, except as provided in Section 6.4. In the event Termination of Service shall constitute a payment event with respect to any Award subject to Code

6



Section 409A, Termination of Service shall only be deemed to occur upon a “separation from service” as such term is defined under Code Section 409A and applicable authorities.

2.40Total and Permanent Disability” of an individual shall mean the inability of such individual to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than twelve
(12) months, within the meaning of Section 22(e)(3) of the Code.

2.41Unit” shall mean a bookkeeping unit, which represents such monetary amount as shall be designated by the Committee in each Performance Unit Agreement, or represents one Share for purposes of each Restricted Stock Unit Award.

2.42Unrestricted Stock Award” shall mean an Award granted under Article IX of the Plan of Shares which are not subject to Restrictions.

2.43Unrestricted Stock Agreement” shall mean a written agreement between the Company and a Holder with respect to an Unrestricted Stock Award.
image_2a.jpg
EFFECTIVE DATE OF PLAN

The Plan shall be effective as of the Effective Date, provided that the Plan is approved by the stockholders of the Company within twelve (12) months of such date.
image_3a.jpg
ADMINISTRATION

4.1Composition of Committee. The Plan shall be administered by the Committee, which shall be appointed by the Board. If necessary, in the Board’s discretion, to comply with Rule 16b-3 under the Exchange Act or relevant securities exchange or inter-dealer quotation service, the Committee shall consist solely of two (2) or more Directors who are each (i) “non-employee directors” within the meaning of Rule 16b-3 and (ii) “independent” for purposes of any applicable listing requirements;. If a member of the Committee shall be eligible to receive an Award under the Plan, such Committee member shall have no authority hereunder with respect to his or her own Award.

4.2Powers. Subject to the other provisions of the Plan, the Committee shall have the sole authority, in its discretion, to make all determinations under the Plan, including but not limited to (i) determining which Employees, Directors or Consultants shall receive an Award, (ii) the time or times when an Award shall be made (the date of grant of an Award shall be the date on which the Award is awarded by the Committee),
(iii) what type of Award shall be granted, (iv) the term of an Award, (v) the date or dates on which an Award vests, (vi) the form of any payment to be made pursuant to an Award,
(vii) the terms and conditions of an Award (including the forfeiture of the Award, and/or any financial gain, if the Holder of the Award violates any applicable restrictive covenant

7



thereof), (viii) the Restrictions under a Restricted Stock Award, (ix) the number of Shares which may be issued under an Award, (x) Performance Goals applicable to any Award and certification of the achievement of such goals, and (xi) the waiver of any Restrictions or Performance Goals, subject in all cases to compliance with applicable laws. In making such determinations the Committee may take into account the nature of the services rendered by the respective Employees, Directors and Consultants, their present and potential contribution to the Company’s (or the Affiliate’s) success and such other factors as the Committee in its discretion may deem relevant.

4.3Additional Powers. The Committee shall have such additional powers as are delegated to it under the other provisions of the Plan. Subject to the express provisions of the Plan, the Committee is authorized to construe the Plan and the respective Award Agreements executed hereunder, to prescribe such rules and regulations relating to the Plan as it may deem advisable to carry out the intent of the Plan, to determine the terms, restrictions and provisions of each Award and to make all other determinations necessary or advisable for administering the Plan. The Committee may correct any defect or supply any omission or reconcile any inconsistency in any Award Agreement in the manner and to the extent the Committee shall deem necessary, appropriate or expedient to carry it into effect. The determinations of the Committee on the matters referred to in this Article IV shall be conclusive and binding on the Company and all Holders.

4.4Committee Action. Subject to compliance with all applicable laws, action by the Committee shall require the consent of a majority of the members of the Committee, expressed either orally at a meeting of the Committee or in writing in the absence of a meeting. No member of the Committee shall have any liability for any good faith action, inaction or determination in connection with the Plan.
image_4a.jpg
SHARES SUBJECT TO PLAN AND LIMITATIONS THEREON

5.1Authorized Shares and Award Limits. The Committee may from time to time grant Awards to one or more Employees, Directors and/or Consultants determined by it to be eligible for participation in the Plan in accordance with the provisions of Article VI. Subject to Article XV, the aggregate number of Shares that may be issued under the Plan shall not exceed twenty million, eight hundred sixty-eight thousand, seven hundred and fifty (20,868,750) Shares. Shares shall be deemed to have been issued under the Plan solely to the extent actually issued and delivered pursuant to an Award. To the extent that an Award lapses, expires, is canceled, is terminated unexercised or ceases to be exercisable for any reason, or the rights of its Holder terminate, any Shares subject to such Award shall again be available for the grant of a new Award. Notwithstanding any provision in the Plan to the contrary, the maximum number of Shares that may be subject to Awards of Incentive Stock Options shall not be more than twenty million, eight hundred sixty-eight thousand, seven hundred and fifty (20,868,750) Shares (subject to adjustment in the same manner as provided in Article XV with respect to Shares subject to Awards then outstanding).

8



5.2Types of Shares. The Shares to be issued pursuant to the grant or exercise of an Award may consist of authorized but unissued Shares, Shares purchased on the open market or Shares previously issued and outstanding and reacquired by the Company.
image_5a.jpg
ELIGIBILITY AND TERMINATION OF SERVICE

6.1Eligibility. Awards made under the Plan may be granted solely to individuals who, at the time of grant, are Employees, Directors or Consultants. An Award may be granted on more than one occasion to the same Employee, Director or Consultant, and, subject to the limitations set forth in the Plan, such Award may include, a Non-qualified Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, an Unrestricted Stock Award, a Distribution Equivalent Right Award, a Performance Stock Award, a Performance Unit Award, a Stock Appreciation Right, a Tandem Stock Appreciation Right, or any combination thereof, and solely for Employees, an Incentive Stock Option.

6.2Termination of Service. Except to the extent inconsistent with the terms of the applicable Award Agreement and/or the provisions of Section 6.3 or 6.4, the following terms and conditions shall apply with respect to a Holder’s Termination of Service with the Company or an Affiliate, as applicable:

(b)The Holder’s rights, if any, to exercise any then exercisable Options and/or Stock Appreciation Rights shall terminate:

(i)If such termination is for a reason other than the Holder’s Total and Permanent Disability or death, ninety (90) days after the date of such Termination of Service;

(ii)If such termination is on account of the Holder’s Total and Permanent Disability, one (1) year after the date of such Termination of Service; or

(iii)If such termination is on account of the Holder’s death, one
(1) year after the date of the Holder’s death.

Upon such applicable date the Holder (and such Holder’s estate, designated beneficiary or other legal representative) shall forfeit any rights or interests in or with respect to any such Options and Stock Appreciation Rights. Notwithstanding the foregoing, the Committee, in its sole discretion, may provide for a different time period in the Award Agreement, or may extend the time period, following a Termination of Service, during which the Holder has the right to exercise any vested Non-qualified Stock Option or Stock Appreciation Right, which time period may not extend beyond the expiration date of the Award term.

(c)In the event of a Holder’s Termination of Service for any reason prior to the actual or deemed satisfaction and/or lapse of the Restrictions, vesting requirements, terms and conditions applicable to a Restricted Stock Award and/or Restricted Stock Unit Award, such Restricted Stock and/or RSUs shall immediately be

9



canceled, and the Holder (and such Holder’s estate, designated beneficiary or other legal representative) shall forfeit any rights or interests in and with respect to any such Restricted Stock and/or RSUs.

6.3Special Termination Rule. Except to the extent inconsistent with the terms of the applicable Award Agreement, and notwithstanding anything to the contrary contained in this Article VI, if a Holder’s employment with, or status as a Director of, the Company or an Affiliate shall terminate, and if, within ninety (90) days of such termination, such Holder shall become a Consultant, such Holder’s rights with respect to any Award or portion thereof granted thereto prior to the date of such termination may be preserved, if and to the extent determined by the Committee in its sole discretion, as if such Holder had been a Consultant for the entire period during which such Award or portion thereof had been outstanding. Should the Committee effect such determination with respect to such Holder, for all purposes of the Plan, such Holder shall not be treated as if his or her employment or Director status had terminated until such time as his or her Consultant status shall terminate, in which case his or her Award, as it may have been reduced in connection with the Holder’s becoming a Consultant, shall be treated pursuant to the provisions of Section 6.2, provided, however, that any such Award which is intended to be an Incentive Stock Option shall, upon the Holder’s no longer being an Employee, automatically convert to a Non-qualified Stock Option. Should a Holder’s status as a Consultant terminate, and if, within ninety (90) days of such termination, such Holder shall become an Employee or a Director, such Holder’s rights with respect to any Award or portion thereof granted thereto prior to the date of such termination may be preserved, if and to the extent determined by the Committee in its sole discretion, as if such Holder had been an Employee or a Director, as applicable, for the entire period during which such Award or portion thereof had been outstanding, and, should the Committee effect such determination with respect to such Holder, for all purposes of the Plan, such Holder shall not be treated as if his or her Consultant status had terminated until such time as his or her employment with the Company or an Affiliate, or his or her Director status, as applicable, shall terminate, in which case his or her Award shall be treated pursuant to the provisions of Section 6.2.

6.4Termination of Service for Cause. Notwithstanding anything in this Article VI or elsewhere in the Plan to the contrary, and unless a Holder’s Award Agreement specifically provides otherwise, in the event of a Holder’s Termination of Service for Cause, all of such Holder’s then outstanding Awards shall expire immediately and be forfeited in their entirety upon such Termination of Service.
image_6a.jpg
OPTIONS

7.1Option Period. The term of each Option shall be as specified in the Option Agreement; provided, however, that except as set forth in Section 7.3, no Option shall be exercisable after the expiration of ten (10) years from the date of its grant.

7.2Limitations on Exercise of Option. An Option shall be exercisable in whole or in such installments and at such times as specified in the Option Agreement

10



7.3Special Limitations on Incentive Stock Options. To the extent that the aggregate Fair Market Value (determined at the time the respective Incentive Stock Option is granted) of Shares with respect to which Incentive Stock Options are exercisable for the first time by an individual during any calendar year under all plans of the Company and any parent corporation or subsidiary corporation thereof (both as defined in Section 424 of the Code) which provide for the grant of Incentive Stock Options exceeds One Hundred Thousand Dollars ($100,000) (or such other individual limit as may be in effect under the Code on the date of grant), the portion of such Incentive Stock Options that exceeds such threshold shall be treated as Non-qualified Stock Options. The Committee shall determine, in accordance with applicable provisions of the Code, Treasury Regulations and other administrative pronouncements, which of a Holder’s Options, which were intended by the Committee to be Incentive Stock Options when granted to the Holder, will not constitute Incentive Stock Options because of such limitation, and shall notify the Holder of such determination as soon as practicable after such determination. No Incentive Stock Option shall be granted to an Employee if, at the time the Incentive Stock Option is granted, such Employee is a Ten Percent Stockholder, unless (i) at the time such Incentive Stock Option is granted the Option price is at least one hundred ten percent (110%) of the Fair Market Value of the Shares subject to the Incentive Stock Option, and (ii) such Incentive Stock Option by its terms is not exercisable after the expiration of five (5) years from the date of grant. No Incentive Stock Option shall be granted more than ten (10) years from the earlier of the Effective Date or date on which the Plan is approved by the Company’s stockholders. The designation by the Committee of an Option as an Incentive Stock Option shall not guarantee the Holder that the Option will satisfy the applicable requirements for “incentive stock option” status under Section 422 of the Code.

7.4Option Agreement. Each Option shall be evidenced by an Option Agreement in such form and containing such provisions not inconsistent with the other provisions of the Plan as the Committee from time to time shall approve, including, but not limited to, provisions intended to qualify an Option as an Incentive Stock Option. An Option Agreement may provide for the payment of the Option price, in whole or in part, by the delivery of a number of Shares (plus cash if necessary) that have been owned by the Holder for at least six (6) months and having a Fair Market Value equal to such Option price, or such other forms or methods as the Committee may determine from time to time, in each case, subject to such rules and regulations as may be adopted by the Committee. Each Option Agreement shall, solely to the extent inconsistent with the provisions of Sections 6.2, 6.3, and 6.4, as applicable, specify the effect of Termination of Service on the exercisability of the Option. Moreover, without limiting the generality of the foregoing, a Non-qualified Stock Option Agreement may provide for a “cashless exercise” of the Option, in whole or in part, by (a) establishing procedures whereby the Holder, by a properly-executed written notice, directs (i) an immediate market sale or margin loan as to all or a part of Shares to which he is entitled to receive upon exercise of the Option, pursuant to an extension of credit by the Company to the Holder of the Option price, (ii) the delivery of the Shares from the Company directly to a brokerage firm and (iii) the delivery of the Option price from sale or margin loan proceeds from the brokerage firm directly to the Company, or (b) reducing the number of Shares to be issued upon exercise of the Option by the number of such Shares having an aggregate

11



Fair Market Value equal to the Option price (or portion thereof to be so paid) as of the date of the Option’s exercise. An Option Agreement may also include provisions relating to: (i) subject to the provisions hereof, accelerated vesting of Options, including but not limited to, upon the occurrence of a Change of Control, (ii) tax matters (including provisions covering any applicable Employee wage withholding requirements) and (iii) any other matters not inconsistent with the terms and provisions of the Plan that the Committee shall in its sole discretion determine. The terms and conditions of the respective Option Agreements need not be identical.

7.5Option Price and Payment. The price at which an Share may be purchased upon exercise of an Option shall be determined by the Committee; provided, however, that such Option price (i) shall not be less than the Fair Market Value of an Share on the date such Option is granted (or 110% of Fair Market Value for an Incentive Stock Option held by Ten Percent Stockholder, as provided in Section 7.3), and (ii) shall be subject to adjustment as provided in Article XV. The Option or portion thereof may be exercised by delivery of an irrevocable notice of exercise to the Company. The Option price for the Option or portion thereof shall be paid in full in the manner prescribed by the Committee as set forth in the Plan and the applicable Option Agreement, which manner, with the consent of the Committee, may include the withholding of Shares otherwise issuable in connection with the exercise of the Option. Separate share certificates shall be issued by the Company for those Shares acquired pursuant to the exercise of an Incentive Stock Option and for those Shares acquired pursuant to the exercise of a Non-qualified Stock Option.

7.6Stockholder Rights and Privileges. The Holder of an Option shall be entitled to all the privileges and rights of a stockholder of the Company solely with respect to such Shares as have been purchased under the Option and for which share certificates have been registered in the Holder’s name.

7.7Options and Rights in Substitution for Stock or Options Granted by Other Corporations. Options may be granted under the Plan from time to time in substitution for stock options held by individuals employed by entities who become Employees, Directors or Consultants as a result of a merger or consolidation of the employing entity with the Company or any Affiliate, or the acquisition by the Company or an Affiliate of the assets of the employing entity, or the acquisition by the Company or an Affiliate of stock or shares of the employing entity with the result that such employing entity becomes an Affiliate. Any substitute Awards granted under this Plan shall not reduce the number of Shares authorized for grant under the Plan.

7.8Prohibition Against RePricing. Except to the extent (i) approved in advance by holders of a majority of the shares of the Company entitled to vote generally in the election of directors, or (ii) as a result of any Change of Control or any adjustment as provided in Article XV, the Committee shall not have the power or authority to reduce, whether through amendment or otherwise, the exercise price under any outstanding Option or Stock Appreciation Right, or to grant any new Award or make any payment of cash in substitution for or upon the cancellation of Options and/or Stock Appreciation Rights previously granted.
12



image_7a.jpg
RESTRICTED STOCK AWARDS

8.1Award. A Restricted Stock Award shall constitute an Award of Shares to the Holder as of the date of the Award which are subject to a “substantial risk of forfeiture” as defined under Section 83 of the Code during the specified Restriction Period. At the time a Restricted Stock Award is made, the Committee shall establish the Restriction Period applicable to such Award. Each Restricted Stock Award may have a different Restriction Period, in the discretion of the Committee. The Restriction Period applicable to a particular Restricted Stock Award shall not be changed except as permitted by Section 8.2.

8.2Terms and Conditions. At the time any Award is made under this Article VIII, the Company and the Holder shall enter into a Restricted Stock Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Company shall cause the Shares to be issued in the name of Holder, either by book-entry registration or issuance of one or more stock certificates evidencing the Shares, which Shares or certificates shall be held by the Company or the stock transfer agent or brokerage service selected by the Company to provide services for the Plan. The Shares shall be restricted from transfer and shall be subject to an appropriate stop-transfer order, and if any certificate is issued, such certificate shall bear an appropriate legend referring to the restrictions applicable to the Shares. After any Shares vest, the Company shall deliver the vested Shares, in book- entry or certificated form in the Company’s sole discretion, registered in the name of Holder or his or her legal representatives, beneficiaries or heirs, as the case may be, less any Shares withheld to pay withholding taxes. If provided for under the Restricted Stock Agreement, the Holder shall have the right to vote Shares subject thereto and to enjoy all other stockholder rights, including the entitlement to receive dividends on the Shares during the Restriction Period. At the time of such Award, the Committee may, in its sole discretion, prescribe additional terms and conditions or restrictions relating to Restricted Stock Awards, including, but not limited to, rules pertaining to the effect of Termination of Service prior to expiration of the Restriction Period. Such additional terms, conditions or restrictions shall, to the extent inconsistent with the provisions of Sections 6.2, 6.3 and 6.4, as applicable, be set forth in a Restricted Stock Agreement made in conjunction with the Award. Such Restricted Stock Agreement may also include provisions relating to:
(i) subject to the provisions hereof, accelerated vesting of Awards, including but not limited to accelerated vesting upon the occurrence of a Change of Control, (ii) tax matters (including provisions covering any applicable Employee wage withholding requirements) and (iii) any other matters not inconsistent with the terms and provisions of the Plan that the Committee shall in its sole discretion determine. The terms and conditions of the respective Restricted Stock Agreements need not be identical. All Shares delivered to a Holder as part of a Restricted Stock Award shall be delivered and reported by the Company or the Affiliate, as applicable, to the Holder at the time of vesting.
13


8.1Payment for Restricted Stock. The Committee shall determine the amount and form of any payment from a Holder for Shares received pursuant to a Restricted Stock Award, if any, provided that in the absence of such a determination, a Holder shall not be required to make any payment for Shares received pursuant to a Restricted Stock Award, except to the extent otherwise required by law.
image_8a.jpg
UNRESTRICTED STOCK AWARDS

9.1Award. Shares may be awarded (or sold) to Employees, Directors or Consultants under the Plan which are not subject to Restrictions of any kind, in consideration for past services rendered thereby to the Company or an Affiliate or for other valid consideration.

9.2Terms and Conditions. At the time any Award is made under this Article IX, the Company and the Holder shall enter into an Unrestricted Stock Agreement setting forth each of the matters contemplated hereby and such other matters as the Committee may determine to be appropriate.

9.3Payment for Unrestricted Stock. The Committee shall determine the amount and form of any payment from a Holder for Shares received pursuant to an Unrestricted Stock Award, if any, provided that in the absence of such a determination, a Holder shall not be required to make any payment for Shares received pursuant to an Unrestricted Stock Award, except to the extent otherwise required by law.
image_9a.jpg
RESTRICTED STOCK UNIT AWARDS

10.1Award. A Restricted Stock Unit Award shall constitute a promise to grant Shares (or cash equal to the Fair Market Value of Shares) to the Holder at the end of a specified vesting schedule. At the time a Restricted Stock Unit Award is made, the Committee shall establish the vesting schedule applicable to such Award. Each Restricted Stock Unit Award may have a different vesting schedule, in the discretion of the Committee. A Restricted Stock Unit shall not constitute an equity interest in the Company and shall not entitle the Holder to voting rights, dividends or any other rights associated with ownership of Shares prior to the time the Holder shall receive a distribution of Shares pursuant to Section 10.3.

10.2Terms and Conditions. At the time any Award is made under this Article X, the Company and the Holder shall enter into a Restricted Stock Unit Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Restricted Stock Unit Agreement shall set forth the individual service-based vesting requirement which the Holder would be required to satisfy before the Holder would become entitled to distribution pursuant to Section 10.3 and the number of Units awarded to the Holder. Such conditions shall be sufficient to constitute a “substantial risk of forfeiture” as such term is defined under Section 409A of the Code. At the time of such Award, the Committee may, in its sole

14



discretion, prescribe additional terms and conditions or restrictions relating to Restricted Stock Unit Awards in the Restricted Stock Unit Agreement, including, but not limited to, rules pertaining to the effect of Termination of Service prior to expiration of the applicable vesting period. The terms and conditions of the respective Restricted Stock Unit Agreements need not be identical.

10.3Distributions of Shares. The Holder of a Restricted Stock Unit shall be entitled to receive Shares or a cash payment equal to the Fair Market Value of a Share, or one Share, as determined in the sole discretion of the Committee and as set forth in the Restricted Stock Unit Agreement, for each Restricted Stock Unit subject to such Restricted Stock Unit Award, if the Holder satisfies the applicable vesting requirement. Such distribution shall be made no later than by the fifteenth (15th) day of the third (3rd) calendar month next following the end of the calendar year in which the Restricted Stock Unit first becomes vested (i.e., no longer subject to a “substantial risk of forfeiture”).
image_10a.jpg
PERFORMANCE UNIT AWARDS

11.1Award. A Performance Unit Award shall constitute an Award under which, upon the satisfaction of predetermined individual and/or Company (and/or Affiliate) Performance Goals based on selected Performance Criteria, a cash payment shall be made to the Holder, based on the number of Units awarded to the Holder. At the time a Performance Unit Award is made, the Committee shall establish the Performance Period and applicable Performance Goals. Each Performance Unit Award may have different Performance Goals, in the discretion of the Committee. A Performance Unit Award shall not constitute an equity interest in the Company and shall not entitle the Holder to voting rights, dividends or any other rights associated with ownership of Shares.

11.2Terms and Conditions. At the time any Award is made under this Article XI, the Company and the Holder shall enter into a Performance Unit Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Committee shall set forth in the applicable Performance Unit Agreement the Performance Period, Performance Criteria and Performance Goals which the Holder and/or the Company would be required to satisfy before the Holder would become entitled to payment pursuant to Section 11.3, the number of Units awarded to the Holder and the dollar value or formula assigned to each such Unit. Such payment shall be subject to a “substantial risk of forfeiture” under Section 409A of the Code. At the time of such Award, the Committee may, in its sole discretion, prescribe additional terms and conditions or restrictions relating to Performance Unit Awards, including, but not limited to, rules pertaining to the effect of Termination of Service prior to expiration of the applicable performance period. The terms and conditions of the respective Performance Unit Agreements need not be identical.

11.3Payments. The Holder of a Performance Unit shall be entitled to receive a cash payment equal to the dollar value assigned to such Unit under the applicable

15



Performance Unit Agreement if the Holder and/or the Company satisfy (or partially satisfy, if applicable under the applicable Performance Unit Agreement) the Performance Goals set forth in such Performance Unit Agreement. All payments shall be made no later than by the fifteenth (15th) day of the third (3rd) calendar month next following the end of the Company’s fiscal year to which such performance goals and objectives relate.
image_11a.jpg
PERFORMANCE STOCK AWARDS

12.1Award. A Performance Stock Award shall constitute a promise to grant Shares (or cash equal to the Fair Market Value of Shares) to the Holder at the end of a specified Performance Period subject to achievement of specified Performance Goals. At the time a Performance Stock Award is made, the Committee shall establish the Performance Period and applicable Performance Goals based on selected Performance Criteria. Each Performance Stock Award may have different Performance Goals, in the discretion of the Committee. A Performance Stock Award shall not constitute an equity interest in the Company and shall not entitle the Holder to voting rights, dividends or any other rights associated with ownership of Shares unless and until the Holder shall receive a distribution of Shares pursuant to Section 12.3.

12.2Terms and Conditions. At the time any Award is made under this Article XII, the Company and the Holder shall enter into a Performance Stock Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Committee shall set forth in the applicable Performance Stock Agreement the Performance Period, selected Performance Criteria and Performance Goals which the Holder and/or the Company would be required to satisfy before the Holder would become entitled to the receipt of Shares pursuant to such Holder’s Performance Stock Award and the number of Shares subject to such Performance Stock Award. Such distribution shall be subject to a “substantial risk of forfeiture” under Section 409A of the Code. If such Performance Goals are achieved, the distribution of Shares (or the payment of cash, as determined in the sole discretion of the Committee), shall be made in accordance with Section 12.3, below. At the time of such Award, the Committee may, in its sole discretion, prescribe additional terms and conditions or restrictions relating to Performance Stock Awards, including, but not limited to, rules pertaining to the effect of the Holder’s Termination of Service prior to the expiration of the applicable performance period. The terms and conditions of the respective Performance Stock Agreements need not be identical.

12.3Distributions of Shares. The Holder of a Performance Stock Award shall be entitled to receive a cash payment equal to the Fair Market Value of a Share, or one Share, as determined in the sole discretion of the Committee, for each Performance Stock Award subject to such Performance Stock Agreement, if the Holder satisfies the applicable vesting requirement. Such distribution shall be made no later than by the fifteenth (15th) day of the third (3rd) calendar month next following the end of the Company’s fiscal year to which such performance goals and objectives relate.
16


image_12a.jpg
DISTRIBUTION EQUIVALENT RIGHTS

13.1Award. A Distribution Equivalent Right shall entitle the Holder to receive bookkeeping credits, cash payments and/or Share distributions equal in amount to the distributions that would have been made to the Holder had the Holder held a specified number of Shares during the specified period of the Award.

13.2Terms and Conditions. At the time any Award is made under this Article XIII, the Company and the Holder shall enter into a Distribution Equivalent Rights Award Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Committee shall set forth in the applicable Distribution Equivalent Rights Award Agreement the terms and conditions, if any, including whether the Holder is to receive credits currently in cash, is to have such credits reinvested (at Fair Market Value determined as of the date of reinvestment) in additional Shares or is to be entitled to choose among such alternatives. Such receipt shall be subject to a “substantial risk of forfeiture” under Section 409A of the Code and, if such Award becomes vested, the distribution of such cash or Shares shall be made no later than by the fifteenth (15th) day of the third (3rd) calendar month next following the end of the Company’s fiscal year in which the Holder’s interest in the Award vests. Distribution Equivalent Rights Awards may be settled in cash or in Shares, as set forth in the applicable Distribution Equivalent Rights Award Agreement. A Distribution Equivalent Rights Award may, but need not be, awarded in tandem with another Award (other than an Option or a SAR), whereby, if so awarded, such Distribution Equivalent Rights Award shall expire, terminate or be forfeited by the Holder, as applicable, under the same conditions as under such other Award.

13.3Interest Equivalents. The Distribution Equivalent Rights Award Agreement for a Distribution Equivalent Rights Award may provide for the crediting of interest on a Distribution Rights Award to be settled in cash at a future date (but in no event later than by the fifteenth (15th) day of the third (3rd) calendar month next following the end of the Company’s fiscal year in which such interest is credited and vested), at a rate set forth in the applicable Distribution Equivalent Rights Award Agreement, on the amount of cash payable thereunder.
image_13a.jpg
STOCK APPRECIATION RIGHTS

14.1Award. A Stock Appreciation Right shall constitute a right, granted alone or in connection with a related Option, to receive a payment equal to the increase in value of a specified number of Shares between the date of Award and the date of exercise.

14.2Terms and Conditions. At the time any Award is made under this Article XIV, the Company and the Holder shall enter into a Stock Appreciation Right Agreement setting forth each of the matters contemplated thereby and such other matters as the Committee may determine to be appropriate. The Committee shall set forth in the applicable Stock Appreciation Right Agreement the terms and conditions of the Stock
17


Appreciation Right, including (i) the base value (the “Base Value”) for the Stock Appreciation Right, which shall be not less than the Fair Market Value of a Share on the date of grant of the Stock Appreciation Right, (ii) the number of Shares subject to the Stock Appreciation Right, (iii) the period during which the Stock Appreciation Right may be exercised; provided, however, that no Stock Appreciation Right shall be exercisable after the expiration of ten (10) years from the date of its grant, and (iv) any other special rules and/or requirements which the Committee imposes upon the Stock Appreciation Right. Upon the exercise of some or all of the portion of a Stock Appreciation Right, the Holder shall receive a payment from the Company, in cash or in the form of Shares having an equivalent Fair Market Value or in a combination of both, as determined in the sole discretion of the Committee, equal to the product of:

(a)The excess of (i) the Fair Market Value of a Share on the date of exercise, over (ii) the Base Value, multiplied by,

(b)The number of Shares with respect to which the Stock Appreciation Right is exercised.

14.1Tandem Stock Appreciation Rights. If the Committee grants a Stock Appreciation Right which is intended to be a Tandem Stock Appreciation Right, the Tandem Stock Appreciation Right shall be granted at the same time as the related Option, and the following special rules shall apply:

(c)The Base Value shall be equal to or greater than the per Share exercise price under the related Option;

(d)The Tandem Stock Appreciation Right may be exercised for all or part of the Shares which are subject to the related Option, but solely upon the surrender by the Holder of the Holder’s right to exercise the equivalent portion of the related Option (and when a Share is purchased under the related Option, an equivalent portion of the related Tandem Stock Appreciation Right shall be canceled);

(e)The Tandem Stock Appreciation Right shall expire no later than the date of the expiration of the related Option;

(f)The value of the payment with respect to the Tandem Stock Appreciation Right may be no more than one hundred percent (100%) of the difference between the per Share exercise price under the related Option and the Fair Market Value of the Shares subject to the related Option at the time the Tandem Stock Appreciation Right is exercised, multiplied by the number of the Shares with respect to which the Tandem Stock Appreciation Right is exercised; and

(g)The Tandem Stock Appreciation Right may be exercised solely when the Fair Market Value of the Shares subject to the related Option exceeds the per Share exercise price under the related Option.
18


image_14a.jpg
RECAPITALIZATION OR REORGANIZATION

15.1Adjustments to Shares. The shares with respect to which Awards may be granted under the Plan are Shares as presently constituted; provided, however, that if, and whenever, prior to the expiration or distribution to the Holder of Shares underlying an Award theretofore granted, the Company shall effect a subdivision or consolidation of the Shares or the payment of an Share dividend on Shares without receipt of consideration by the Company, the number of Shares with respect to which such Award may thereafter be exercised or satisfied, as applicable, (i) in the event of an increase in the number of outstanding Shares, shall be proportionately increased, and the purchase price per Share shall be proportionately reduced, and (ii) in the event of a reduction in the number of outstanding Shares, shall be proportionately reduced, and the purchase price per Share shall be proportionately increased. Notwithstanding the foregoing or any other provision of this Article XV, any adjustment made with respect to an Award (x) which is an Incentive Stock Option, shall comply with the requirements of Section 424(a) of the Code, and in no event shall any adjustment be made which would render any Incentive Stock Option granted under the Plan to be other than an “incentive stock option” for purposes of Section 422 of the Code, and (y) which is a Non-qualified Stock Option, shall comply with the requirements of Section 409A of the Code, and in no event shall any adjustment be made which would render any Non-qualified Stock Option granted under the Plan to become subject to Section 409A of the Code.

15.2Recapitalization. If the Company recapitalizes or otherwise changes its capital structure, thereafter upon any exercise or satisfaction, as applicable, of a previously granted Award, the Holder shall be entitled to receive (or entitled to purchase, if applicable) under such Award, in lieu of the number of Shares then covered by such Award, the number and class of shares and securities to which the Holder would have been entitled pursuant to the terms of the recapitalization if, immediately prior to such recapitalization, the Holder had been the holder of record of the number of Shares then covered by such Award.

15.3Other Events. In the event of changes to the outstanding Shares by reason of an extraordinary cash dividend, reorganization, merger, consolidation, combination, split-up, spin-off, exchange or other relevant change in capitalization occurring after the date of the grant of any Award and not otherwise provided for under this Article XV, any outstanding Awards and any Award Agreements evidencing such Awards shall be adjusted by the Board in its discretion in such manner as the Board shall deem equitable or appropriate taking into consideration the applicable accounting and tax consequences, as to the number and price of Shares or other consideration subject to such Awards. In the event of any adjustment pursuant to Sections 15.1, 15.2 or this Section 15.3, the aggregate number of Shares available under the Plan pursuant to Section 5.1 may be appropriately adjusted by the Board, the determination of which shall be conclusive. In addition, the Committee may make provision for a cash payment to a Holder or a person who has an outstanding Award.
19


15.1Change of Control. The Committee may, in its sole discretion, at the time an Award is made or at any time prior to, coincident with or after the time of a Change of Control, cause any Award either (i) to be canceled in consideration of a payment in cash or other consideration in amount per share equal to the excess, if any, of the price or implied price per Share in the Change of Control over the per Share exercise, base or purchase price of such Award, which may be paid immediately or over the vesting schedule of the Award; (ii) to be assumed, or new rights substituted therefore, by the surviving corporation or a parent or subsidiary of such surviving corporation following such Change of Control; (iii) accelerate any time periods, or waive any other conditions, relating to the vesting, exercise, payment or distribution of an Award so that any Award to a Holder whose employment has been terminated as a result of a Change of Control may be vested, exercised, paid or distributed in full on or before a date fixed by the Committee; (iv) to be purchased from a Holder whose employment has been terminated as a result of a Change of Control, upon the Holder’s request, for an amount of cash equal to the amount that could have been obtained upon the exercise, payment or distribution of such rights had such Award been currently exercisable or payable; or (v) terminate any then outstanding Award or make any other adjustment to the Awards then outstanding as the Committee deems necessary or appropriate to reflect such transaction or change. The number of Shares subject to any Award shall be rounded to the nearest whole number.

15.2Powers Not Affected. The existence of the Plan and the Awards granted hereunder shall not affect in any way the right or power of the Board or of the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change of the Company’s capital structure or business, any merger or consolidation of the Company, any issue of debt or equity securities ahead of or affecting Shares or the rights thereof, the dissolution or liquidation of the Company or any sale, lease, exchange or other disposition of all or any part of its assets or business or any other corporate act or proceeding.

15.3No Adjustment for Certain Awards. Except as hereinabove expressly provided, the issuance by the Company of shares of any class or securities convertible into shares of any class, for cash, property, labor or services, upon direct sale, upon the exercise of rights or warrants to subscribe therefor or upon conversion of shares or obligations of the Company convertible into such shares or other securities, and in any case whether or not for fair value, shall not affect previously granted Awards, and no adjustment by reason thereof shall be made with respect to the number of Shares subject to Awards theretofore granted or the purchase price per Share, if applicable.
image_15a.jpg
AMENDMENT AND TERMINATION OF PLAN

The Plan shall continue in effect, unless sooner terminated pursuant to this Article XVI, until the tenth (10th) anniversary of the date on which it is adopted by the Board (except as to Awards outstanding on that date). The Board in its discretion may terminate the Plan at any time with respect to any shares for which Awards have not theretofore been granted; provided, however, that the Plan’s termination shall not materially and adversely impair the rights of a Holder with respect to any Award theretofore granted

20



without the consent of the Holder. The Board shall have the right to alter or amend the Plan or any part hereof from time to time; provided, however, that without the approval by a majority of the votes cast at a meeting of stockholders at which a quorum representing a majority of the shares of the Company entitled to vote generally in the election of directors is present in person or by proxy, no amendment or modification of the Plan may (i) materially increase the benefits accruing to Holders, (ii) except as otherwise expressly provided in Article XV, materially increase the number of Shares subject to the Plan or the individual Award Agreements specified in Article V,
(iii) materially modify the requirements for participation in the Plan, or (iv) amend, modify or suspend Section 7.7 (re-pricing prohibitions) or this Article XVI. In addition, no change in any Award theretofore granted may be made which would materially and adversely impair the rights of a Holder with respect to such Award without the consent of the Holder (unless such change is required in order to exempt the Plan or any Award from Section 409A of the Code).
image_16a.jpg
MISCELLANEOUS

17.1No Right to Award. Neither the adoption of the Plan by the Company nor any action of the Board or the Committee shall be deemed to give an Employee, Director or Consultant any right to an Award except as may be evidenced by an Award Agreement duly executed on behalf of the Company, and then solely to the extent and on the terms and conditions expressly set forth therein.

17.2No Rights Conferred. Nothing contained in the Plan shall (i) confer upon any Employee any right with respect to continuation of employment with the Company or any Affiliate, (ii) interfere in any way with any right of the Company or any Affiliate to terminate the employment of an Employee at any time, (iii) confer upon any Director any right with respect to continuation of such Director’s membership on the Board,
(iv) interfere in any way with any right of the Company or an Affiliate to terminate a Director’s membership on the Board at any time, (v) confer upon any Consultant any right with respect to continuation of his or her consulting engagement with the Company or any Affiliate, or (vi) interfere in any way with any right of the Company or an Affiliate to terminate a Consultant’s consulting engagement with the Company or an Affiliate at any time.

17.3Other Laws; No Fractional Shares; Withholding. The Company shall not be obligated by virtue of any provision of the Plan to recognize the exercise of any Award or to otherwise sell or issue Shares in violation of any laws, rules or regulations, and any postponement of the exercise or settlement of any Award under this provision shall not extend the term of such Award. Neither the Company nor its directors or officers shall have any obligation or liability to a Holder with respect to any Award (or Shares issuable thereunder) (i) that shall lapse because of such postponement, or (ii) for any failure to comply with the requirements of any applicable law, rules or regulations, including but not limited to any failure to comply with the requirements of Section 409A of this Code. No fractional Shares shall be delivered, nor shall any cash in lieu of fractional Shares be paid. The Company shall have the right to deduct in cash (whether

21



under this Plan or otherwise) in connection with all Awards any taxes required by law to be withheld and to require any payments required to enable it to satisfy its withholding obligations. In the case of any Award satisfied in the form of Shares, no Shares shall be issued unless and until arrangements satisfactory to the Company shall have been made to satisfy any tax withholding obligations applicable with respect to such Award. Subject to such terms and conditions as the Committee may impose, the Company shall have the right to retain, or the Committee may, subject to such terms and conditions as it may establish from time to time, permit Holders to elect to tender, Shares (including Shares issuable in respect of an Award) to satisfy, in whole or in part, the amount required to be withheld.

17.4No Restriction on Corporate Action. Nothing contained in the Plan shall be construed to prevent the Company or any Affiliate from taking any corporate action which is deemed by the Company or such Affiliate to be appropriate or in its best interest, whether or not such action would have an adverse effect on the Plan or any Award made under the Plan. No Employee, Director, Consultant, beneficiary or other person shall have any claim against the Company or any Affiliate as a result of any such action.

17.5Restrictions on Transfer. No Award under the Plan or any Award Agreement and no rights or interests herein or therein, shall or may be assigned, transferred, sold, exchanged, encumbered, pledged or otherwise hypothecated or disposed of by a Holder except (i) by will or by the laws of descent and distribution, or (ii) where permitted under applicable tax rules, by gift to any Family Member of the Holder, subject to compliance with applicable laws. An Award may be exercisable during the lifetime of the Holder only by such Holder or by the Holder’s guardian or legal representative unless it has been transferred by gift to a Family Member of the Holder, in which case it shall be exercisable solely by such transferee. Notwithstanding any such transfer, the Holder shall continue to be subject to the withholding requirements provided for under
Section 17.3 hereof.

17.6Beneficiary Designations. Each Holder may, from time to time, name a beneficiary or beneficiaries (who may be contingent or successive beneficiaries) for purposes of receiving any amount which is payable in connection with an Award under the Plan upon or subsequent to the Holder’s death. Each such beneficiary designation shall serve to revoke all prior beneficiary designations, be in a form prescribed by the Company and be effective solely when filed by the Holder in writing with the Company during the Holder’s lifetime. In the absence of any such written beneficiary designation, for purposes of the Plan, a Holder’s beneficiary shall be the Holder’s estate.

17.7Rule 16b-3. It is intended that the Plan and any Award made to a person subject to Section 16 of the Exchange Act shall meet all of the requirements of Rule 16b-
3. If any provision of the Plan or of any such Award would disqualify the Plan or such Award under, or would otherwise not comply with the requirements of, Rule 16b-3, such provision or Award shall be construed or deemed to have been amended as necessary to conform to the requirements of Rule 16b-3.

22



17.8Clawback Policy. Notwithstanding anything contained herein or in any incentive “performance based” award, Awards under the Plan shall be subject to reduction, forfeiture or repayment by reason of a correction or restatement of the Company’s financial information if and to the extent such reduction or repayment is required by any applicable law.

17.9No Obligation to Notify or Minimize Taxes. The Company shall have no duty or obligation to any Holder to advise such Holder as to the time or manner of exercising any Award. Furthermore, the Company shall have no duty or obligation to warn or otherwise advise such Holder of a pending termination or expiration of an Award or a possible period in which the Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to any person.

17.10Section 409A. Notwithstanding any other provision of the Plan, the Committee shall have no authority to issue an Award under the Plan with terms and/or conditions which would cause such Award to constitute non-qualified “deferred compensation” under Section 409A of the Code unless such Award shall be structured to be exempt from or comply with all requirements of Code Section 409A. The Plan and all Award Agreements are intended to comply with the requirements of Section 409A of the Code (or to be exempt therefrom) and shall be so interpreted and construed and no amount shall be paid or distributed from the Plan unless and until such payment complies with all requirements of Code Section 409A. If an Award is subject to Section 409A of the Code, (i) distributions shall only be made in a manner and upon an event permitted under Section 409A of the Code, (ii) payments to be made upon a termination of employment or service shall only be made upon a “separation from service” under section 409A of the Code, (iii) unless the Award specifies otherwise, each installment payment shall be treated as a separate payment for purposes of Section 409A of the Code, and (iv) in no event shall a Holder, directly or indirectly, designate the calendar year in which a distribution is made except in accordance with Section 409A of the Code. Any Award that is subject to Section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation from service shall be administered so that any distribution with respect to such Award shall be postponed for six months following the date of the Holder’s separation from service (unless an earlier death), if required by Section 409A. The determination of Key Employees, including the number and identity of persons considered Key Employees and the identification date, shall be made by the Committee or its delegate each year in accordance with section 416(i) of the Code and the “specified employee” requirements of Section 409A of the Code. It is the intent of the Company that the provisions of this Plan and all other plans and programs sponsored by the Company be interpreted to comply in all respects with Code Section 409A, however, the Company shall have no liability to the Holder, or any successor or beneficiary thereof, in the event taxes, penalties or excise taxes may ultimately be determined to be applicable to any payment or benefit received by the Holder or any successor or beneficiary thereof.

17.11Indemnification. Each person who is or shall have been a member of the Committee or of the Board shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense that may be imposed upon or reasonably incurred thereby in connection with or resulting from any claim, action, suit, or proceeding to which such person may be made a party or may be involved by reason

23



of any action taken or failure to act under the Plan and against and from any and all amounts paid thereby in settlement thereof, with the Company’s approval, or paid thereby in satisfaction of any judgment in any such action, suit, or proceeding against such person; provided, however, that such person shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own behalf. The foregoing right of indemnification shall not be exclusive and shall be independent of any other rights of indemnification to which such persons may be entitled under the Company’s Articles of Incorporation or By-laws, by contract, as a matter of law, or otherwise.

17.12Other Benefit Plans. No Award, payment or amount received hereunder shall be taken into account in computing an Employee’s salary or compensation for the purposes of determining any benefits under any pension, retirement, life insurance or other benefit plan of the Company or any Affiliate, unless such other plan specifically provides for the inclusion of such Award, payment or amount received. Nothing in the Plan shall be construed to limit the right of the Company to establish other plans or to pay compensation to its employees, in cash or property, in a manner which is not expressly authorized under the Plan.

17.13Limits of Liability. Any liability of the Company with respect to an Award shall be based solely upon the contractual obligations created under the Plan and the Award Agreement. None of the Company, any member of the Board nor any member of the Committee shall have any liability to any party for any action taken or not taken, in good faith, in connection with or under the Plan.

17.14Governing Law. Except as otherwise provided herein, the Plan shall be construed in accordance with the laws of the State of Delaware, without regard to principles of conflicts of law.

17.15Subplans. The Board may from time to time establish one or more sub- plans under the Plan for purposes of satisfying applicable blue sky, securities or tax laws of various jurisdictions. The Board shall establish such sub-plans by adopting supplements to the Plan setting forth (i) such limitations on the Committee’s discretion under the Plan as the Board deems necessary or desirable and (ii) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable. All supplements adopted by the Board shall be deemed to be part of the Plan, but each supplement shall apply only to Holders within the affected jurisdiction and the Company shall not be required to provide copies of any supplement to Holders in any jurisdiction that is not affected.

17.16Severability of Provisions. If any provision of the Plan is held invalid or unenforceable, such invalidity or unenforceability shall not affect any other provision of the Plan, and the Plan shall be construed and enforced as if such invalid or unenforceable provision had not been included in the Plan.

17.17No Funding. The Plan shall be unfunded. The Company shall not be required to establish any special or separate fund or to make any other segregation of
24


funds or assets to ensure the payment of any Award. Prior to receipt of Shares or a cash distribution pursuant to the terms of an Award, such Award shall represent an unfunded unsecured contractual obligation of the Company and the Holder shall have no greater claim to the Shares underlying such Award or any other assets of the Company or Affiliate than any other unsecured general creditor.

17.1Headings. Headings used throughout the Plan are for convenience only and shall not be given legal significance.

    1
OMM_US:79990995.3


________________________________________________________________________________________
Notice of Restricted Stock Unit Award
and
Terms and Conditions of Restricted Stock Unit Award
________________________________________________________________________________________
Participant__________________________Award No:__________________________
Address:__________________________ID:__________________________
__________________________Plan:2021 Omnibus Equity Incentive Plan
________________________________________________________________________________________
Effective [___________] (the “Award Date”), you (the “Participant”) have been granted an award (the “Award”) with respect to an aggregate of [_________] stock units (the “Restricted Stock Units”).1

The Award will vest and become nonforfeitable with respect to [twenty-five percent (25%) of the total number of Restricted Stock Units on each of the first, second, third and fourth anniversaries1, 2] of the Award Date.
____________________________________________________________________________________
By your signature and the Corporation’s signature below, you and the Corporation agree that the Award is granted under and governed by the terms and conditions of the Corporation's 2021 Omnibus Equity Incentive Plan (the “Plan”) and the Terms and Conditions of Restricted Stock Unit Award (the “Terms”), which are attached and incorporated herein by this reference. This Notice of Restricted Stock Unit Award, together with the Terms, will be referred to as your Restricted Stock Unit Award Agreement. The Award has been granted to you in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to you. Capitalized terms are defined in the Plan if not defined herein or in the Terms. You acknowledge receipt of a copy of the Terms and the Plan.


INDIE SEMICONDUCTOR, INC.,
a Delaware corporation


By:__________________________________

Print Name:___________________________

Its:__________________________________
PARTICIPANT



__________________________________
Signature


__________________________________
Print Name



INDIE SEMICONDUCTOR, INC.
2021 OMNIBUS EQUITY INCENTIVE PLAN
TERMS AND CONDITIONS OF RESTRICTED STOCK UNIT AWARD
1.General. These Terms and Conditions of Restricted Stock Unit Award (these “Terms”) apply to a particular restricted stock unit grant (the “Award”) if incorporated by reference in the Notice of Restricted Stock Unit Award (the “Grant Notice”) corresponding to that particular grant. The recipient of the Award identified in the Grant Notice is referred to as
1 Subject to adjustment under Section 8 of the Terms and Article XV of the Plan.
2 Subject to termination under Section 7 of the Terms and Section 15.4 of the Plan.
    2
OMM_US:79990995.3


the “Participant.” The effective date of grant of the Award as set forth in the Grant Notice is referred to as the “Award Date.” The number of Shares covered by the Award is subject to adjustment under Article XV of the Plan.
The Award was granted under and subject to the indie Semiconductor 2021 Omnibus Equity Incentive Plan (the “Plan”). Capitalized terms are defined in the Plan if not defined herein. The Award has been granted to the Participant in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Participant. The Grant Notice and these Terms are collectively referred to as the “Restricted Stock Unit Award Agreement” or the “Agreement” applicable to the Award.
2.Restricted Stock Units. Subject to the terms of this Agreement, the Corporation hereby grants to the Participant an Award as set forth in the Grant Notice (subject to adjustment as provided in Article XV of the Plan) (the “Restricted Stock Units”). As used herein, the term “stock unit” shall mean a non-voting unit of measurement which is deemed for bookkeeping purposes to be equivalent to one outstanding Share of the Corporation’s Class A Common Stock (subject to adjustment as provided in Article XV of the Plan) solely for purposes of the Plan and this Agreement. The Restricted Stock Units shall be used solely as a device for the determination of the payment to eventually be made to the Participant if such Restricted Stock Units vest pursuant to the terms of the Grant Notice. The Restricted Stock Units shall not be treated as property or as a trust fund of any kind.
3.Continuance of Employment/Service. The vesting schedule requires continued employment or service through each applicable vesting date as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Agreement. Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 7 below or under the Plan.
Nothing contained in this Agreement or the Plan constitutes an employment or service commitment by the Corporation, affects the Participant’s status as an employee at will who is subject to termination without cause, confers upon the Participant any right to remain employed by or in service to the Corporation or any Affiliate, interferes in any way with the right of the Corporation or any Affiliate at any time to terminate such employment or services, or affects the right of the Corporation or any Affiliate to increase or decrease the Participant’s other compensation or benefits. Nothing in this Agreement, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.
4.Dividend and Voting Rights.
(a)    Limitations on Rights Associated with Units. The Participant shall have no rights as a stockholder of the Corporation, no dividend rights (except as expressly provided in Section 4(b) with respect to Distribution Equivalent Rights) and no voting rights, with respect to the Restricted Stock Units and any Shares underlying or issuable in respect of such Restricted Stock Units until such Shares are actually issued to and held of record by the Participant. No adjustments will be made for dividends or other rights of a holder for which the record date is prior to the date of issuance of such Shares.
(b)    As of any date that the Corporation pays an ordinary cash dividend on its Shares, the Corporation shall credit the Participant with an additional number of Restricted Stock Units equal to (i) the per Share cash dividend paid by the Corporation on its Shares on such date, multiplied by (ii) the total number of Restricted Stock Units (including any dividend equivalents previously credited hereunder) (with such total number adjusted pursuant to Article XV of the Plan) subject to the Award as of the related dividend payment record date, divided by (iii) the fair market value of a Share on the date of payment of such dividend. Any Restricted Stock Units credited pursuant to the foregoing provisions of this Section 4(b) shall be subject to the same vesting, payment and other terms, conditions and restrictions as the original Restricted Stock Units to which they relate. No crediting of Restricted Stock Units shall be
    3
OMM_US:79990995.3


made pursuant to this Section 4(b) with respect to any Restricted Stock Units which, as of such record date, have either been paid pursuant to Section 6 or terminated pursuant to Section 7.
5.Restrictions on Transfer. Neither the Award, nor any interest therein or amount or Shares payable in respect thereof may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily. The transfer restrictions in the preceding sentence shall not apply to (a) transfers to the Corporation, or (b) transfers by will or the laws of descent and distribution.
6.Timing and Manner of Payment of Restricted Stock Units. On or as soon as administratively practical following each vesting of the applicable portion of the total Award pursuant to the terms of the Grant Notice or Article XV of the Plan (and in all events not later than two and one-half months after the applicable vesting date), the Corporation shall deliver to the Participant a number of Shares (either by delivering one or more certificates for such Shares or by entering such Shares in book entry form, as determined by the Corporation in its discretion) equal to the number of Restricted Stock Units subject to this Award that vest on the applicable vesting date, unless such Restricted Stock Units terminate prior to the given vesting date pursuant to Section 7. The Corporation’s obligation to deliver Shares or otherwise make payment with respect to vested Restricted Stock Units is subject to the condition precedent that the Participant or other person entitled under the Plan to receive any Shares with respect to the vested Restricted Stock Units deliver to the Corporation any representations or other documents or assurances as the Committee deems necessary or desirable to assure compliance with all applicable legal and accounting requirements. The Participant shall have no further rights with respect to any Restricted Stock Units that are paid or that terminate pursuant to Section 7.
7.Effect of Termination of Employment or Service. The Participant’s Restricted Stock Units shall terminate to the extent such units have not become vested prior to the first date the Participant is no longer employed by or in service to the Corporation or one of its Affiliates, regardless of the reason for the termination of the Participant’s employment or service with the Corporation or an Affiliate, whether with or without cause, voluntarily or involuntarily. If any unvested Restricted Stock Units are terminated hereunder, such Restricted Stock Units shall automatically terminate and be cancelled as of the applicable termination date without payment of any consideration by the Corporation and without any other action by the Participant, or the Participant’s beneficiary or personal representative, as the case may be.
8.Adjustments Upon Specified Events. Upon the occurrence of certain events relating to the Corporation’s stock contemplated by Article XV of the Plan (including, without limitation, an extraordinary cash dividend on such stock), the Committee shall make adjustments in accordance with such section in the number of Restricted Stock Units then outstanding and the number and kind of securities that may be issued in respect of the Award. No such adjustment shall be made with respect to any ordinary cash dividend for which dividend equivalents are credited pursuant to Section 4(b).
9.Tax Withholding. The Corporation or any Affiliate shall be entitled to require a cash payment by or on behalf of the Participant (including, without limitation, subject to such procedures as the Committee may adopt, pursuant to a broker-assisted “cashless” arrangement with a third party who facilitates the sale of Shares deliverable upon any payment of Restricted Stock Units) and/or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to the grant, vesting or payment of the Restricted Stock Units in whole or in part. The Corporation may, in its discretion, agree that it will, upon any payment of Shares in respect of the Restricted Stock Units, automatically reduce the number of Shares to be delivered by (or otherwise reacquire) the appropriate number of whole Shares, valued at their then fair market value, to satisfy any
    4
OMM_US:79990995.3


withholding obligations of the Corporation or any Affiliate with respect to such distribution of Shares at the applicable withholding rates.3
10.Notices. Any notice to be given under the terms of this Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant’s last address reflected on the Corporation’s records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be given only when received, but if the Participant is no longer an employee of or in service to the Corporation, shall be deemed to have been duly given by the Corporation when enclosed in a properly sealed envelope addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.
11.Plan. The Award and all rights of the Participant under this Agreement are subject to the terms and conditions of the provisions of the Plan, incorporated herein by reference. The Participant agrees to be bound by the terms of the Plan and this Agreement. The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, and this Agreement. Unless otherwise expressly provided in other sections of this Agreement, provisions of the Plan that confer discretionary authority on the Board or the Committee do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Committee so conferred by appropriate action of the Board or the Committee under the Plan after the date hereof.
12.Entire Agreement. This Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Agreement may be amended pursuant to Article XVI of the Plan. Such amendment must be in writing and signed by the Corporation. The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.
13.Limitation on Participant’s Rights. Participation in the Plan confers no rights or interests other than as herein provided. This Agreement creates only a contractual obligation on the part of the Corporation as to amounts payable and shall not be construed as creating a trust. Neither the Plan nor any underlying program, in and of itself, has any assets. The Participant shall have only the rights of a general unsecured creditor of the Corporation with respect to amounts credited and benefits payable, if any, with respect to the Restricted Stock Units, and rights no greater than the right to receive the Common Stock as a general unsecured creditor with respect to Restricted Stock Units, as and when payable hereunder.
3 For Section 16 officers, Section 9 to read as follows: “Unless (1) otherwise determined by the Committee at any time after the Award Date or (2) the Participant has previously notified the Chief Financial Officer of the Corporation (or his designee) that he or she will pay the amount of any applicable federal, state or local tax law withholding taxes directly to the Corporation in cash, upon any payment of Shares in respect of the Restricted Stock Units, the Corporation shall automatically reduce the number of Shares to be delivered by (or otherwise reacquire) the appropriate number of whole Shares, valued at their then fair market value, to satisfy any withholding obligations of the Corporation or any Affiliate with respect to such distribution of Shares at the applicable withholding rates. In the event that the Committee determines not to satisfy, or the Corporation cannot legally satisfy, such withholding obligations by such reduction of Shares, or in the event of a cash payment or any other withholding event in respect of the Restricted Stock Units, the Corporation or any Affiliate shall be entitled to require a cash payment by or on behalf of the Participant and/or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to such distribution or payment.”
    5
OMM_US:79990995.3


14.Counterparts; Electronic Signature. This Agreement may be signed and/or transmitted in one or more counterparts by facsimile, e-mail of a .PDF, .TIF, .GIF, .JPG or similar attachment or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties, it being understood that all parties need not sign the same counterpart, and that any such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party’s hand-written signature. To the extent a party signs this Agreement using electronic signature technology, by clicking “sign,” “accept,” or similar acknowledgement of acceptance, such party is signing this Agreement electronically, and electronic signatures appearing on this Agreement (or entered as to this Agreement using electronic signature technology) shall be treated, for purposes of validity, enforceability and admissibility, the same as hand-written signatures.
15.Section Headings. The section headings of this Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.
16.Governing Law. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to conflict of law principles thereunder.
17.Construction. It is intended that the terms of the Award will not result in the imposition of any tax liability pursuant to Section 409A of the Code. This Agreement shall be construed and interpreted consistent with that intent.
18.Clawback Policy. The Restricted Stock Units are subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Restricted Stock Units or any Shares or other cash or property received with respect to the Restricted Stock Units (including any value received from a disposition of the Shares acquired upon payment of the Restricted Stock Units).
19.No Advice Regarding Award. The Participant is hereby advised to consult with his or her own tax, legal and/or investment advisors with respect to any advice the Participant may determine is needed or appropriate with respect to the Restricted Stock Units (including, without limitation, to determine the foreign, state, local, estate and/or gift tax consequences with respect to the Award). Neither the Corporation nor any of its officers, directors, affiliates or advisors makes any representation (except for the terms and conditions expressly set forth in this Restricted Stock Unit Award Agreement) or recommendation with respect to the Award. Except for the withholding rights set forth in Section 9 above, the Participant is solely responsible for any and all tax liability that may arise with respect to the Award.

    6
OMM_US:79990995.3


________________________________________________________________________________________
Notice of Restricted Stock Award
and
Terms and Conditions of Restricted Stock Award
________________________________________________________________________________________
Participant:Award Number:
Address:ID:
Plan:2021 Omnibus Equity
Incentive Plan
____________________________________________________________________________________
Effective [___________] (the “Award Date”), you (the “Participant”) have been granted a restricted stock award (the “Award”) with respect to an aggregate of [________] restricted Shares of the Corporation (the “Restricted Stock”).4

The Award will vest and become nonforfeitable with respect to [twenty-five percent (25%) of the total number of Shares of Restricted Stock on each of the first, second, third and fourth anniversaries1, 5] of the Award Date.
___________________________________________________________________________________
By your signature and the Corporation’s signature below, you and the Corporation agree that the Award is granted under and governed by the terms and conditions of the Corporation's 2021 Omnibus Equity Incentive Plan (the “Plan”) and the Terms and Conditions of Restricted Stock Award (the “Terms”), which are attached and incorporated herein by this reference. This Notice of Restricted Stock Award, together with the Terms, will be referred to as your Restricted Stock Award Agreement. The Award has been granted to you in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to you. Capitalized terms are defined in the Plan if not defined herein or in the Terms. You acknowledge receipt of a copy of the Terms and the Plan.
____________________________________________________________________________________
IN WITNESS WHEREOF, the Corporation has caused this Award to be executed on its behalf by a duly authorized officer and the Participant has hereunto set his or her hand as of the date and year first above written.


INDIE SEMICONDUCTOR, INC.,
a Delaware corporation


By:__________________________________

Print Name:___________________________

Its:__________________________________
PARTICIPANT



______________________________________
Signature


______________________________________
Print Name


4 Subject to adjustment under Section 7 of the Terms and Article XV of the Plan.
5 Subject to termination under Section 6 of the Terms and Section 15.4 of the Plan.
    7
OMM_US:79990995.3


INDIE SEMICONDUCTOR, INC.
2021 OMNIBUS EQUITY INCENTIVE PLAN
TERMS AND CONDITIONS OF RESTRICTED STOCK AWARD


1.General. These Terms and Conditions of Restricted Stock Award (these “Terms”) apply to a particular restricted stock grant (the “Award”) if incorporated by reference in the Notice of Restricted Stock Award (the “Grant Notice”) corresponding to that particular grant. The recipient of the Award identified in the Grant Notice is referred to as the “Participant.” The effective date of grant of the Award as set forth in the Grant Notice is referred to as the “Award Date.” The number of Shares covered by the Award is subject to adjustment under Article XV of the Plan.
The Award was granted under and subject to the indie Semiconductor 2021 Omnibus Equity Incentive Plan (the “Plan”). Capitalized terms are defined in the Plan if not defined herein. The Award has been granted to the Participant in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Participant. The Grant Notice and these Terms are collectively referred to as the “Restricted Stock Award Agreement” or “Award Agreement” applicable to the Award.
2.Continuance of Employment. The vesting schedule requires continued employment or service through each applicable vesting date as a condition to the vesting of the applicable installment of the Award and the rights and benefits under this Award Agreement. Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Participant to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 6 below or under the Plan.
Nothing contained in this Award Agreement or the Plan constitutes an employment or service commitment by the Corporation, affects the Participant’s status as an employee at will who is subject to termination without cause, confers upon the Participant any right to remain employed by or in service to the Corporation or any of its Affiliates, interferes in any way with the right of the Corporation or any of its Affiliates at any time to terminate such employment or services, or affects the right of the Corporation or any of its Affiliates to increase or decrease the Participant’s other compensation or benefits. Nothing in this Award Agreement, however, is intended to adversely affect any independent contractual right of the Participant without his or her consent thereto.
3.Dividend and Voting Rights. After the Award Date, the Participant shall be entitled to cash dividends and voting rights with respect to the Shares of Restricted Stock subject to the Award even though such Shares are not vested, provided that such rights shall terminate immediately as to any Shares of Restricted Stock that are forfeited pursuant to Section 6 below. Any dividends payable on unvested Shares of Restricted Stock shall be held in escrow by the Corporation and will be paid to the Participant within sixty (60) days after the date (if any) that such Shares vest, with such dividends forfeited if the underlying Shares do not vest.
4.Restrictions on Transfer. Prior to the time that they have become vested pursuant to the terms of the Grant Notice or Article XV of the Plan, neither the Restricted Stock, nor any interest therein, amount payable in respect thereof, or Restricted Property (as defined in Section 7 hereof) may be sold, assigned, transferred, pledged or otherwise disposed of, alienated or encumbered, either voluntarily or involuntarily. The transfer restrictions in the preceding sentence shall not apply to (a) transfers to the Corporation, or (b) transfers by will or the laws of descent and distribution.
5.Stock Certificates.
(c)Book Entry Form. The Corporation shall issue the Shares of Restricted Stock subject to the Award either: (a) in certificate form as provided in Section 5(b) below; or (b)
    8
OMM_US:79990995.3


in book entry form, registered in the name of the Participant with notations regarding the applicable restrictions on transfer imposed under this Award Agreement.
(d)Certificates to be Held by Corporation; Legend. Any certificates representing Shares of Restricted Stock that may be delivered to the Participant by the Corporation prior to vesting shall be redelivered to the Corporation to be held by the Corporation until the restrictions on such Shares shall have lapsed and the Shares shall thereby have become vested or the Shares represented thereby have been forfeited hereunder. Such certificates shall bear the following legend and any other legends the Corporation may determine to be necessary or advisable to comply with all applicable laws, rules, and regulations:
“The ownership of this certificate and the Shares of stock evidenced hereby and any interest therein are subject to substantial restrictions on transfer under an Agreement entered into between the registered owner and indie Semiconductor, Inc. A copy of such Agreement is on file in the office of the Secretary of indie Semiconductor, Inc.”
(e)Delivery of Certificates Upon Vesting. Promptly after the vesting of any Shares of Restricted Stock pursuant to the terms of the Grant Notice or Article XV of the Plan and the satisfaction of any and all related tax withholding obligations pursuant to Section 8, the Corporation shall, as applicable, either remove the notations on any Shares of Restricted Stock issued in book entry form which have vested or deliver to the Participant a certificate or certificates evidencing the number of Shares of Restricted Stock which have vested (or, in either case, such lesser number of Shares as may result after giving effect to Section 8). The Participant (or the beneficiary or personal representative of the Participant in the event of the Participant’s death or disability, as the case may be) shall deliver to the Corporation any representations or other documents or assurances as the Corporation or its counsel may determine to be necessary or advisable in order to ensure compliance with all applicable laws, rules, and regulations with respect to the grant of the Award and the delivery of Shares in respect thereof. The Shares so delivered shall no longer be restricted Shares hereunder.
(f)Stock Power; Power of Attorney. Concurrently with the execution and delivery of this Award Agreement, the Participant shall deliver to the Corporation an executed stock power in the form attached hereto as Exhibit A, in blank, with respect to such Shares. The Corporation shall not deliver any Share certificates in accordance with this Award Agreement unless and until the Corporation shall have received such stock power executed by the Participant. The Participant, by acceptance of the Award, shall be deemed to appoint, and does so appoint by execution of this Award Agreement, the Corporation and each of its authorized representatives as the Participant’s attorney(s)-in-fact to effect any transfer of unvested forfeited Shares (or Shares otherwise reacquired by the Corporation hereunder) to the Corporation as may be required pursuant to the Plan or this Award Agreement and to execute such documents as the Corporation or such representatives deem necessary or advisable in connection with any such transfer.
    9
OMM_US:79990995.3


6.Effect of Termination of Employment or Services. If the Participant ceases to be employed by or ceases to provide services to the Corporation or an Affiliate (the date of such termination of employment or service is referred to as the Participant’s “Severance Date”), the Participant’s Shares of Restricted Stock (and related Restricted Property as defined in Section 7 hereof) shall be forfeited to the Corporation to the extent such Shares have not become vested pursuant to the terms of the Grant Notice or Article XV of the Plan upon the Severance Date (regardless of the reason for such termination of employment or service, whether with or without cause, voluntarily or involuntarily, or due to death or disability). Upon the occurrence of any forfeiture of Shares of Restricted Stock hereunder, such unvested, forfeited Shares and related Restricted Property shall be automatically transferred to the Corporation as of the Severance Date, without any other action by the Participant (or the Participant’s beneficiary or personal representative in the event of the Participant’s death or disability, as applicable). No consideration shall be paid by the Corporation with respect to such transfer. The Corporation may exercise its powers under Section 5(d) hereof and take any other action necessary or advisable to evidence such transfer. The Participant (or the Participant’s beneficiary or personal representative in the event of the Participant’s death or disability, as applicable) shall deliver any additional documents of transfer that the Corporation may request to confirm the transfer of such unvested, forfeited Shares and related Restricted Property to the Corporation.
7.Adjustments Upon Specified Events. Upon the occurrence of certain events relating to the Corporation’s stock contemplated by Article XV of the Plan, the Committee shall make adjustments in accordance with such section in the number and kind of securities that may become vested under the Award. If any adjustment shall be made under Article XV of the Plan or an event described in Section 15.4 of the Plan shall occur and the Shares of Restricted Stock are not fully vested upon such event or prior thereto, the restrictions applicable to such Shares of Restricted Stock shall continue in effect with respect to any consideration, property or other securities (the “Restricted Property” and, for the purposes of this Award Agreement, “Restricted Stock” shall include “Restricted Property”, unless the context otherwise requires) received in respect of such Restricted Stock. Such Restricted Property shall vest at such times and in such proportion as the Shares of Restricted Stock to which the Restricted Property is attributable vest, or would have vested pursuant to the terms hereof if such Shares of Restricted Stock had remained outstanding.
8.Tax Withholding. The Corporation or any Affiliate shall be entitled to require a cash payment by or on behalf of the Participant (including, without limitation, subject to such procedures as the Committee may adopt, pursuant to a broker-assisted “cashless” arrangement with a third party who facilitates the sale of Shares deliverable upon any payment of Restricted Stock) and/or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to the grant, vesting or payment of the Restricted Stock in whole or in part. The Corporation may, in its discretion, agree that it will, upon any payment of Shares in respect of the Restricted Stock, automatically reduce the number of Shares to be delivered by (or otherwise reacquire) the appropriate number of whole Shares, valued at their then fair market value, to satisfy any withholding obligations of the
    10
OMM_US:79990995.3


Corporation or any Affiliate with respect to such distribution of Shares at the applicable withholding rates.6
9.Notices. Any notice to be given under the terms of this Award Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Participant at the Participant’s last address reflected on the Corporation’s records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be given only when received, but if the Participant is no longer an employee of or in service to the Corporation, shall be deemed to have been duly given by the Corporation when enclosed in a properly sealed envelope addressed as aforesaid, registered or certified, and deposited (postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.
10.Plan. The Award and all rights of the Participant under this Award Agreement are subject to the terms and conditions of the provisions of the Plan, incorporated herein by reference. The Participant agrees to be bound by the terms of the Plan and this Award Agreement. The Participant acknowledges having read and understanding the Plan, the Prospectus for the Plan, and this Award Agreement. Unless otherwise expressly provided in other sections of this Award Agreement, provisions of the Plan that confer discretionary authority on the Board or the Committee do not (and shall not be deemed to) create any rights in the Participant unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Committee so conferred by appropriate action of the Board or the Committee under the Plan after the date hereof.
11.Entire Agreement. This Award Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Award Agreement may be amended pursuant to Article XVI of the Plan. Such amendment must be in writing and signed by the Corporation. The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Participant hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.
12.Counterparts; Electronic Signature. This Award Agreement may be signed and/or transmitted in one or more counterparts by facsimile, e-mail of a .PDF, .TIF, .GIF, .JPG or similar attachment or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties, it being understood that all parties need not sign the same counterpart, and that any such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party’s hand-written signature. To the extent a party signs this Award Agreement using electronic signature technology, by clicking “sign,” “accept,” or similar acknowledgement of acceptance, such party is signing this Award Agreement electronically, and electronic signatures appearing on this Award
6 For Section 16 officers, Section 8 to read as follows: “Unless (1) otherwise determined by the Committee at any time after the Grant Date or (2) the Participant has previously notified the Chief Financial Officer of the Corporation (or his designee) that he or she will pay the amount of any applicable federal, state or local tax law withholding taxes directly to the Corporation in cash, upon any payment of Shares in respect of the Restricted Stock, the Corporation shall automatically reduce the number of Shares to be delivered by (or otherwise reacquire) the appropriate number of whole Shares, valued at their then fair market value, to satisfy any withholding obligations of the Corporation or any Affiliate with respect to such distribution of Shares at the applicable withholding rates. In the event that the Committee determines not to satisfy, or the Corporation cannot legally satisfy, such withholding obligations by such reduction of Shares, or in the event of a cash payment or any other withholding event in respect of the Restricted Stock, the Corporation or any Affiliate shall be entitled to require a cash payment by or on behalf of the Participant and/or to deduct from other compensation payable to the Participant any sums required by federal, state or local tax law to be withheld with respect to such distribution or payment.”
    11
OMM_US:79990995.3


Agreement (or entered as to this Award Agreement using electronic signature technology) shall be treated, for purposes of validity, enforceability and admissibility, the same as hand-written signatures.
13.Section Headings. The section headings of this Award Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.
14.Governing Law. This Award Agreement shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to conflict of law principles thereunder.
15.Clawback Policy. The Restricted Stock is subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require repayment or forfeiture of the Restricted Stock or other cash or property received with respect to the Restricted Stock (including any value received from a disposition of the Restricted Stock).
16.No Advice Regarding Award. The Participant is hereby advised to consult with his or her own tax, legal and/or investment advisors with respect to any advice the Participant may determine is needed or appropriate with respect to the Restricted Stock (including, without limitation, to determine the foreign, state, local, estate and/or gift tax consequences with respect to the Award, the advantages and disadvantages of making an election under Section 83(b) of the Code with respect to the Award, and the process and requirements for such an election). Neither the Corporation nor any of its officers, directors, affiliates or advisors makes any representation (except for the terms and conditions expressly set forth in this Award Agreement) or recommendation with respect to the Award or the making an election under Section 83(b) of the Code with respect to the Award. In the event the Participant desires to make an election under Section 83(b) of the Code with respect to the Award, it is the Participant’s sole responsibility to do so timely. Except for the withholding rights set forth in Section 8 above, the Participant is solely responsible for any and all tax liability that may arise with respect to the Award.
[Remainder of page intentionally left blank]

    12
OMM_US:79990995.3


IN WITNESS WHEREOF, the Corporation has caused this Award to be executed on its behalf by a duly authorized officer and the Participant has hereunto set his or her hand as of the date and year first above written.
INDIE SEMICONDUCTOR, INC.,
a Delaware corporation

By:    
Print Name:    
Its:    
PARTICIPANT
    
Signature
    
Print Name

    13
OMM_US:79990995.3


CONSENT OF SPOUSE
In consideration of the execution of the foregoing Restricted Stock Award Agreement by indie Semiconductor, Inc., I, _____________________________, the spouse of the Participant therein named, do hereby join with my spouse in executing the foregoing Restricted Stock Award Agreement and do hereby agree to be bound by all of the terms and provisions thereof and of the Plan.
Dated:    _____________, 2021
    
Signature of Spouse
    
Print Name
    14
OMM_US:79990995.3


EXHIBIT A

STOCK POWER

FOR VALUE RECEIVED and pursuant to that certain Restricted Stock Award Agreement between indie Semiconductor, Inc., a Delaware corporation (the “Corporation”), and the individual named below (the “Individual”) dated as of _____________, ____, the Individual, hereby sells, assigns and transfers to the Corporation, an aggregate ________ Shares of the Corporation, standing in the Individual’s name on the books of the Corporation and represented by stock certificate number(s) _____________________________________________ to which this instrument is attached, and hereby irrevocably constitutes and appoints _________________ ____________________________________ as his or her attorney in fact and agent to transfer such Shares on the books of the Corporation, with full power of substitution in the premises.
Dated _____________, ________
    
Signature
    
Print Name
(Instruction: Please do not fill in any blanks other than the signature line. The purpose of the assignment is to enable the Corporation to exercise its sale/purchase option set forth in the Restricted Stock Award Agreement without requiring additional signatures on the part of the Individual.)

OMM_US:79990955.3


________________________________________________________________________________________
Notice of Grant of Stock Option
and
Terms and Conditions of Stock Option
________________________________________________________________________________________
Grantee:Award Number:
Address:ID:
Plan:2021 Omnibus Equity
Incentive Plan
Type of Grant:        ☐ Nonqualified Stock Option
        ☐ Incentive Stock Option
________________________________________________________________________________________
Effective [___________] (the “Award Date”), you (the “Grantee”) have been granted [an incentive][a nonqualified] stock option (the “Option”) to buy [________] Shares7 of Common Stock of indie Semiconductor, Inc. (the “Corporation”) at a price of $[_______] per Share1 (the “Exercise Price”).

The aggregate Exercise Price of the Shares subject to the Option is $[__________].1

[The Option will become vested as to 25% of the total number of Shares subject to the Option on each of the first, second, third and fourth anniversaries of the Award Date.1, 8]

The Option will expire on [_________] (the “Expiration Date”).1, 2
____________________________________________________________________________________
By your signature and the Corporation’s signature below, you and the Corporation agree that the Option is granted under and governed by the terms and conditions of the Corporation's 2021 Omnibus Equity Incentive Plan (the “Plan”) and the Terms and Conditions of Stock Option (the “Terms”), which are attached and incorporated herein by this reference. This Notice of Grant of Stock Option, together with the Terms, will be referred to as your Option Agreement. The Option has been granted to you in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to you. Capitalized terms are defined in the Plan if not defined herein or in the Terms. You acknowledge receipt of a copy of the Terms and the Plan.


INDIE SEMICONDUCTOR, INC.,
a Delaware corporation


By:__________________________________

Print Name:___________________________

Its:__________________________________
GRANTEE



______________________________________
Signature


______________________________________
Print Name
____________________________________    ______________________________________
Date    Date                    
7 Subject to adjustment under Article XV of the Plan.
8 Subject to early termination under Section 5 of the Terms and Section 15.4 of the Plan.
OMM_US:79990955.3


INDIE SEMICONDUCTOR, INC.
2021 OMNIBUS EQUITY INCENTIVE PLAN
TERMS AND CONDITIONS OF STOCK OPTION
General.
These Terms and Conditions of Stock Option (these “Terms”) apply to a particular stock option (the “Option”) if incorporated by reference in the Notice of Grant of Stock Option (the “Grant Notice”) corresponding to that particular grant. The recipient of the Option identified in the Grant Notice is referred to as the “Grantee.” The per Share exercise price of the Option as set forth in the Grant Notice is referred to as the “Exercise Price.” The effective date of grant of the Option as set forth in the Grant Notice is referred to as the “Award Date.” The exercise price and the number of Shares covered by the Option are subject to adjustment under Article XV of the Plan.
The Option was granted under and subject to the indie Semiconductor 2021 Omnibus Equity Incentive Plan (the “Plan”). Capitalized terms are defined in the Plan if not defined herein. The Option has been granted to the Grantee in addition to, and not in lieu of, any other form of compensation otherwise payable or to be paid to the Grantee. The Grant Notice and these Terms are collectively referred to as the “Option Agreement” applicable to the Option.
Vesting; Limits on Exercise; Incentive Stock Option Status.
The Option shall vest and become exercisable in percentage installments of the aggregate number of Shares subject to the Option as set forth on the Grant Notice. The Option may be exercised only to the extent the Option is vested and exercisable.
Cumulative Exercisability. To the extent that the Option is vested and exercisable, the Grantee has the right to exercise the Option (to the extent not previously exercised), and such right shall continue, until the expiration or earlier termination of the Option.
No Fractional Shares. Fractional Share interests shall be disregarded, but may be cumulated.
Minimum Exercise. No fewer than 100 Shares (subject to adjustment under Article XV of the Plan) may be purchased at any one time, unless the number purchased is the total number at the time exercisable under the Option.
ISO Status. The Option [is][is not] intended as an incentive stock option within the meaning of Section 422 of the Code (an “ISO”).
ISO Value Limit. If the aggregate fair market value of the Shares with respect to which ISOs (whether granted under the Option or otherwise) first become exercisable by the Grantee in any calendar year exceeds $100,000, as measured on the applicable Award Dates, the limitations of Section 7.3 of the Plan shall apply and to such extent the Option will be rendered a nonqualified stock option.
Continuance of Employment/Service Required; No Employment/Service Commitment.
    The vesting schedule applicable to the Option requires continued employment or service through each applicable vesting date as a condition to the vesting of the applicable installment of the Option and the rights and benefits under this Option Agreement. Employment or service for only a portion of the vesting period, even if a substantial portion, will not entitle the Grantee to any proportionate vesting or avoid or mitigate a termination of rights and benefits upon or following a termination of employment or services as provided in Section 5 below or under the Plan.
OMM_US:79990955.3


    Nothing contained in this Option Agreement or the Plan constitutes a continued employment or service commitment by the Corporation or any of its Affiliates, affects the Grantee’s status, if he or she is an employee, as an employee at will who is subject to termination without cause, confers upon the Grantee any right to remain employed by or in service to the Corporation or any Affiliate, interferes in any way with the right of the Corporation or any Affiliate at any time to terminate such employment or service, or affects the right of the Corporation or any Affiliate to increase or decrease the Grantee’s other compensation. Nothing in this Option Agreement, however, is intended to adversely affect any independent contractual right of the Grantee without his/her consent thereto.
Method of Exercise of Option.
The Option shall be exercisable by the delivery to the Secretary of the Corporation (or such other person as the Committee may require pursuant to such administrative exercise procedures as the Committee may implement from time to time) of:
a written notice stating the number of Shares to be purchased pursuant to the Option or by the completion of such other administrative exercise procedures as the Committee may require from time to time,
payment in full for the Exercise Price of the Shares to be purchased in cash, check or by electronic funds transfer to the Corporation;
any written statements or agreements requested by the Corporation or one of its Affiliates to provide assurances or representations as the Committee deems necessary or desirable to assure compliance with all applicable legal and accounting requirements; and
satisfaction of the tax withholding provisions of Section 17.3 of the Plan.
The Committee also may, but is not required to, authorize a non-cash payment alternative by one or more of the following methods (subject in each case to compliance with all applicable laws, rules, regulations and listing requirements and further subject to such rules as the Committee may adopt as to any such payment method):
notice and third-party payment in such manner as may be authorized by the Committee;
in Shares already owned by the Grantee, valued at their fair market value (as determined under the Plan) on the exercise date;
a reduction in the number of Shares otherwise deliverable to the Grantee (valued at their fair market value on the exercise date, as determined under the Plan) pursuant to the exercise of the Option; or
a “cashless exercise” with a third party who provides simultaneous financing for the purposes of (or who otherwise facilitates) the exercise of the Option.
If the Option is intended to be an ISO, the Option will qualify as an ISO only if it meets all of the applicable requirements of the Code. The Option may be rendered a nonqualified stock option if the Committee permits the use of one or more of the non-cash payment alternatives referenced above.
Early Termination of Option.
Expiration Date. Subject to earlier termination as provided below in this Section 5, the Option will terminate on the “Expiration Date” set forth in the Grant Notice (the “Expiration Date”).
OMM_US:79990955.3


Possible Termination of Option upon Certain Corporate Events. The Option is subject to termination in connection with certain corporate events as provided in Section 15.4 of the Plan.
Termination of Option upon a Termination of Grantee’s Employment or Services. Subject to earlier termination on the Expiration Date of the Option or pursuant to Section 5.2 above, if the Grantee ceases to be employed by or ceases to provide services to the Corporation or an Affiliate, the following rules shall apply (the last day that the Grantee is employed by or provides services to the Corporation or an Affiliate is referred to as the Grantee’s “Severance Date”):
other than as expressly provided below in this Section 5.3, (a) the Grantee will have until the date that is 3 months after his or her Severance Date to exercise the Option (or portion thereof) to the extent that it was vested on the Severance Date, (b) the Option, to the extent not vested on the Severance Date, shall terminate on the Severance Date, and (c) the Option, to the extent exercisable for the 3-month period following the Severance Date and not exercised during such period, shall terminate at the close of business on the last day of the 3-month period;
if the termination of the Grantee’s employment or services is the result of the Grantee’s death or Total and Permanent Disability, (a) the Grantee (or his beneficiary or personal representative, as the case may be) will have until the date that is 12 months after the Grantee’s Severance Date to exercise the Option (or portion thereof) to the extent that it was vested on the Severance Date, (b) the Option, to the extent not vested on the Severance Date, shall terminate on the Severance Date, and (c) the Option, to the extent exercisable for the 12-month period following the Severance Date and not exercised during such period, shall terminate at the close of business on the last day of the 12-month period;
if the Grantee’s employment or services are terminated by the Corporation or an Affiliate for Cause, the Option (whether vested or not) shall terminate on the Severance Date.
In all events the Option is subject to earlier termination on the Expiration Date of the Option or as contemplated by Section 5.2. The Committee shall be the sole judge of whether the Grantee continues to render employment or services for purposes of this Option Agreement.
Notwithstanding any post-termination exercise period provided for herein or in the Plan, if the Option is intended to be an ISO, the Option will qualify as an ISO only if it is exercised within the applicable exercise periods for ISOs under, and meets all of the other requirements of, the Code. If the Option is not exercised within the applicable exercise periods for ISOs or does not meet such other requirements, the Option will be rendered a nonqualified stock option.
Non-Transferability.
The Option and any other rights of the Grantee under this Option Agreement or the Plan are nontransferable and exercisable only by the Grantee, except as set forth in Section 17.5 of the Plan.
Notices.
Any notice to be given under the terms of this Option Agreement shall be in writing and addressed to the Corporation at its principal office to the attention of the Secretary, and to the Grantee at the Grantee’s last address reflected on the Corporation’s records, or at such other address as either party may hereafter designate in writing to the other. Any such notice shall be given only when received, but if the Grantee is no longer an employee of or in service to the Corporation, shall be deemed to have been duly given by the Corporation when enclosed in a properly sealed envelope addressed as aforesaid, registered or certified, and deposited
OMM_US:79990955.3


(postage and registry or certification fee prepaid) in a post office or branch post office regularly maintained by the United States Government.
Plan.
The Option and all rights of the Grantee under this Option Agreement are subject to the terms and conditions of the Plan, incorporated herein by this reference. The Grantee agrees to be bound by the terms of the Plan and this Option Agreement. The Grantee acknowledges having read and understanding the Plan, the Prospectus for the Plan, and this Option Agreement. Unless otherwise expressly provided in other sections of this Option Agreement, provisions of the Plan that confer discretionary authority on the Board or the Committee do not and shall not be deemed to create any rights in the Grantee unless such rights are expressly set forth herein or are otherwise in the sole discretion of the Board or the Committee so conferred by appropriate action of the Board or the Committee under the Plan after the date hereof.
Entire Agreement.
This Option Agreement and the Plan together constitute the entire agreement and supersede all prior understandings and agreements, written or oral, of the parties hereto with respect to the subject matter hereof. The Plan and this Option Agreement may be amended pursuant to Article XVI of the Plan. Such amendment must be in writing and signed by the Corporation. The Corporation may, however, unilaterally waive any provision hereof in writing to the extent such waiver does not adversely affect the interests of the Grantee hereunder, but no such waiver shall operate as or be construed to be a subsequent waiver of the same provision or a waiver of any other provision hereof.
Governing Law.
This Option Agreement (including the Notice) shall be governed by and construed and enforced in accordance with the laws of the State of Delaware without regard to conflict of law principles thereunder.
Effect of this Agreement.
Subject to the Corporation’s right to terminate the Option pursuant to Section 15.4 of the Plan, this Option Agreement shall be assumed by, be binding upon and inure to the benefit of any successor or successors to the Corporation.
Counterparts; Electronic Signature.
This Option Agreement may be signed and/or transmitted in one or more counterparts by facsimile, e-mail of a .PDF, .TIF, .GIF, .JPG or similar attachment or using electronic signature technology (e.g., via DocuSign or similar electronic signature technology), all of which will be considered one and the same agreement and will become effective when one or more counterparts have been signed by each of the parties hereto and delivered to the other parties, it being understood that all parties need not sign the same counterpart, and that any such signed electronic record shall be valid and as effective to bind the party so signing as a paper copy bearing such party’s hand-written signature. To the extent a party signs this Option Agreement using electronic signature technology, by clicking “sign,” “accept,” or similar acknowledgement of acceptance, such party is signing this Option Agreement electronically, and electronic signatures appearing on this Option Agreement (or entered as to this Option Agreement using electronic signature technology) shall be treated, for purposes of validity, enforceability and admissibility, the same as hand-written signatures.
Section Headings.
The section headings of this Option Agreement are for convenience of reference only and shall not be deemed to alter or affect any provision hereof.
OMM_US:79990955.3


Clawback Policy.
The Option is subject to the terms of the Corporation’s recoupment, clawback or similar policy as it may be in effect from time to time, as well as any similar provisions of applicable law, any of which could in certain circumstances require forfeiture of the Option and repayment or forfeiture of any Shares or other cash or property received with respect to the Option (including any value received from a disposition of the Shares acquired upon exercise of the Option).
No Advice Regarding Grant.
The Grantee is hereby advised to consult with his or her own tax, legal and/or investment advisors with respect to any advice the Grantee may determine is needed or appropriate with respect to the Option (including, without limitation, to determine the foreign, state, local, estate and/or gift tax consequences with respect to the Option and any Shares that may be acquired upon exercise of the Option). Neither the Corporation nor any of its officers, directors, affiliates or advisors makes any representation (except for the terms and conditions expressly set forth in this Option Agreement) or recommendation with respect to the Option. Except for the withholding rights contemplated by Section 4 above and Section 17.3 of the Plan, the Grantee is solely responsible for any and all tax liability that may arise with respect to the Option and any Shares that may be acquired upon exercise of the Option.


OMM_US:79990955.3
Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Donald McClymont, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of indie Semiconductor, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

1.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

2.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

3.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

4.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

1.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

2.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


November 10, 2022
/s/ Donald McClymont
Date
Donald McClymont
Chief Executive Officer

Exhibit 31.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) AND RULE 15d-14(a)
OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED

I, Thomas Schiller, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of indie Semiconductor, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

1.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; and

2.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and

3.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

4.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

1.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

2.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.



November 10, 2022
/s/ Thomas Schiller
Date
Thomas Schiller
Chief Financial Officer & EVP of Strategy

Exhibit 32
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
AND CHIEF FINANCIAL OFFICER PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of indie Semiconductor, Inc. (the "Company") on Form 10-Q for the quarter ended September 30, 2022 as filed with the Securities and Exchange Commission (the "Report"), we, Donald McClymont, Chief Executive Officer of the Company, and Thomas Schiller, Chief Financial Officer and EVP of Strategy of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to our knowledge: (1). The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and (2). The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Donald McClymont
Donald McClymont
Chief Executive Officer
/s/ Thomas Schiller
Thomas Schiller
Chief Financial Officer and EVP of Strategy
November 10, 2022